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ABSTRACT 
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THERAPEUTIC ACTIONS OF ANTIDEPRESSANTS 
Ali Alrumaih 
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Following decades of research on stress and its impact on behaviour, it is now 
widely accepted that selective psycho-pathologies, in particular clinical 
depression are more prevalent in humans with prior history of life-stress events. 
Interest in stress has led to questions about how it might affect the physiology 
and behaviour of animals exposed indirectly during gestational development. 
Not unexpectedly gestational stress has been shown to affect the offspring in 
several ways: endocrine responses to stress are elevated, fear, arousal and 
affective disturbances are all subject to vary if the pregnant animal is subjected 
to periods of aversive stimulation. 
Beginning in 1997, Michael Meaney of McGill University produced a series of 
publications suggesting that peri-natal events influence offspring and infant 
development, not via physical discomfort or physiological disturbance, but does 
so through modifications of maternal behaviour. Highly nurturant mothers (those 
who engage in active arched-back nursing (ABN), and spend more time licking 
and grooming (L/G) their pups), programme their offspring with improved 
cognitive abilities, decreased anxiety and fear, and reduced HPA axis hormone 
secretion. Low-nurturant mothers, who engage in less ABN and less L/G, tend 
ii 
 
to programme the opposite responses in their offspring. Our initial foray into this 
field was to investigate if gestational stress might also produce responses in the 
offspring via changes in maternal behaviour, and indeed ABN and L/G were 
reduced in dams which were subjected to gestational stress. 
We queried why stressed Dams would be less maternal towards their infants, 
and tested gestationally-stressed Dams in the Porsolt test for depressive-like 
behaviour. Our results suggested that these stressed Dams were actually 
depressed and this resulted in less maternal behaviour. Human mothers with 
depression are also less maternal and have been shown to divest themselves 
of infant care much like our prenatally-stressed Dams. On this basis we have 
proposed that gestational stress induced decrements in maternal behaviour 
represent a novel rat model for postnatal depression with face and construct 
validities.  
In the present work we have attempted to replicate the findings of Smythe‘s 
group (Smith et al., 2004), and have investigated the potential for 
antidepressants to alter the influence of gestational stress on maternal 
behaviours and depressive-like response, and whether or not the offspring‘ are 
modified by maternal treatment with ant-depressants. 
Approximately 140 time-mated, lister hooded rats were generated in house, and 
subjected to gestational stress on days 10-20 (1hr restraint/day) or remained 
undisturbed in their home cages. Following birth, cohorts of control and 
stressed Dams were administered vehicle or an antidepressant (imipramine 
15mg/kg; or sertraline 10mg/kg) once daily until postnatal day 10. 
We assessed maternal Porsolt activity, nurturance (ABN, L/G, nest building) 
and anxiety-like behaviour in the elevated plus maze (EPM). Representative 
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offspring of each Dam‘s treatment conditions were maintained post weaning 
and assessed in the Porsolt and EPM to determine if any changes in maternal 
behaviour elicited by the antidepressants altered their behavioural 
programming. 
Our findings confirm that Dams show depressive-like symptoms following 
gestational stress, and that administration of antidepressants to the Dams 
reduces depressive-like behaviour and increased maternal care. 
We propose that rat gestational stress is a putative model for human postnatal 
depression. Prenatal stress effects on maternal behaviour in the rat Dam 
represent a novel, and innovative model for human postnatal depression. 
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CHAPTER ONE: 
INTRODUCTION 
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1. INTRODUCTION 
1.1 STRESS OVERVIEW 
 
           Every day human beings experience various challenges, consciously or 
unconsciously that are often referred to as ‗stress‘. These challenges may affect 
us physiologically or psychologically; or as a combination of both. Physical 
stressors include restraint, heat, cold, noise, electric foot shock, and swimming.  
Identifying and defining stress scientifically is a challenging task. Many 
definitions and ideas characterising stress have been accepted but the most 
notable definition originates with Hans Selye, often considered the father of 
modern stress research. Selye (1956) defined stress in physico-mechanistic 
terms as ―the rate of wear and tear in the body" such as the tiredness 
experienced after a day of strenuous work, feeling anxious or becoming ill. 
These all create sensations of stress. Until recently the concept of stress had 
been left unaltered due to the lack of identifiable markers to measure it as well 
as the lack of metrics to assess its impact on humans. Realising that, stress is 
not only an adaptive reaction but also impacts individuals differently. 
Chrousos et al. (1992) reported that Thomas Sydenham (1665) suggested that 
an individual‘s adaptive response to such forces could itself be capable of 
producing pathological changes (Chrousos, 1992).  
Claude Bernard (1813–78) pioneered the doctrine of stability of milieu interieur 
otherwise known as homeostasis (Selye, 1973b). In the middle of the Twentieth 
Century, Hans Selye and Walter Cannon both proposed concepts of stress and 
discussed the relationship between diseases and stress reactivity with respect 
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to homeostasis (Rosmond, 2005). Walter Cannon (1871–1945), in his 1929 
report promoted the concept of physiologic organisation and regulations 
involved in stress and homeostasis. Homeostasis can be defined as the 
maintenance of steady state conditions in biological systems or as the 
regulation of optimal conditions the body needs to maintain consistent 
functioning in biological systems e.g. nervous system, endocrine system, 
muscular system, circulatory system, reproductive system, digestive system 
lymphatic system, respiratory system and skeletal system by means of 
automatic mechanisms (Chrousos, 2009). It has been proposed that feedback 
systems act to buffer influences (stressors) that tend towards disequilibrium. In 
order to maintain homeostasis, the body has internal mechanisms to maintain 
constant functioning and equilibrium of these systems at a stable state. Once 
the individuals are exposed to different challenges, the body reacts to each of 
these challenges by adjusting its different physiological systems in order to 
recover from these challenges. For example, the body releases more waste 
fluid by excessive urination and sweating when an organism is ―under stress‖. 
To counteract this effect, increased water intake; fluid regulation is required to 
maintain body equilibrium (Cannon, 1939; Chrousos, 2009).  
Cannon in his pioneering work explored the sympathetic-parasympathetic 
nervous system response to an immediate stressor. Individuals responded to 
danger through Sympathetic Nervous System (SNS) arousal, causing 
significantly increasing respiration rate and heart rate. The body‘s 
compensatory response involves either reducing SNS activity or increasing 
parasympathetic nervous system as counter-activity. Hans Selye published his 
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synthetic theory of the General Adaptation Syndrome (GAS) and diseases of 
adaptation (Selye, 1946). He defined GAS as the "physiological mechanism 
which raises the resistance to damage‖ and proposed a three-stage reaction to 
stress; The first stage is an alarm reaction which is then followed by a 
resistance reaction and concludes with an exhaustion stage. Importantly, Selye 
characterised the release of hormones (glucocorticoids) from the adrenal cortex 
and the role of medullary hormones (adrenaline, noradrenaline) in mediating 
these three stages of response (Selye, 1973a).  
Selye (1956) further defined stress as responses to demands placed on the 
body. Although numerous other definitions defining stress also exist, perhaps 
the most notable is by Burchfield (1979). Burchfield specified that psychological 
factors as well as physical factors could play an important contributing factor to 
stress (Burchfield, 1979).  
John Mason (Mason, 1968; Mason, 1975) pointed out that stress is triggered by 
activating the pituitary-adrenocortical system and the most potent stimuli for 
activating the pituitary-adrenocortical system are; (a) the physiological and 
psychological reactions to perceived internal states of the organism; (b) natural 
disasters, trauma and major life events, i.e. external factors; and (c) early life 
experiences such as poverty, poor education and poor social conditions through 
infancy and childhood (Mason, 1975; Mason, 1968).  
Sterling and Eyer (1988) studied stress and introduced the concept of allostasis, 
a process by which the body responds to stressors thus allowing it to regain its 
basal activity (Sterling and Eyer, 1988). McEwen and Stellar (1993) broadened 
this concept further and promoted allostasis as a process that maintained 
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stability through change and by enabling adaptation (McEwen and Stellar, 1993; 
Flier et al., 1998; McEwen, 1998; McEwen, 2000; Seeman et al., 2001; 
McEwen, 2007). 
 
1.1.1 ANATOMY AND PHYSIOLOGY OF THE STRESS SYSTEM 
The central components of the stress system are located in the hypothalamus 
and the brain stem, the neural systemic sympathetic-adrenomedullary (SAM) 
and the endocrine hypothalamic-pituitary-adrenal (HPA) axis (Figure 1-1). 
These systems act to receive information from both internal and external origins 
and compute an appropriate response. Their central regulators and peripheral 
end products include catecholamines (adrenaline and noradrenaline), 
corticotropin releasing hormone (CRF) and glucocorticoids; these are key 
hormones in the maintenance and re-establishment of cardiovascular, 
metabolic, behavioural and immune homeostasis (Fink, 2000). 
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1.1.2 SUBTYPES OF STRESS 
 
The fact that there are different types of stress complicate the issue of stress 
management. Broadly, stress can be divided into two main categories: acute 
and chronic. 
  
Figure ‎1-1: Schematic showing the main parts of the stress system. 
Hypothalamic-Pituitary-Adrenal (HPA) axis and the sympathetic 
adrenomedullary systems (SAM).  
PVN=paraventricular nucleus; CRF=corticotropin releasing factor; 
ACTH=adrenocorticotrophic hormone; APG=anterior pituitary gland; 
CNS=central nervous system; PNS=peripheral nervous system; 
NA=noradrenaline; AD=adrenaline; DA=dopamine. 
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1.1.2.1 Acute 
 
Acute stress is one of the most common forms of stress reactivity. It arises from 
a transient and brief exposure to an immediately demanding event. Responses 
to acute stress are normal and healthy, and generally assist the individual 
during the stressful event to mount and maintain a response. Examples might 
include meeting deadlines, missing a train or falling over.  
Complexity emerges when considering the magnitude and consequences which 
arise from an acute stress episode. Many acute stressors are unexpected and 
undesired by the individual. The examples above illustrate unpredictable and 
negative acute stressors where controls over the stressful events are beyond 
the individual‘s powers of influence. These stressors may cause brief distress or 
fear and highlight the importance of a person‘s perceptions of such events. If we 
extend our examples we may consider how an individual perceives a visit to the 
dentist. While consciously acknowledging the importance of oral and dental 
health, routine procedure such as a cleaning and fillings may cause pain. This 
creates a sense of dread and temporary helplessness in the individual. Whilst 
the event itself lasts only briefly, the process of attending the clinic, the visual 
and auditory cues and the presence of other patients exhibiting visible worry 
can become associated with each and every subsequent visit to the dentist. 
This shows that the acute stressors and the individual‘s reaction to them are 
influenced by previously learned associations and anticipatory fears (Mack et 
al., 1998; Lerner et al., 2007). Thus, one‘s perception of a transient event 
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includes prior experience and memory and therefore the actual physical event 
and pain of dental procedures may provoke these feelings.  
However, other events may also elicit acute stress responses but can be 
perceived positively and entirely under the control of the individual especially if 
the individual engages in the activity deliberately. For example, parachuting is a 
sporting/thrill-seeking behaviour. The individual makes a conscious decision to 
participate in this activity. It brings with it a heightened sense of excitement and 
anticipation; the exhilaration of free-falling and great relief/enjoyment upon a 
safe and successful landing. The event is planned and predicted with a 
diminished degree of unknowns involved. This form of acute stress is termed  
positive stress and can be a source of great joy, engagement with a shared 
group experience, and can positively broaden an individual‘s experiential 
repertoire (Nelson and Cooper, 2005; Little et al., 2007). 
Both negative and positive stressors produce many identical physiological 
reactions involving the sympathetic nervous system and HPA axis activity. 
Psychologically, both types of stressors may produce equivalent degrees of fear 
and apprehension. The crucial important distinction between them lies in the 
notion of how the individual perceives the stress and reacts to it upon re-
exposure: if it is negative and unpleasant it will be avoided; if it is positive and 
reinforcing it will be welcomed or indeed even sought after (Nelson and Cooper, 
2005; Little et al., 2007). 
Levels of control and predictability become markers for positive and negative 
stressors. Minimal identifiable harm to the individual follows any type of acute 
stress. This is not the case when the stress is chronic in nature, particularly for 
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negative stressors which may underpin deleterious consequences for 
individuals, as will be described below (Mack et al., 1998; Nelson and Cooper, 
2005; Little et al., 2007).   
Acute stress mechanism 
When an acute stress occurs, impulses to the hypothalamus prompt the 
production of corticotropin-releasing factor (CRF) and vasopressin (AVP) which 
in turn activates the release of adrenocorticotrophic hormone (ACTH), and 
ACTH leads to the rapid mobilization of glucocorticoids (GCs). If the stress is 
protracted, the HPA axis generally adapts to it such that the ACTH and GCs 
return to baseline levels quickly. In rats, it has been shown that the response of 
GCs to stress in later life can be modified by neonatal handling, which appears 
to increase the efficiency of negative-feedback control of the stress response, 
protecting the animal from the potentially damaging effects of GCs sustained 
exposure (Fink, 2000). This appears to occur as a result of augmented GC 
receptor densities in the hippocampus which promote greater negative 
feedback control over the HPA axis (Meaney et al., 1985). 
 
1.1.2.2 Chronic stress 
 
Chronic stress is generally viewed negatively. This form of stress occurs day 
after day, year after year and is thought to result in pathologies (Selye, 1946). 
Logically it is the stress of poverty, of dysfunctional families, of feeling trapped 
in abusive relationships or of struggling to find suitable and satisfying 
employment (Selye, 1956).  
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Chronic stress arises when a person fails to arrive at a solution for miserable 
situations (Selye, 1956). It is the stress of persisting demands and pressures for 
seemingly indefinite periods of time. The affected individual often gives up 
looking for solutions and places themselves at risk of various illnesses, 
diseases, or psychopathologies (Coyne and Downey, 1991; Patacchioli et al., 
2001). 
 Chronic stress mechanism 
Most animal models of chronic stress are characterized by persistent 
neuroendocrine, immunological and behavioural changes. For instance, the 
entire HPA axis is activated, the thyroid and reproductive axes are suppressed, 
growth hormone is suppressed and prolactin release is stimulated (Ottenweller, 
2000). Most studies report immune suppression after chronic stress but there 
can also be an enhanced immune function; for example, chronic stress will 
exacerbate pathologies in experimental allergic-encephalomyelitis, an 
autoimmune animal model for multiple sclerosis (Ottenweller, 2000). The 
behavioural changes that are reported include hyperarousal as indicated by 
increased startle responses, fear of novelty and decreased exploration in open 
field tasks (Ottenweller, 2000). In addition, chronic stress can inhibit spatial 
memory in the Morris Water Maze but can also enhance the acquisition of a 
classically conditioned eye-blink response (Ottenweller, 2000). Thus the effects 
on learning and memory may depend on the kind of stressor and the type of 
learning being tested. 
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Although studies conflict, with some showing activation and others attenuation 
of HPA axis function following chronic stress, most studies reveal abnormalities 
of cortisol secretory dynamics (Fink, 2000). 
Evidence suggests that during chronic stress, the CRF: AVP ratio may increase. 
This could possibly be due to differential sensitivity of the secretagogues to 
negative-feedback regulation (Scott and Dinan, 1998; Scott and Dinan, 2002; 
Dinan et al., 2004; Raadsheer et al., 2008). 
Physical or mental stress causes increased activity in the limbic system, 
especially in the region of the amygdala and hippocampus which in turn 
transmit signals to the hypothalamus. These signals cause greatly enhanced 
secretion of CRF (corticotropin releasing factor) into the hypophysial portal 
system which in turn stimulates greater release of ACTH (adrenocorticotropic 
hormone) (Swaab et al., 1992; Meaney et al., 1993; Plotsky, 2006). 
Adrenocorticotropic hormone promotes the rapid synthesis and secretion of 
adrenal cortisol/corticosterone. Impairment of the negative feedback loop at this 
stage could account for the inability of the glucocorticoid to regulate its own 
secretion during chronic stress (Chrousos et al., 1998; McEwen, 1998; 
Charmandari et al., 2005; Chrousos and Kino, 2007; Chrousos, 2009). 
 
1.2 THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS  
1.2.1 THE ROLE OF THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS  
The hypothalamo-pituitary-adrenal (HPA) axis is widely recognized and 
accepted as a key physiological system through which an organism triggers a 
response to stress. Selye (1956) defined stress as responses to demands 
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placed on the body but it can also be defined as alterations in psychological 
homeostatic processes (Burchfield, 1979). This system has a basal level of 
activity which, like many hypothalamically-regulated systems, maintains a strict 
diurnal rhythm (Spangler, 1991). 
While a notable rhythmical pattern is present in the newborn, the adult-like 
circadian rhythm of cortisol develops during the first six months and occurs in 
parallel with the 24 hour sleep-wake cycle (Spangler, 1991). There is a 
fluctuation of plasma cortisol rhythmic activity level corresponding with the 
expected rise in motor activity which reaches its peak in the morning and 
declines prior to sleep. Corticosterone (CORT) levels in nocturnal animals such 
as rodents exhibit a distinct circadian variation with peak values in the later 
portion of day followed by a nadir in the morning. This is believed to play an 
important role in their sleep-wake cycle. Enhanced corticosterone release by 
female rats compared to male rats under basal and stress conditions have been 
observed (Handa et al., 1994; Bingaman et al., 2008). It is also obvious that 
while the rhythm is under the influence of light and dark cycles, it is also 
affected by water and food intake (Krieger, 1974; Krieger and Hauser, 1978; 
Wilkinson et al., 1979; Roland et al., 2008). In rats, 20-fold differences in 
plasma levels of corticosterone concentration occur between the zenith and 
nadir over a 24-hour period. This is thought to arise from two factors: (a) a 
raised adrenal sensitivity to adrenocorticotropic hormone (ACTH); and (b) by an 
augmentative effect of corticotropine releasing factor (CRF) upon ACTH plasma 
secretion (Dallman, 1993).  
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The HPA axis shows significant changes in both threshold and magnitude of 
activation in addition to altered activity corresponding to the circadian rhythm. 
This reflects the importance of the HPA axis responses in maintaining 
homeostasis especially with respect to its impact on metabolic and 
immunological activity (Brindley, 1981; Munck et al., 1984). In evolutionary 
terms, it helps animals to enable and utilise physiological defence mechanisms 
to preserve life. CORT further stimulates the production of additional energy 
substrates through restricting insulin actions and enhancing glucagon 
production (Barseghian and Levine, 1980). Consequently, continuous exposure 
to stress induces catabolic effects upon the body. Such exposures can trigger 
specific alterations to the functioning capacities of the HPA axis. It has been 
reported that chronic activation of the HPA axis has been associated with 
hyperlipidaemia, muscle atrophy, steroid-induced diabetes, hypertension and 
central neurone loss (Meaney et al., 1983; Munck et al., 1984; Brindley and 
Rolland, 1989). 
 
1.2.1.1 The physiology of the HPA axis 
The sequential nature of HPA axis activation has been well documented in the 
adult rat. Acute stress stimulates the paraventricular nucleus (PVN) of the 
hypothalamus to increase the secretion of corticotrophin-releasing-factors 
(CRF) and arginine-vasopressin (AVP) into the capillary bed of the median 
eminence (Antoni, 1986; de Goeij et al., 1992; Whitnall, 1993; De Goeij et al., 
2008). These secretagogues act within the anterior pituitary where they 
stimulate the cleavage of pro-opiomelanocortin (POMC) into 
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adrenocorticotrophic hormone (ACTH), β-endorphin (β-END), α-melanocyte 
stimulating hormone (a-MSH) and various enkephalin-related peptides (for 
review, see Meaney et al. 1993). Following release into the circulatory system, 
ACTH acts on the adrenal gland to upregulate the rapid synthesis and secretion 
of CORT (Gunnar and Quevedo, 2007). The precise roles of the other POMC 
fragments have yet to be elucidated. CRF neurones are widely distributed in the 
Central Nervous System (CNS) including regions other than the hypothalamus, 
such as the prefrontal and cingulate cortices, the central nucleus of the 
amygdala (CeA) and the hippocampus (Owens and Nemeroff, 1991; 
Sawchenko et al., 1993; Champagne et al., 1998; Silverman et al., 2008). 
Interestingly, CRF perikarya are localised in brainstem regions including the 
locus coeruleus (LC), the dorsal raphe nucleus (DRN) and midbrain areas such 
as the ventral tegmental area (VTA). This suggests a possible role for CRF in 
the modulation of noradrenaline (NA), serotonin (5HT) and dopamine (DA) 
projection systems, respectively (De Souza et al., 1985; Valentino et al., 1992; 
Champagne et al., 1998; Valentino and Wehby, 2008). Evidence has led many 
to suggest that CRF influences not only endocrine, but also autonomic and 
immunological responses (Butler et al., 1990; Owens and Nemeroff, 1991; Koob 
et al., 1994; De Souza, 1995). It is therefore unsurprising that Cerebrospinal 
Fluid (CSF) levels of CRF have been shown to be asynchronous with HPA 
activity (Garrick et al., 1987), possibly a reflection of the difference between 
endocrine and non-endocrine functions of CRF systems within the CNS 
(Oldfield et al., 2008).   
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Other than the varied putative roles for CRF in neurochemical activation, it is 
established that the CRF neurones of the parvocellular region of the PVN 
represent the principle hypothalamic component of the HPA axis, i.e. the higher 
centre of control mediating the physiological stress response (Dallman et al., 
1994). In order to co-ordinate HPA axis activity with the bodies demands, the 
PVN receives numerous inputs, particularly from the dorsomedial nucleus of the 
hypothalamus and the bed nucleus of the stria terminalis (BnST) (Silverman et 
al., 1981; Forray and Gysling, 2004; Silverman et al., 2008). In addition to other 
hypothalamic and limbic inputs, the PVN also receives NA and 5HT projections 
from the brainstem (Forray and Gysling, 2004). Thus, it is very possible that the 
PVN plays a key role in integrating and coordinating autonomic, behavioural 
and neuroendocrine responses to stress (Champagne et al., 1998; Tsigos and 
Chrousos, 2002).  
1.2.1.2 Feedback mechanism of the HPA axis 
There is a plethora of literature that detail the complex feedback mechanisms 
involved in the regulation of the HPA axis. Regulation of the HPA axis is 
predominantly mediated by CORT through receptors located in various brain 
areas especially the hypothalamus, anterior pituitary and hippocampus (Wilson 
et al., 1980; Keller-Wood and Dallman, 1984; McEwen et al., 1986; De Kloet 
and Reul, 1987; Jacobson and Sapolsky, 1991; Herman and Cullinan, 1997; 
Sapolsky et al., 2002b).   
Brain cells contain two types of corticosteroid receptors: type 1 or 
Mineralocorticoid Receptors (MRs) and type 2 Glucocorticoid Receptors (GR), 
originally classified during the 1960s (McEwen et al., 1968; Gerlach and 
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McEwen, 1972; Reul and Kloet, 1985). These two receptor subtypes lie 
intracellularly and act as ligand activated transcription factors. MRs display a 
very high affinity for endogenous glucocorticoids (cortisol and corticosterone), 
whereas GRs have lower affinity for cortisol and corticosterone (Fink, 2000; 
Seckl, 2004; de Kloet et al., 2005b; Maccari and Morley-Fletcher, 2007).  
MRs are more specifically located than GRs which are scattered throughout the 
CNS and are present in both neurons and glial cells. MRs have limited 
distribution in the periphery (kidney, lymphocytes, colon) and in the limbic 
system of the brain, whereas GRs have ubiquitous expression in brain and 
periphery (Fink, 2000).  
Meijer et al. (2007) found that MRs are largely found in the limbic system 
including the hypothalamus, the amygdala and dentate gyrus and pyramidal 
cells of the hippocampus: Both GRs and MRs are expressed by hippocampal 
neurones (Table 1.1) (Meijer et al., 2007).  
   Table ‎1.1: Properties of Mineralocorticoid and Glucocorticoid receptors in the brain. 
Receptors  Affinity Locations Examples 
Mineralocorticoid 
receptors (MR)  
(type 1)  
High affinity Limbic system 
(hippocampus) 
Cortisol, 
Corticosterone 
(aldosterone) 
Glucocorticoid 
receptors (GR)   
(type 2) 
Low affinity Ubiquitous Cortisol, 
Corticosterone 
(dexamethasone,RU
486) 
 
Joels et al. (2007) suggested that MR activation is required to maintain neuronal 
integrity and a stable excitatory tone, at least in the hippocampus (Joëls et al., 
2007). Binding studies using hippocampal homogenates show that MRs have a 
6-10-fold greater affinity for CORT in comparison to GRs (Reul and Kloet, 
1985). Moreover, it is thought that this difference between the two receptor 
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subtypes in their affinity for CORT is responsible for the different level of 
occupancy of the receptor system of the hippocampus under basal conditions, 
and stress. In general, it appears that under basal conditions the MR population 
is almost 80% occupied as opposed to the 10-15% occupancy of GRs (Reul 
and Kloet, 1985; Reul et al., 1987; Meaney et al., 1988a). 
It has been hypothesized that the tonic influences of corticosterone are exerted 
via hippocampal MRs (De Kloet et al., 1998), while the additional occupancy of 
GRs with higher levels of corticosterone mediate feedback actions aimed at 
restoring disturbances in homeostasis (de Kloet and Reul, 1987). Under basal 
and stress conditions MR is involved in the regulation of the HPA axis activity in 
the CNS (de Kloet et al., 1998); however they posit two modes of negative 
feedback: (1) Due to circadian rhythms "proactive" negative feedback mediated 
via the MR maintains normal variations; and (2) "reactive" feedback operating 
via the GR serves to inhibit further secretion of ACTH and facilitate the return to 
basal levels. Dallman et al. (1989) suggested that MR may be more important in 
regulating the basal expression of adrenocorticotropin factor (ACTH) and can 
cause secretion of CRF and AVP at the trough of diurnal ACTH secretion, and 
in the regulation of the nadir ACTH release.  
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To maintain homeostatic balance, cortisol in low concentrations gives the PVN 
primarily positive feedback through MRs as well as terminating the axis‘ stress 
via negative feedback to the PVN and anterior pituitary through GRs (Steckler 
et al., 2005) (Figure 1-2). 
Corticosteroids acting through GRs have profound effects on energy 
metabolism; via GR corticosteroids activate psychological stress reactions, but 
inhibit inflammatory and immune responses, as well as the response of the HPA 
axis to stress. Importantly, GR activation generally derives energy sources from 
their catabolism of fat and proteins, ultimately liberating glucose for sustained 
metabolic responses i.e. gluconegenesis. The principle MR is aldosterone – a 
Figure ‎1-2: Hypothalamic-Pituitary-Adrenal (HPA) Axis. 
PVN=paraventricular nucleus; CRF=corticotropin releasing factor; 
ACTH=adrenocorticotrophic hormone; APG=anterior pituitary gland. 
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selectively acting steroid in other epithelial cells and kidney, which is involved in 
the regulation of electrolyte balance (De Kloet et al., 2011). 
For instance, low level CORT mediated activation of the MR enhances neuronal 
excitability e.g. long term potentiation (LTP) an effect that reverses with higher 
levels of CORT activity stimulating MR and GR (Joëls, 2008). Similarly, MR and 
GR appear to have opposite effects on anxiety modulation (Smythe et al., 
1997). 
De Kloet et al. (1999) and Joels (2001) suggested that predominant MR 
activation, as opposed to concomitant activation of MR and GR together, can 
trigger distinct and even opposite responses in, for example, cognitive function 
and neuronal excitability (de Kloet et al., 1999; Joels, 2001).  
Regulation of CRF release is the primary target for CORT-mediated feedback 
upon HPA axis activity (Conrad, 2011). Studies have shown that the levels of 
CRF and AVP messenger ribonucleic acid (mRNA) expression in the 
parvocellular region of the PVN increase following adrenalectomy and thus in 
the absence of CORT (Herman et al., 1995; Makino et al., 1995; Herman et al., 
2008). This can be reversed to normal levels following CORT administration 
(Sawchenko et al., 1984; Sawchenko, 1987; Beyer et al., 1988; Sawchenko et 
al., 1993). Interestingly, oxytocin (OXY) mRNA levels (Sawchenko and Arias, 
2006) and pro-enkephalin levels are unaffected by adrenalectomy (Tanimura 
and Watts, 1998) thus highlighting the specificity of CORT-mediated negative 
feedback towards CRF and AVP. Seemingly, hypophysectomy also induces a 
rise in CRF and AVP transcripts in the parvocellular region of the PVN, 
suggesting a loss of ACTH-mediated negative feedback (Sawchenko and Arias, 
20 
 
2006). From these findings it is apparent that both CORT and ACTH mediate 
negative feedback on CRF release (Figure 1-2).  
The hormones of the HPA axis play an important role in mediating the indirect 
regulation of activity through other brain areas in addition to direct feedback 
occurring within the HPA axis structures themselves. As a means of higher 
centre control, these regions provide an important neuronal input to the 
hypothalamus. For example, Gray and Bingaman (1996) demonstrated that a 
significant population of CRF neurones lie in the central nucleus of the 
amygdala (CeA). Stress responses in addition to autonomic activity may be 
modified through corticosteroids acting upon these neurones.  
In contrast to reducing CRF mRNA expression in the PVN, CORT increases 
CRF mRNA expression in the CeA (Swanson and Simmons, 1989).  
The regulatory influence of the hippocampus upon HPA function is well 
documented (Van Hartesveldt, 1975; Reul and Kloet, 1985; Herman et al., 
1989). Feldman and Conforti (1976) suggested that hippocampal stimulation 
inhibits both adrenocortical activity and the activity of PVN neurones projecting 
to the median eminence (Feldman and Conforti, 1976; Saphier and Feldman, 
1987). Keller-Wood, (1996) also suggested that enhanced CORT feedback at 
the hippocampus negatively controls CRF and thus ACTH secretion. 
Furthermore, in the adult rat, hippocampal lesions or fornix transections lead to 
raised basal and stress-induced levels of CORT and ACTH, in addition to 
increased CRF and AVP mRNA. This indicates the loss of a site critical to 
CORT-mediated negative feedback (Knigge and Hays, 1963; Moberg et al., 
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1971; Fischette et al., 1980; Wilson et al., 1980; Sapolsky et al., 1984; Herman 
et al., 1989; Sapolsky et al., 2002a).  
Landfield et al. (1978) clearly demonstrated the importance of the hippocampus 
in feedback control in the rodent, whereby the loss of hippocampal neurones 
with age corresponds with increasing CORT levels (Landfield et al., 1978).   
Sapolsky et al. (1986) reported that with the loss of neurones, aged rats have 
reduced numbers of hippocampal CORT receptors, corresponding with 
insensitivity to CORT-mediated negative feedback and a consequential 
hypersecretion of CORT both basally and in response to stress.  
Clinically, CORT hypersecretion and associated negative feedback insensitivity 
has been associated with behavioural deficits in aged rats including cognitive 
effects (Landfield et al., 1978; Sapolsky et al., 1985; Sapolsky et al., 2002b).   
Corticosterone at high doses has the effect of reducing the size of cytosolic GR 
populations in the hippocampus (Tornello et al., 1982; Tornello et al., 2008). 
This is consistent with the effects of chronic stress and is associated with 
negative feedback (Herman et al., 2008).  
It has been suggested that sustained elevations of circulating CORT, either by 
repeated stress or exogenous administration significantly reduces CORT 
receptor populations in the hippocampus, the amygdala and frontal cortex 
(Sapolsky et al., 1984; Tornello et al., 1982; Tornello et al., 2008), an effect not 
seen in the hypothalamus or pituitary. These findings provide strong evidence 
for a definitive role of these areas in mediating feedback upon HPA axis activity. 
Sapolsky et al. (1984) demonstrated that exogenous CORT administration has 
no greater effect in reducing receptor populations than stress alone, and thus 
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suggested the presence of a threshold. There is a notable reduction in GR 
levels one week following cessation of CORT treatment which shows the 
reversible properties of the receptors (Reul and Kloet, 1985; Reul et al., 1987; 
Dallman et al., 1989; Ratka et al., 1989; Bradbury et al., 1991; Reul et al., 
2008). There are long-term implications of CORT-mediated inhibitory effects 
upon the HPA axis due to the fluctuation of these receptor populations with 
CORT-mediated stimulation reducing and adrenalectomy increasing receptor 
populations accordingly (Sapolsky and McEwen, 1985; Reul et al., 1987; 
Brinton, 1988; Luttge et al., 1989).  
1.2.2 PATHOPHYSIOLOGICAL CHANGES IN HYPOTHALAMO-ADRENAL-
AXIS AXIS AND ITS RELATED CONSEQUENCES 
Extensive research has focused on age-related abnormalities and the HPA axis 
(Meaney et al., 1985; Seeman et al., 2001; Heine et al., 2004). In rodents, 
ageing has been associated with hypersecretion of CORT, occurring both 
basally and after stress (Sapolsky et al., 1987; Scaccianoce et al., 2008). This 
could due to the loss of hippocampal neurones which has been shown to occur 
in aged rats (Landfield et al., 1978; Sapolsky et al., 1984; Sapolsky and 
Meaney, 1986; Scaccianoce et al., 2008).  
Studies have shown a reduction in the number of hippocampal neurons and a 
reduction in dendritic branching of the remaining neurones and impaired 
synaptic plasticity when rats are exposed to high CORT levels (Sapolsky, 1993; 
Bodnoff et al., 1995; Sunanda et al., 1995). In order to reduce hippocampal 
degeneration and attenuate cognitive impairments typically seen with ageing, it 
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has been suggested that less cumulative CORT exposure throughout life may 
preserve these effects (Meaney et al., 1988a).  
In humans, older men show a reduction in sensitivity of the HPA axis compared 
to younger men. Older men exhibit a slower response of ACTH to CORT-
mediated feedback in comparison to younger men (Boscaro et al., 1998; 
Wilkinson et al., 2008). Further investigations have shown that hippocampal 
atrophy has been associated with traumatic stress, depression, ageing and 
Cushing's syndrome (Golomb et al., 1994; Bremner et al., 1995; Sheline et al., 
1996; Lupien et al., 1998b; Starkman et al., 1999).  
The clinical relevance of HPA disturbances is that they are associated with 
psychiatric disorders, in particular hypocortisolism (Stokes and Sikes, 1991; 
Heim et al., 2000). Hypocortisolism refers to a deficiency of cortisol, a reduction 
in adrenocortical secretion reactivity and enhanced negative feedback inhibition. 
This state has also been described in association with patients suffering from 
other disorders such as chronic fatigue syndrome and various stress-related 
syndromes such as Posttraumatic Stress Disorders (PTSD) (Demitrack et al., 
1991; Cleare et al., 1995).  
Two studies on chronic fatigue syndrome have found a possible therapeutic 
potential from hydrocortisone (Cleare et al, 1999) and dehydroepiandrosterone 
(DHEA) administration (Scott et al., 1999). Hypocortisolism has been reported 
to increase GR levels in lymphocytes (Yehuda et al., 1993) and increase CSF 
concentrations of CRF (Bremner et al., 1997). These findings are strikingly 
different to those associated with hypercortisolism along with other HPA axis 
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alterations, which have been recognised in depression (for review, see 
(Nemeroff, 1996).  
The impact of chronic stress on the HPA axis and sympathetic systems leading 
to hypercortisolism may also lead to factors such as anxiety, feelings of 
hopelessness and depression (Chrousos, 1992).  
With regard to the latter affective disorder, many studies have focused on its 
association with underlying HPA dysfunction. In general, the HPA axis 
abnormalities which commonly accompany depression represent a failure of 
stress adaptive processes (Chrousos GP, 1988), often expressed as raised 
HPA axis activity (Maes et al., 1991).  
In humans, major depression is frequently associated with elevated circulating 
CORT and unpaired CORT feedback (Kalin et al., 1982; Evans et al., 1983; 
Murphy, 1991). Hence, the dexamethasone suppression test, a quantifier of 
delayed CORT feedback at the pituitary level  has been adopted as a diagnostic 
tool to assess depressed patients (Carroll, 1982; Checkley, 1996).  
Feedback abnormalities of chronically-stressed animals and those of patients 
with depression bear some resemblance, such as enlargement of the pituitary 
and adrenal glands (Young et al., 1991; Nemeroff et al., 1992).  
HPA axis disturbances and its role in CORT alterations are also evident at the 
hypothalamic level. Depressed patients have been found to hypersecrete CRF 
(Gold et al., 1984; Roy et al., 1987; Owens and Nemeroff, 1993), have reduced 
density of CRF binding sites in the frontal cortex (Nemeroff et al., 1988) and a 
blunted ACTH response to CRF (Holsboer et al., 1984; Amsterdam Jd, 1987; 
Arborelius et al., 1999).  
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The exact relationship between HPA axis dysfunction and depressive 
symptomatology remains uncertain. There are similarities between chronic 
stress-mediated alterations to HPA activity and changes accompanying 
depression (Charmandari et al., 2005), yet it has not been established which is 
the cause and which is the effect, or whether are both develop simultaneously.  
 
1.2.3 STRESS AND NEURODEGENERATIVE DISORDERS 
Hypercortisolemia and hippocampal atrophy are associated with Alzheimer‘s 
disease (AD) during old age. The role of stress in memory dysfunction and AD 
pathology has logically attracted some attention. According to the glucocorticoid 
cascade hypothesis, the loss of normal negative hippocampal feedback to the 
HPA axis could lead to increased cortisol secretion and hippocampal 
degeneration in AD. It is potentially a vicious circle as an overactive HPA 
system in AD could lead to additional neuronal degeneration thereby inducing 
progressive cognitive impairment (Davis et al., 1986; Sapolsky et al., 2002a; 
Pomara et al., 2003). 
Researchers suggest that persistent HPA activation and high cortisol levels 
could lead to memory dysfunction. This is one of the major clinical findings in 
Cushing‘s disease (CD), Parkinson‘s disease (PD) and major depressive 
disorders (MDD) (Lupien et al., 1998b; Lupien et al., 1999; Fink, 2000).  
Women with a history of recurrent major depression have smaller hippocampal 
volumes; this was correlated with a lifetime of depression. The study also found 
that they did poorly on verbal memory tests (Lupien et al., 1999; Sheline et al., 
1999; Fink, 2000). 
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In Parkinson‘s disease (PD), it is widely accepted that elevated cortisol levels 
result from abnormalities of the function of the HPA axis, possibly contributing to 
loss of dopaminergic neurons in the substantia nigra by a variety of 
mechanisms (Drevets, 2000; Pålhagen, 2009). These include excitotoxic cell 
death, increased intracellular calcium levels and increased oxidative stress 
(Dong et al., 2009). However, more research is required in order to characterise 
and understand the contributions of stress in Parkinson‘s disease (PD) and with 
other neurodegenerative disorders (Fink, 2000). 
Prolonged HPA overactivity is associated with cognitive decline and 
hippocampal atrophy in rodents (McEwen and Sapolsky, 1995; Lupien et al., 
1998a; McEwen, 1999). Rodents exposed to stress paradigms or administered 
large doses of corticosterone have been reported to have atrophy of the 
hippocampal neurons and an increased sensitivity to toxins. These finding 
however were not replicated in pigtailed macaque monkeys exposed to high 
doses of cortisone for a period of 12 months (de Kloet et al., 1999; Koob and 
Heinrichs, 1999; Leverenz et al., 1999; Pryce et al., 2002; Tamashiro et al., 
2005). Cross-species differences may be an important factor as these primates 
in particular have proportionately fewer hippocampal GRs compared to rodents 
(Fink, 2000, Seeman et al., 1997; Sapolsky et al., 2002, de Kloet et al., 2011; 
De Kloet et al., 1998, Reul et al., 1987). 
 
1.2.4 STRESS AND EARLY LIFE EXPERIENCE 
Early stressful life experiences are related to changes in behaviour, 
physiological responses to stress and may heighten the capacity to develop 
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psychopathology in adulthood (Heim and Nemeroff, 2001). For example, 
Maternal Separation (MS) is a well-characterized model of early life stress in 
rodents (Levine, 2000; Sanchez et al., 2001; Newport et al., 2002a). Long-
lasting MS results in activation of the HPA axis during the stress 
hyporesponsive period (Huot et al., 2002), a neonatal time characterised by 
weakened glucocorticoid responses to most adult stressors (Sapolsky and 
Meaney, 1986). Interestingly, long-lasting MS during the early postnatal period 
does not affect basal measures of HPA function in adulthood but instead 
causes discrete differences in the regulation of the HPA axis that emerge after 
exposure to stressors. Rodents exposed to extensively long periods of MS 
show increases in CRF, ACTH and CORT levels (Plotsky and Meaney, 1993; 
Liu et al., 2000a).  
In contrast, short periods of MS (e.g. neonatal handling (NH)) results in reduced 
CRF, mRNA, ACTH and CORT in response to stress (Meaney et al., 1989; 
Plotsky and Meaney, 1993; Viau et al., 1993; Liu et al., 2000a). In addition to 
these hormonal changes, MS and NH are correlated with behavioural 
differences in later life. MS increases measures of anxiety (Huot et al., 2001), 
debilitates maternal care (Lovic et al., 2001) and diminishes spatial navigation 
learning (Huot et al., 2002).  
McCauley et al. (1997) in a human study on approximately 2,000 women, found 
that women with no history of childhood abuse showed fewer symptoms 
associated with depression and anxiety in comparison to women who had a 
history of physical or childhood sexual abuse. These women also had a higher 
frequency of suicide attempts (McCauley et al., 1997). Moreover, suicide victims 
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in general have larger adrenal glands and low prefrontal cortex levels of 
corticotropin releasing binding protein consistent with a hyperactive HPA axis 
(Mann et al., 1999; Fink, 2000; Mann, 2003; Oquendo Ma and et al., 2003). 
It has also been reported that parental loss, along with other childhood 
adversities are related to the development of depression and anxiety disorders 
in adulthood (Kendler et al., 1992; Kessler and Magee, 1993; Agid et al., 1999). 
Adverse events during childhood have been reported to predispose individuals 
to the developing of post-traumatic stress disorder (PTSD) in response to 
extreme trauma (Bremner et al., 1993; Zaidi and Foy, 1994). In addition to 
early-life trauma, stress in adulthood can also contribute to the expression of 
major depression and anxiety disorders, including PTSD (Read et al., 2005; 
McEwen, 2008).  
 
1.2.5 THE DEVELOPMENTAL PROFILE OF THE HYPOTHALAMO-
PITUITARY-ADRENAL AXIS  
Hormonal and receptor levels fluctuate greatly throughout the perinatal period 
with relation to the HPA axis. Sapolsky and Meaney (1986) have extensively 
reviewed these perinatal developmental changes (Sapolsky and Meaney, 
1986). There is initial activity of the foetal rat HPA axis followed by a period of 
inactivity known as the stress hyporesponsive period. During this time there is 
reduced adrenal responsiveness to ACTH reduced, levels of CORT (Levine et 
al., 1967; Guillet et al., 1980; Guillet and Michaelson, 2008) and low 
hypothalamic levels of CRF (Bugnon et al., 1984).  
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Over the succeeding period (postnatal days 2-7), levels of ACTH, CORT and 
CRF increase, and achieve adult levels by the third or fourth week postnatally 
(POMC) levels (Grino et al., 1989; Sakly and Koch, 2008).  
Analysis of glucocorticoid (GR) and mineralocorticoid (MR) receptors show that 
in the last week of gestation forebrain GR densities are comparable to those of 
the adult rat (Meaney et al., 1985; Meaney et al., 2008). This is in contrast to 
the first week of life, where the level of GR receptor binding in the rat brain is 
approximately 30% those of adult values in regions such as the hypothalamus, 
hippocampus and cortex (Meaney et al., 1985; Rosenfeld et al., 1988; Sarrieau 
et al., 1988; Meaney et al., 2008). The hippocampus receptor densities decline 
during the second postnatal week (Rosenfeld et al., 1988; Rosenfeld et al., 
1992). In week three the GR levels increase to those of the adult suggesting the 
rat brain, especially the forebrain, is less sensitive to CORT for a 3-week 
postnatal period. It has been observed that GR binding patterns in the lung, 
intestine and pituitary are higher in contrast to regional development when 
compared to the adult during the first week of life (Henning et al., 1975; Olpe 
and McEwen, 1976; Sakly and Koch, 1981; Kalimi, 1984; Sakly and Koch, 
2008).  
These disparities may highlight the functional involvement of GR activation 
during this 3-week period; for instance the importance of CORT in the induction 
of lung surfactant production. The same ontogenetic developmental pattern is 
followed by the plasma free CORT regulator corticotrophin binding globulin 
(CBG) and it achieves adult levels during the last week of gestation. CBG then 
decreases to a very low level at birth before requiring adult levels by the second 
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or third week postnatally (Henning, 1978; Smith and Hammond, 1991; 
Takahashi, 1998; Henning et al., 2009).  
In comparison to GRs, the development of MRs does not vary during the early 
postnatal period. The hippocampus shows a similar pattern for MR as for GR 
and no differences in mRNA levels for MR and GR between postnatal days two 
to four (Van Eekelen et al., 1991; Lawson et al., 1992). 
1.2.5.1 HPA axis activity during pregnancy   
Wasser (1999) suggested that social and psychological stressors have great 
influence upon reproductive success. Studies have attempted to identify the 
relationship between pregnancy and the role of the HPA axis along with others 
associated hormones. However, complications arise due to determining 
changes in HPA activity through gestation; both the placenta and foetus 
contribute to circulating hormone levels. Therefore, it is subject to debate 
regarding the hormones' origins and its derivation.  During early gestation, there 
is a decrease in plasma CORT levels in rats (Ogle and Kitay, 1977; Atkinson 
and Waddell, 1995; Johnstone et al., 2000; Brunton et al., 2008).  
Pregnancy represents a state of mild but sustained hypercortisolism, with 
maternal plasma CORT levels increasing during the second trimester until term 
in both rodents and humans (Carr et al., 1981; Okamoto et al., 1989; Waddell 
and Atkinson, 1994; Johnstone et al., 2000).  
Okamoto et al. (1989) reported that human infants showed a plasma ACTH rise 
after 16-20 weeks, reaching a peak at delivery (Okamoto et al., 1989). 
Alterations in the relationship between CORT and ACTH also occur during this 
period. These changes occur due to alterations in sensitivity of the adrenal 
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glands to ACTH or reduced metabolic clearance of CORT (Waddell and 
Atkinson, 1994). Furthermore, there could also be a contribution from foetal 
adrenal glands (Dupont et al., 1991). These data highlight the difficulty in 
establishing the actual status of the HPA axis and how its function changes 
during gestation and ensuing parturition.  
Welberg and Seckl (2001) reported that the enzyme 11β-hydroxysteroid 
dehydrogenase (11β-HSD) ameliorated the influence of prenatal CORT 
administration on foetal HPA activity (Welberg and Seckl, 2001). This enzyme 
exists in two isoforms and is prevalent within a variety of tissues including the 
placenta (Monder, 1991; Brown et al., 1993; Lakshmi et al., 1993). The enzyme 
catalyses the conversion of CORT (Cortisol in humans) to 11-dehydro CORT 
(Cortisone), the latter form being relatively inert in its actions. The type II form 
(11β-HSD-2) is of interest due to its localisation in placental tissues (Waddell et 
al., 1998) and the possibility that this protects foetal tissues against maternal 
CORT influences (Meyer, 1985).  
During gestation the adaptation of the HPA axis occurs at many different levels, 
including changes in limbic feedback (Johnstone H.A, 1997), CRF and AVP 
hypothalamic neurones (Douglas and Russell, 1994), and pituitary and adrenal 
gland (Carr et al., 1981; Waddell and Atkinson, 1994). In response to CORT, 
CRF and ACTH secretion is reduced while the adrenal gland shows an increase 
in sensitivity to ACTH and consequent CORT secretion (Dupouy et al., 1975; 
Carr et al., 1981; Waddell and Atkinson, 1994; Keller-Wood, 1996).  
There appears to be an alteration in excitability and adaptation of the HPA axis 
(De Kloet et al., 2005a). Throughout the third trimester in rats there is a rise in 
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both CORT and ACTH which then attenuates (Williams et al., 1999). Since 
CRF-stimulated ACTH secretion is reduced with the advance of pregnancy and 
lactation, this blunting of the HPA response to stress may be due to 
physiological adaptations at the pituitary level (Magiakou et al., 1996; 
Mastorakos and Ilias, 2003).  
Neumann et al. (1998) reported a significant reduction in CRF receptor binding 
in the pituitary on gestational day 11 which is further reduced by gestational day 
22 (Neumann et al., 1998). On day 21 of pregnancy reduced responses to 
stress alongside reductions in PVN CRF and mRNA expression have been 
shown (Douglas and Russell, 1994; Neumann et al, 1998).  
In view of the data, it has been suggested that the reduced HPA 
responsiveness to stressors may be a protective mechanism for both the 
pregnant rat and its offspring against maternal CORT concentrations 
(Weinstock, 1997).  
 
1.3 PRENATAL MANIPULATIONS: NEUROCHEMICAL AND 
BEHAVIOURAL RESPONSES OF OFFSPRING AND 
MOTHERS  
1.3.1 IMPACT OF PRENATAL STRESS ON DEVELOPMENT  
Behavioural development of offspring may be adversely affected by increased 
HPA activity during pregnancy. For example, adult monkeys and rodent‘s show 
reduced abilities to cope under stress when subjected to prenatal stress. The 
related HPA dysfunction manifests as a prolonged rise in stress-induced plasma 
CORT and reduced feedback inhibition of CRF.  
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Weinstock (1997) highlighted that these effects are thought to be programmed 
into the offspring's physiology by exposure to high levels of maternal hormones 
during gestation (Weinstock, 1997). These alterations may affect offspring 
making them more vulnerable to physiological and psychological disturbances 
in later life.  
In general, pregnant rats exposed to stress gain less weight in pregnancy, give 
birth earlier and have fewer progeny compared to non-stressed controls (Barlow 
et al, 1978; Fride and Weinstock, 1984; Williams et al, 1998).  
Furthermore, a significant positive correlation between infant morbidity and 
maternal stress has been found (Stott, 1973; Jones and Tauscher, 1978; Cohen 
et al., 1980; Turner et al., 2005). Studies by Sackett (1990) in monkeys showed 
that while gestational stress is associated with increased foetal loss (Sackett, 
1990), the surviving offspring exhibit an increased prevalence of cognitive 
deficits (Sackett, 1991).  
Jones and Tauscher (1978) reported that in humans, psychological stress 
during pregnancy correlates with an increased likelihood of the offspring 
suffering from congenital malformations and low birth weight (Jones and 
Tauscher, 1978). Prenatal Stress (PS) has been associated with developmental 
delays, cognitive impairments and altered emotionality.  
Retrospective analysis of emotionally disturbed youths and their maternal 
background indicates that there is a strong link between both physiological and 
psychological risk factors to later development of childhood psychopathology 
and chronic stress experienced by the mother during pregnancy (Ward, 1991). 
Similar retrospective studies have found associations between PS and 
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depression, schizophrenia, psychosis, hyperactivity and alcoholism (Huttunen 
and Niskanen, 1978; Brixey et al., 1993; Weinstock, 1997).  
1.3.2 PRENATAL STRESS AND HYPOTHALAMO-PITUITARY-ADRENAL 
AXIS CHANGES  
Many studies show that disturbances in HPA axis function follow from PS-
induced manipulations (Weinstock et al., 1988; Henry et al., 1994a; 
Barbazanges et al., 1996b; Zagron and Weinstock, 2006).  
For example, maternal CRF administration during the third trimester reduces 
pup weights, increases the anogenital distance of male progeny and increases 
ultrasonic vocalizations (USVs) of pups emitted during isolation (Williams and 
Russell, 1972; Williams et al., 1995; Williams et al., 1998b).  
It has been shown that prolonged gestation, abnormal development of the 
young and impaired onset of maternal behaviour occur following daily treatment 
with ACTH during the third trimester (Fameli et al., 1995).  
Fride et al. (1986) reported that the offspring of pregnant rats exposed to 
chronic stress had significantly higher levels of plasma CORT compared to non-
stressed controls. These increased levels of CORT impact foetal adrenal 
function since maternal CORT reaches the foetal bloodstream through the 
placenta (Zarrow et al., 1970; Henry et al., 1995). Hence, the effects of PS on 
the offspring are partly mediated via placental hormone transfer (Joffe and 
Joffe, 1978; Kapoor et al., 2006).  
Observations of infant primates show that the primate HPA axis is not mature 
until after birth (Ducsay et al., 1991) yet the foetal primate HPA axis does 
respond to exogenous hormonal stimulation by mid-gestation (Ducsay et al., 
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1991; Nguyen and Conley, 2008). It has been reported that such vulnerability to 
external activation is readily apparent in the offspring of monkeys who were 
psychologically stressed through mid-to-late gestation and were shown to have 
higher basal ACTH and CORT levels in comparison to controls and exhibit 
higher ACTH levels during stress (Clarke et al., 1994).  
It has been established that maternal stress experienced throughout gestation 
influences foetal HPA development (Welberg and Seckl, 2001). The overall 
effect of PS is to elevate HPA axis reactivity of the offspring, the manifestations 
of which are seen in the very early stages of life.  
Following prenatal stress, (e.g. footshock), every other day during gestation 
produces offspring which, exhibit significantly higher basal levels of ACTH and 
CORT in comparison to controls as early on as postnatal day one (Takahashi 
and Kalin, 1991). Moreover, 14 day old offspring of prenatally-stressed dams, 
also exhibit increased ACTH and CORT responses to footshock (Takahashi et 
al., 1988; Takahashi and Kalin, 1991), but emit fewer USV's in response to 
isolation (Takahashi et al., 1990).  
On further investigation, by postnatal day 14 it can be seen in both prenatally-
stressed and control offspring that CORT/ACTH significant increases in 
response to footshock stress and similar patterns of decline, although 
prenatally-stressed rats' show greater magnitude responses than the controls 
(Takahashi and Kalin, 1991). This difference was not observed when the 
offspring were assessed on postnatal day 21.  
Takahashi et al. (1992a) reported no differences amongst stressed/control 
progeny as adults, although others researchers have shown that prenatally-
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stressed rats exhibit increased basal and stress-induced plasma ACTH 
(Takahashi et al., 1992a; McCormick et al., 1995). In addition, compared to the 
controls, stressed progeny show prolonged stress-induced CORT secretion 
(Peters, 1982b; Fride et al., 1986b; Weinstock et al., 1992; Henry et al., 1994b; 
Maccari et al., 1995a; McCormick et al., 1995).  
Various theories suggest the mechanisms by which programming of foetal HPA 
activity takes place. Most importantly, the release of maternal pituitary-adrenal 
hormones in response to stress has been suggested to downregulate GRs 
and/or cause degeneration of hippocampal cells in the progeny (Sapolsky et al., 
1987; Sapolsky et al., 1990). This, in turn, may alter infant HPA reactivity 
through an impairment of negative feedback (Sapolsky et al., 1984; Fride et al., 
1986a; Sapolsky et al., 1990). Similar findings have been reported in previous 
investigations of stressed offspring where these impairments such as prolonged 
elevated secretion of CRF and CORT have been found (Weinstock, 1997). In 
agreement other reports showing that blocking the mothers' stress-induced 
CORT secretion leads to a suppression of both stress-induced CORT 
hypersecretion and a reduction in hippocampal GRs in adult offspring of 
stressed rats (Barbazanges et al., 1996a).  
The hippocampus is vulnerable to damage during early development and the 
binding capacity of hippocampal CORT receptors is a primary regulating factor 
in subsequent CORT secretion (De Kloet and Reul, 1987; McEwen et al., 1986). 
Thus, the findings by Maccari et al. (1995) show that the reduced binding 
capacity of hippocampal CORT receptors in prenatally-stressed adult rats 
(Maccari et al., 1995) represents one possible mechanism via which such 
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altered HPA axis activity in the offspring is mediated. Interestingly, the MRs of 
the hippocampus are thought to be responsible for maintaining basal CORT 
activity.  
It has been identified that a reduction in population size of MR may convey 
disturbances in basal levels of CORT following prenatal stress. Whether 
hypothalamic mechanisms controlling CORT are affected by PS remains 
unclear. Smythe et al. (1996) found that changes in CRF content in the median 
eminence following PS were dependent upon the early postnatal environment 
(Smythe et al., 1996).  
1.3.3 PRENATAL STRESS AND CENTRAL AMINERGIC SYSTEMS  
It has been well documented that PS affects the serotonergic system (Peters, 
1982b; Peters, 1986a; Peters, 1986b; Peters, 1990). Prenatal stress also 
affects other brain neurochemical systems including catecholamines and opioid 
systems (Peters, 1982a; Fride et al., 1985; Fride and Weinstock, 1989; Insel et 
al., 1990; Peters, 1990; Takahashi et al., 1992b; Alonso et al., 1994), which in 
later life may indirectly affect behaviour and stress responses. For example, PS 
reduces the density of benzodiazepine receptors in the hippocampus, which act 
as an inhibitory in effect upon the stress response (Fride et al., 1985; 
Weinstock, 2007).  
Serotonin plays an important role in the regulation of the HPA axis (Mitchell et 
al., 1990; Tsigos and Chrousos, 2002) and in early brain development (Lauder 
and Krebs, 2010).  
Stress exposure during gestation increases levels of 5HT and its primary 
metabolite 5-hydroxy-indole acetic acid (5HIAA) and tryptophan as pre-cursor in 
38 
 
the mother, in addition to increasing foetal brain tryptophan synthesis (Knott and 
Curzon, 1972; Peters, 1986a; Muneoka et al., 1997). Moreover, the brains of 
prenatally-stressed adult rats have been shown to contain reduced levels of 
5HT in conjunction with raised 5HIAA, indicating elevated 5HT metabolism 
(Hayashi et al., 1998).  
Animals also display persistent alterations in 5HT receptor binding, with 
increases in cortex, reductions in the hippocampus and normal binding in the 
pons and medulla (Peters, 1986a).  
Matsukawa et al. (1997) have suggested that serotonin is implicated in the 
facilitation of synapse formation and maintenance (Okado et al., 1993; 
Matsukawa et al., 1997). This concept together with the above findings may 
offer some explanation as to the mechanisms responsible for the significant 
reduction in hippocampal synaptic density found to occur in prenatally-stressed 
rats (Hayashi et.al, 1998).  
Rats prenatally exposed to ACTH have reduced dopamine (DA) activity in 
addition to increased 5HT activity (Fameli et al., 1994), notably within the medial 
preoptic nucleus (Fride et al., 1985), a region specifically associated with sexual 
differentiation. One of the many behaviours which PS appears to disrupt is 
sexual differentiation and sexual activation. DA levels are reduced in 
conjunction with increased levels of DA metabolites, indicative of elevated 
turnover, have been found in the ventral tegmental area (VTA) of stressed 
animals, in parallel to raised NA turnover in the LC (Takahashi et al., 1992b). 
Noradrenergic cells of the LC innervate the hippocampus and increase NA 
release in the hippocampus following stress (Tanaka et al., 1983; 1991). 
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Moreover, it has been identified that in addition to MR and GR mRNA, a large 
majority of cells in the cornu ammonis fields and dentate granule cell layers 
express α1- receptors (Williams et al., 1997).  
Lesioning of these ascending noradrenergic pathways have been shown to 
increase hippocampal CORT binding and attenuate stress-induced CORT 
secretion (Maccari et al., 1990). This suggests that CORT receptors may be 
regulated via the noradrenergic system (Blanchard et al., 2001).  
The increased manifestation of stress-induced behaviours may be partly 
explained by increased catecholamine turnover following prenatally-stressed 
and it may, therefore be associated with the regulation of hippocampal CORT 
receptor populations (Takahashi, 1998; Koehl et al., 1999). It may represent a 
key pathway by which PS increases the behavioural responsiveness to stress, 
evident in early life and continuing into adulthood in the offspring of stressed 
rats (Fumagalli et al., 2007; Wright et al., 2007).  
 
1.3.4 PRENATAL STRESS AND BEHAVIOUR  
Several studies have investigated the effects of prenatal stress upon behaviour. 
One of the earliest studies was by Thompson (1957), who found that there was 
a reduced level of exploration in an open field procedure in progeny of 
prenatally-stressed rats (Thompson, 1957). This finding has since been 
reproduced (Hockman, 1961; Fride et al., 1986b; Wakshlak and Weinstock, 
1990) alongside similar findings such as increased defecation (Thompson, 
1957; Wakshlak and Weinstock, 1990).  
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The data supports the view that prenatally-stressed rats exhibit heightened 
emotionality like-behaviour during development and adulthood (Thompson, 
1957; Hockman, 1961; Archer and Blackman, 1971; Peters, 1982a; Weinstock 
et al., 1988; Vallée et al., 1997). However, reduced emotionality like-behaviour 
has been observed by using dams stressed during pregnancy that did not 
postnatally change the emotionality like-behaviour of non-prenatally stressed 
offspring when reared. However, the reasons for this may be that the prenatal 
stress during gestation period is inadequate by itself to change the offspring‘s 
emotionality like-behaviour.  
It is suggested that the direction of changes occurred in offspring behaviour is 
probably dependent on the magnitude of stress and the trimester during 
pregnancy at which it was administered (Thompson, 1957; Hockman, 1961; 
Chapman and Stern, 1979; Huizink et al., 2004). 
Prenatally-stressed offspring also exhibit behavioural disturbances such as 
suppressed social behaviour (Dunn and File, 1987; Takahashi et al., 1992a) 
and raised anxiety like-behaviour in novel environments such as, the Elevated 
Plus maze (Fride and Weinstock, 1988; Dunn and Berridge, 1990; Vallée et al., 
1997). Interestingly, primates display general behavioural alterations in 
response to PS. It was found that such offspring demonstrate more abnormal 
social behaviour such as mutual clinging and reduced proximity and contact, 
when compared to non-stressed controls (Clarke and Schneider, 1993).  
These findings suggest that social behaviours are more affected than non-social 
ones and that enhanced responsiveness to stressors may occurs in later life, 
showing agreement with the rodent findings (Weinstock, 1997).  
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Retarded motor development is another important finding that has been 
identified within the progeny of prenatally-stressed animals (Fride et al., 1986). 
They are generally found to be less active motorically. In addition to being less 
active, prenatally-stressed rats exhibited significantly raised CORT levels 
following each exposure to an open field from birth to postnatal day 8. This 
latter finding offers a link between changes in HPA axis activity and behaviour. 
It has been reported that many of the behavioural alterations seen in prenatally-
stressed offspring are similar to those of adult rats following 
intracerebroventricular administration of CRF (Ward, 1972a; Weinstock et al., 
1988).  
In tandem with such findings, adrenalectomy attenuates some behavioural 
effects of PS (Weinstock, 1997). Evidently the HPA axis is involved in the 
behavioural changes manifested in prenatally-stressed progeny (Fujioka et al., 
2001; Bosch et al., 2007). 
  
1.3.5 PRENATAL STRESS AND SEXUAL BEHAVIOUR  
It has been well documented that there are recognised differences between the 
sexes in terms of PS-induced effects on sexual behaviour. Male offspring of 
dams having undergone gestational stress display a feminisation of sexual 
behaviour and incomplete masculinity (Ward, 1972b; Ward, 1984; Anderson et 
al., 1986; Ward, 1991; Ward and Stehm, 1991). Prenatal stress promotes 
maternal behaviour in male rats towards neonates (Ward, 1972a; Gué et al., 
2004), with males displaying full maternal behaviour faster than females 
(Kinsley and Bridges, 1988; Lonstein and De Vries, 2000).  
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The differential effects of PS upon sexualisation and associated behaviours 
appear to be reflected in other behaviours involving motoric performance and 
emotionality (Lonstein and De Vries, 2000).  
In active avoidance tasks PS appears to suppress the performance of males, 
but facilitates the performance of females (Fride et al, 1986). However, the sex 
differences seen in open field behaviour, where females are usually more active 
than males, has been shown to be unaffected by PS (Alonso et al., 1991b; 
Palanza, 2001).  
The enhanced performance of prenatally-stressed males compared with 
controls in a water maze task, is thought to be related to raised emotionality and 
a heightened response to stress, rather than effects on cognition (Szuran et al., 
1994).  
Furthermore, PS reduces sex differences reported for depressive tasks such as, 
swim tasks where males normally exhibit greater immobility during a forced 
swim task than females (Alonso et al., 1991a; Palanza, 2001).  
These latter findings together with those of Alonso et al. (1991b) with regard to 
open field behaviour show that the effect of PS on sex differences in behaviour 
are dependent on the nature of the behaviour (Alonso et al., 1991b). The 
authors suggest that sex differences in models of depression may possibly be 
under the influence of gonadal steroids during prenatal development (Alonso et 
al., 1991b; Palanza, 2001). 
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1.4 POSTNATAL MANIPULATIONS: NEUROCHEMICAL AND 
BEHAVIOURAL RESPONSES IN MOTHERS AND OFFSPRING  
1.4.1 POSTNATAL ENVIRONMENT AND THE HYPATHALAMO-
PITUITARY-ADRENAL AXIS  
Environmental conditions in early in life can impose long-lasting effects upon 
HPA axis regulation (Levine, 1962; Levine et al., 1967; Meaney et al., 1988b; 
Meaney et al., 1989; Plotsky and Meaney, 1993; Ladd et al., 1996). Evidence 
suggests that prenatal and postnatal manipulations such as PS, neonatal 
handling and maternal deprivation produce effects at various levels of the HPA 
axis that persist long into adulthood (Maccari et al., 1995a; Meaney et al., 
1996b).  
Maternal deprivation is thought to be the most potent naturalistic stressor to 
which rats can be exposed during the first two postnatal weeks (Stanton et al., 
1988; Kuhn et al., 1990). This treatment imposed during the pre-weaning period 
for just one hour is sufficient to increase CORT release in pups (Kuhn et al., 
1990; Stanton et al., 1988) and such an experience can increase HPA 
responses to stress in the offspring as adults if prolonged up to 24 hours 
(Plotsky and Meaney, 1993).  
The effects of neonatal handling upon HPA axis programming contrast with 
maternal deprivation. Even though the standard animal care regiments such as 
routine cage changing produce a slight handling-like effect, it is not as powerful 
as the neonatal handling paradigm (Meaney et al., 1991). The procedure 
developed by Ader and Grota (1969) involves rat pups being briefly removed 
and isolated from their mothers for a 20 minute period on 1-14 of the postnatal 
period . Weinberg and Levine reported that neonatal handling has the effect of 
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modifying HPA responses well into adulthood (Weinberg and Levine, 1977; 
Weinstock et al., 1992) and that these alterations remain apparent even at two 
years of age (Zarrow et al., 1972; Meaney et al., 1988b; Liu et al., 1997a; 
Meaney, 2001). Rats exposed to such treatment display reduced ACTH and 
CORT responses to acute stress challenge (Hess et al., 1969; Vallée et al., 
1997) and a faster recovery of these hormones to basal plasma levels following 
acute stress (Hess et al., 1969; Ader, 1970; Weinberg and Levine, 1977; Freide 
and Weinstock, 1984; Wakshlak and Weinstock, 1990; Weinstock, 1997).  
The rapid normalisation of basal HPA axis activity is believed to occur either 
through a strengthened response of CORT-mediated feedback (Levine, 1962; 
Meaney et al., 1988) or by enhanced sensitivity to such feedback (Meaney et 
al., 1989). In accordance with these changes in CORT and ACTH, studies 
showed that hypothalamic responses to stress are altered, with levels of CRF 
and AVP being lower than normal (Campbell et al., 1973; Plotsky and Meaney, 
1993; Liu et al., 1997a). These handling effects upon HPA activity provide 
strong evidence that environmental conditions have a great influence upon early 
development and programming (Meaney, 2001; Weaver et al., 2004; Zhang et 
al., 2004). 
Neonatal handling reduces hypothalamic CRF and AVP levels and thus causes 
reduced stimulation of ACTH release. Handling increases GRs in the 
hippocampus (Meaney and Aitken, 1985; Liu et al., 1997b). It is reported that a 
significantly greater expression of GRs in the hippocampus and frontal cortex 
may be indicative of the mechanism by which enhanced suppression of post-
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stress HPA activity occurs in these animals (Meaney et al., 1989; Liu et al., 
1997a).  
In handled rats both CORT and dexamethasone showed a more effective 
inhibition of ACTH responses to stress and the alterations to hippocampal GRs 
are consistent with increased negative feedback efficiency (Meaney et al., 1989; 
O'Donnell et al., 1994; Weinberg et al., 1995; Liu et al., 1997a).  
Early handling has shown related behavioural effects such as reduction in 
anxiety and helplessness behaviour (Ferré et al., 1995), increased nociceptive 
thresholds (Smythe et al., 1994) and prevents age-related hippocampal 
neurone loss and memory impairment (Meaney et al., 1991). The mechanisms 
involved in all of these receptors are yet to be fully understood.  
 
1.4.2 MATERNAL CARE AND OFFSPRING DEVELOPMENT  
Adverse early experience in humans, such as parental loss, inadequate care, 
neglect, or abuse, is often precedent in the later development of affective 
disorders (Harris et al., 1990). For example, childhood abuse and neglect may 
lead to poor mental health including antisocial personality disorder (Luntz and 
Widom, 1994) and major depressive disorders (Hall et al., 1993).  
Coplan et al. (1996) suggested that such adverse early experience and 
associated psychopathology are related to disruption of hormonal and 
neurochemical systems (Coplan et al., 1996).  
This has been demonstrated using infant rhesus monkeys, which were exposed 
to more complex-environments, compared to less complex environments and 
exhibited diminished adrenocortical responses to stress (Clarke et al., 1994). 
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 In one study, infant monkeys displayed persistently raised levels of CSF CRF 
following exposure to adverse early rearing conditions which were thought to 
suggest differential effects upon extrahypothalamic CRF systems and the HPA 
axis (Coplan et al., 1996). Interestingly, these findings suggest that hyperactivity 
of CRF neurones is implicated in the pathophysiology of certain human affective 
and anxiety disorders (Gold et al., 1984). Hence, CRF is thought to be a 
potential neurobiological mediator through which early life stress may contribute 
to adult psychopathology. The pathways by which such proposed CRF-
mediated pathology occurs may or may not involve those in association with the 
HPA.  
Perinatal manipulations where the effects persist into adulthood and which 
affect physiology and behaviour (Meaney et al., 1989; Takahashi et al., 1992a; 
McCormick et al., 1995) often relate to mother-pup interactions (Moore, 1984; 
Power and Moore, 1986). Maternal behaviours such as nursing (Maccari et al., 
1995) and licking pups (Barbazanges et al., 1996a) are altered and these 
alterations have been associated with changes of the HPA axis in the offspring. 
It has been reported that as adults, pups that receive more licking and grooming 
from their mothers in the first ten days of life have reduced plasma ACTH and 
CORT responses to stress. These changes occur in addition to raised 
hippocampal GR mRNA, enhanced CORT feedback sensitivity and reduced 
hypothalamic CRF mRNA (Liu et al., 1997a).  
Moreover, neonatal handling alters maternal care; for example, mothers of 
handled pups lick and groom their offspring more and demonstrate greater 
amounts of arched-back nursing compared to the mothers of non-handled pups.  
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Similar observations have been reported by Lee and Williams with altered 
mother-pup interactions following handling (Lee and Williams, 1974; 
Champagne et al., 2004). The altered HPA axis mechanism of handled pups, 
be it a direct effect of the handling or as a result of handling-induced changes in 
maternal behaviour, has yet to be confirmed. However, it appears that individual 
differences in responses to stress are strongly related to maternal caregiving 
through such behaviours affecting the programming of HPA axis activity in 
offspring. Furthermore, it has been shown that this pattern of HPA axis activity 
may be passed to subsequent generations of offspring as an inheritable trait i.e. 
epigenetic (Francis et al., 1999a; Weaver et al., 2004; Weaver et al., 2006).  
The precise reason as to why patterns of maternal care may differ towards 
offspring remains unknown. Several studies have reported that pups that differ 
from one another may themselves elicit different patterns of care from the same 
dam (Ressler, 1962; Meier and Schutzman, 1968; Lee and Williams, 1974; 
Moore and Morelli, 1979; Macrì and Würbel, 2006; Tang et al., 2006; Macrì et 
al., 2008).  
For example, handled pups produce more ultrasonic vocalisations (Bell et al., 
1971), possibly leading to increased maternal care. It has been reported that 
ultrasonic calls from pups have been associated with the initiation of anogenital 
licking by the dam (Brouette-Lahlou et al., 1992; Hofer, 1996; Branchi et al., 
2001).  
Moreover, prenatally-stressed pups elicit less maternal licking from non- 
stressed foster dams than do controls while stressed dams lick non-stressed 
foster pups less than do control pups (Moore and Power, 1986; Meaney, 2001; 
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Weinstock, 2008). Such studies reveal that the bond between a mother and her 
offspring is complex (Fleming et al., 1999).  
Apparently the biochemistry of the infant appears to be influenced by both the 
environment and the maternal care it received (Kalinichev et al., 2002). Both 
factors are recognised as key for HPA axis function programming (Weaver et 
al., 2004). Another key factor is the influence of the offspring toward maternal 
care and how infant behaviours may well elicit different levels, magnitude and 
type of maternal nurturance (Herbert et al., 1982; Francis et al., 1999b; 
Bornstein, 2002).  
  
1.5 DEPRESSION 
1.5.1  OVERVIEW  
Depression has long been recognised and described in human history. 
However, it was Hippocrates who was the first to suggest that depression is due 
to physiological dysfunction. About 400BC Hippocrates argued that depression 
was due to an imbalance in the four humours: blood, phlegm, yellow bile and 
black bile, with an excess of melancholia or black bile causing depression 
(Sierra and Berrios, 1998). 
More recently, Freud in his classic paper ―Mourning and Melancholia‖, 
discussed possible psychological causes for depression and noted that some 
depressions were clearly biological in aetiology (Freud, 1957). Over the past 3 
decades, considerable progress has been made in understanding depressive 
disorders. 
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The signs and symptoms of depression are complicated and differ widely 
between people (Table 1-2). 
Table1- 2: Signs and symptoms of depression.  
Lethargy. 
Sadness.  
Loss of self-confidence and self-esteem.  
Difficulty concentrating. 
Not being comfortable in a group.  
Feeling anxious all the time. 
Avoiding people, sometimes even your close friends.  
Feelings of hopelessness and helplessness. 
Insomnia. 
Very strong feelings of guilt or worthlessness.  
Finding it hard to function at work/college/school.  
Loss of appetite.  
Loss of sex drive and/or sexual problems.  
Physical aches and pains.  
Suicidal tendency. 
Self-harm. 
 
1.5.2 DEPRESSION – FACTS AND FIGURES 
Depression is one of the most prevalent psychiatric disorders affecting 
approximately 20-25% of women and 10-15% of men (Kessler et al., 2005; 
Levinson, 2006). It is not certain why there are consistently higher figures for 
women in comparison to men. According to the longitudinal study on mental 
health of Adults in Great Britain by National Statistics in (2003) women are more 
likely to report symptoms of common mental health problems (Lewis, 2003). 
The National Institute for Health and Clinical Excellence (NICE) predicts that 
9.8% of 16 to 65 year olds in the UK are suffering from mixed depression and 
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anxiety at any one time. 1 in 4 women will require treatment for depression at 
some time in their lives, compared to 1 in 10 men. The reasons for this are 
unclear, but are thought to be due to both social and biological factors. It has 
been suggested that depression in men may be under diagnosed because they 
present themselves to their general practitioner (GP) with different symptoms 
(National Institute For Clinical Excellence, 2003).   
Depressive disorders are more common in urban than rural populations and, in 
general, the prevalence is higher in groups with adverse socio-economic factors 
(e.g., homeless people) (Lorant et al., 2003).  
Depression is recurrent with each episode increasing the risk of developing 
subsequent ones (Kessler, 2005). 1 in 5 people will not recover fully from their 
first episode and, in 70-80% of those reaching remission, depression will 
reoccur at least once (Kessler, 2005). This high reoccurrence rate seen in 
depression suggests that there are specific factors that serve to increase 
people‘s risk of developing repeated episodes of the disorder. 
 
1.5.3 IMPACT OF DEPRESSION 
The World Health Organisation (WHO) estimates that depression is the second 
leading cause of disability worldwide (Murray and Lopez, 1997). In 2007 the 
burden of depression was compared with that of chronic illnesses including 
angina, arthritis, asthma and diabetes. Depression was shown to have the 
largest effect on worsening health and individuals with depression comorbid 
(Moussavi et al., 2007). 
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The economic burden of depression largely focuses on increased healthcare 
costs. Depression is associated with increased costs in every aspect of 
healthcare, including the costs of antidepressants and specialist mental health 
services. In the UK the cost of depression from working days lost and lost 
productivity is much higher than compared with its direct healthcare costs. In 
2000 the total cost of depression to the economy was estimated to be over £9 
billion, with only £370 million attributed to direct National Health Service (NHS) 
costs (Thomas and Morris, 2003). 
The burden of ill health experienced by individuals with depression is 
associated with poorer physical health, especially high rates of cardiac 
problems and higher rates of smoking. Besides physical problems associated 
with depression, research indicates that individuals with depression have 
impaired social and work functioning, compared with non-depressed individuals 
(Hammen, 2005).   
Depression adversely affects the quality of interpersonal relationships, in 
particular, relationships with children and spouses. Divorce rate is higher among 
depressed individuals than among non-depressed individuals (Wade and 
Cairney, 2000) and children of depressed parents are themselves found to be at 
increased risk of developing a related psychopathology (Goodman and Gotlib, 
1999). The impact of depression on the individual‘s quality of life is reported to 
be directly related to the level of its symptom severity. 
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1.5.4 CAUSES OF DEPRESSION 
The cause of depression remains a mystery even though researchers suggest 
various reasons for it e.g. unemployment, bereavement, adverse childhood 
experiences, family problems or other life changing events, or as a result of 
sudden physical illness (Beck and Alford, 2009).  
There are a few examples of chronic illness that may be linked to depression 
including heart disease, spinal damage leading to back pain, renal disease and 
cancer. It has been clearly established the role of HPA axis in depression 
(Pariante and Lightman, 2008). Thus pituitary damage may also lead to 
depression (Beck and Alford, 2009). 
Schatzberg and Rothschild (1992) reported that a variety of biological variables 
e.g. glucocorticoid activity, levels of dopamine, dopamine beta-hydroxylase 
activity and serotonin metabolites, have been examined in psychotic depression 
(Schatzberg and Rothschild, 1992). The secretion of cortisol is the most 
frequently studied measure and the method is most commonly used by 
dexamethasone suppression test (DST) (Carroll et al., 1981; Nelson and Davis, 
1997). Although an elevated level of cortisol has been reported in depression, 
other studies did not find a significant difference in rates of non-suppression of 
cortisol on the DST (Schatzberg, 1983; Evans and Nemeroff, 1987; Rothschild 
et al., 1987).  
Pariante (2006) reported that new evidence showing abnormalities in the GR 
play an important role in the pathophysiology of HPA axis hyperactivity in 
depression. The Mineralocorticoid Receptors (MR) have a high affinity for 
endogenous corticosteroids, while the GR have a high affinity for 
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dexamethasone and a lower affinity for endogenous corticosteroids (Pariante, 
2006). The GR considered more substantial in the regulation of the response to 
stress when glucocorticoids endogenous levels are high in cases of depression 
(Pariante, 2006).  
It found that a major depression is impaired of GR-mediated feedback inhibition, 
these came from other studies showing both expression in the GR and 
functional changes in those patients: administration of dexamethasone causes 
non-suppression in cortisol secretion; in vitro impaired GR function in peripheral 
blood mononuclear cells isolated and cultivated , or in vivo impaired in 
peripheral cells examined  using vascular or metabolic indices; in 
postmortem human brains showed a reduction in GR expression in 
neuropathological studies (Pariante et al., 2004; Juruena et al., 2006; Pariante, 
2006; Carvalho et al., 2008; Carvalho and Pariante, 2008; Pariante and 
Lightman, 2008). Moreover, other ideas suggested that impaired GR function is 
crucial for HPA axis hyperactivity in depression, in laboratory animals and 
humans, antidepressant drugs have been shown to increase GR function, GR 
expression and GR-mediated HPA axis feedback inhibition, herewith, stimulated 
HPA axis and reducing resting activity. Finally, long-term clinical outcome, 
antidepressant drugs have been found to be a significant predictor of 
normalisation of GR function (Pariante et al., 2004; Juruena et al., 2006; 
Pariante, 2006; Carvalho et al., 2008; Carvalho and Pariante, 2008; Pariante 
and Lightman, 2008). 
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Recently, Chourbaji et al. (2008) have shown that depressive-like behaviour 
occurs by decreasing of GR expression in experimental models (Chourbaji et 
al., 2008).  
 
 
1.5.5 CLASSIFICATION OF DEPRESSION 
The International Classification of Diseases (ICD) is the standard diagnostic tool 
for epidemiology, health management and clinical purposes (World Health, 
1977). The International Classification of Disease (ICD-10) Classification of 
Mental and Behavioural Disorders, is the diagnostic framework used by 
clinicians in the United Kingdom (UK) to diagnose depression (All, 1995). The 
ICD-10 is a uni-axial system (World Health, 1992). The Diagnostic and 
Statistical Manual of Mental Diseases Fourth edition (DSM-IV) is a multi-axial 
system and forms the diagnostic framework used by clinicians in the United 
States of America (USA) to diagnose depression (American Psychiatric, 2000). 
DSM-IV is the most widely used diagnostic classification system in research, 
whereas ICD-10 is more widely used clinically (American Psychiatric, 2000 , All, 
1995). 
Various assessment scales are also used to assist in diagnosis, examples 
include; Hamilton Depression Rating Scale (HDRS) which is used to measure 
the symptoms of patients suffering from depression (Hamilton, 1960) and the 
Beck Depression Inventory (BDI), which is used to assess the intensity of the 
depression (Beck At, 1961). 
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1.5.6 RISK FACTORS FOR DEPRESSION 
1.5.6.1 Genetic Factors 
Parents, siblings and children of severely depressed patients have a higher 
lifetime risk of developing a mood disorder (10-15%) in comparison to the 
general population (1- 2%) (Mood, 1996). Two studies provide strong evidence 
that these may be a contributing factor in the development of depression 
(Kendler et al., 1992; Kendler et al., 1993; Kendler et al., 1995; Kendler, 1998). 
Studies have shown that adopted children born to parents with a history of 
depressive disorder, but raised by adoptive parents with no such history have a 
higher risk of developing depressive disorder themselves, in comparison to a 
child who is born to parents with no history of depressive disorders (Levinson, 
2006; O'Connell et al., 2009). 
Specific genes or series of genes have not been fully identified in the causation 
of depression; however, polymorphisms may increase the risk for later 
developing depression. Genes can predispose individuals to depressive 
disorder in many ways (Caspi and Moffitt, 2006; Levinson, 2006; Risch et al., 
2009). 
 
1.5.6.2  Socio-economic Factors 
The literature on SES provides strong evidence which indicates that social class 
and economic status may predispose an individual to depression (Lorant et al., 
2003). Low SES can lead to adversity and life stress, which in turn can serve as 
a precursor in the translation of SES vulnerability and an individual‘s risk of 
developing depression (Dohrenwend, 2000).  
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According to the Mental Health Foundation, the socio-economic cost of mental 
health problems outweighs that of crime estimated at 60 billion for England and 
Wales in 1999/2000 (Brand et al., 2000). The most consistent finding in 
psychopathology research is the relationship between socioeconomic status 
(SES) and psychiatric disorders. Research has demonstrated that an inverse 
linear association including lower SES, correlates with higher depressive 
symptomatology (Turner and Lloyd, 1999; Lorant et al., 2003).  
However, not all individuals with a low SES become depressed. Depression is 
found even in individuals from a more privileged, higher social class. Therefore, 
other factors need to be considered, not just social or economic study. For 
example, Reynolds and Ross (1998) found occupational status was associated 
with physiological and psychological symptoms of stress (Reynolds and Ross, 
1998). It has been reported that job characteristics appear to mediate SES 
effects on depression (Pappas et al., 1993; Adler et al., 1994; House and 
Williams, 2000). 
 
1.5.7 STRESS AND DEPRESSION 
Chronic stress leads to elevated cortisol levels and reduced serotonin levels 
along with other neurotransmitter changes, such as dopamine, which has also 
been linked to depression.  When these chemical systems work normally, they 
regulate many biological processes, such as sleep, appetite, energy, sex drive 
and emotions. When a stress response causes dysregulations of these 
hormones after a difficult situation has occurred this could lead to depression or 
a mood disorder in susceptible people. 
57 
 
As mentioned previously, life stressors and depression are closely interlinked. 
The involvement of stressful life events has been long implicated and well 
established in the aetiology of depression (Kessler, 1997; Mazure, 1998; 
Monroe et al., 1999; Paykel, 2003; Hammen, 2006). Exposure to stressful or 
adverse life events is suggested to increase the risk of developing depression 
(Kendler Ks, 2003; Kendler et al., 2006).  
However, exposure to stressful life events may predispose an individual to 
depression, without necessarily increasing the lifetime risk of depression 
(Kessler, 1997; Richardson et al., 2006). Stressful life events examined in the 
literature have included: childhood sexual abuse, premature parental loss, 
lifetime traumas (e.g., natural disasters) and divorce/marital problems.  
Both chronic stress (Hammen, 2005; Hammen et al., 2009) and acute stress 
(Kendler, 1998) have been linked to the risk of predisposition to later 
development of depression and mood disorders. This correlation, although 
widely reported, is not necessarily caused by childhood sexual abuse (CSA), 
confounding influence of disturbed and disadvantageous family backgrounds 
including impaired parenting, parental marital problems and parent 
maladjustment (Hawker and Boulton, 2000). Exposure to a disturbed family 
environment, itself, has been shown to increase the risk of developing 
depression (Holmes and Robins, 1988; Kessler, 1997; Kendler and Prescott, 
2007). Events involving loss of parent, divorce or the threat of separation are 
associated with depression. However, this relationship is not specific to 
depression as these events have been shown to precede other illnesses e.g. 
schizophrenia, anxiety and bulimia (Monroe et al., 1999; Kendler Ks, 2003). 
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Depressed patients with severe life stress have been found to have greater 
depressive symptomatology in compared to depressed patients without stress 
and these effects in symptom severity are primarily due to pre-onset severe 
events and post-onset events (Monroe et al., 1999). 
Researchers have reported that depressed patients typically have 
approximately 50%  incidence of recent severe stress; further supporting the 
role of stress and the onset of depression (Mazure, 1998). Stressful or adverse 
life events do not necessarily predict depression or increase the overall risk of 
developing depression, but may predispose individuals to later developing 
depression. 
 
1.5.8 PATHOPHYSIOLOGY AND PHARMACOLOGY OF DEPRESSION 
Neurochemical Dysfunction 
The monoamine Hypothesis opines that depression is the result of monoamine 
under activity. The monoamine hypothesis proposes that antidepressant drugs 
have many therapeutic benefits because they increase monoaminergic 
transmission (Hirschfeld, 2000).  
Schildkraut‘s catecholamine hypothesis of depression specifically suggested the 
principle involvement of a Noradrenaline (NA) deficiency and other types of 
dysregulation of receptor functioning (Nestler et al., 2002). The basis for these 
findings is largely early pharmacological clinical observations (Berton and 
Nestler, 2006; Pittenger and Duman, 2007). Two structurally unrelated 
compounds developed for use of non-psychiatric conditions, namely Iproniazid, 
Imipramine were showed to have potent antidepressant effects in humans 
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(Nestler, 2002). Iproniazid, a drug studied as an antitubercular agent elevated 
the mood of tuberculosis patients (Pare and Sandler, 1959).  
Further investigation found that Ipronizide inhibits brain monoamine degradation 
by inhibiting enzyme monoamine oxidase. This resulted in an increase of brain 
monoamine levels – monoamine oxidase inhibitor (Pare and Sandler, 1959). 
Roland Kuhl (1958) conducted the first study using imipramine with depressed 
patients in 1955. This became the cornerstone in the formulation of the idea of 
an antidepressant; the results were published in 1958 (Gach, 2008). 
Imipramine is a tricyclic compound originally studied as an antipsychotic (Kuhl, 
1958) and was found to have potent antidepressant effects which inhibited the 
reuptake of NA (and to a lesser extent serotonin) into presynaptic neurons 
(Gach, 2008). 
Reserpine compounds have been indicated in the development of depressive 
states as a potent tranquiliser and the old antihypertensive agent produced a 
severe depressive state in a subset of patients (clinically indistinguishable from 
endogenous depression).  
Suicide attempts were observed in some individuals and these subjects showed 
evidence of depleted brain amines (serotonin and catecholamines) (Ferguson, 
1955; Stein and Himwich, 1995; Baumeister et al., 2003). Similar behaviours 
were seen in rodents administered reserpine (Bogdanski et al., 1958; Krishnan 
and Nestler, 2008).  
These observations led two groups of researchers (Bunney Jr and Davis, 1965; 
Schildkraut, 1965) to argue that NA activity was decreased in depressive 
disorders and elevated in manic or excited states. Data suggests a biological 
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heterogeneity of NA in depression as some patients have low NA activity and 
others have elevated activity (Ressler and Nemeroff, 2000). 
Later aetiology of the theories of depression includes the involvement of 
serotonin (Bogdanski et al., 1958; Meltzer, 1989; Whitaker-Azmitia, 1991; Maes 
and Meltzer, 1995; Nutt, 2002). Serotonin theories have suggested that there is 
a decreased production and/ or reuptake in depression (Bogdanski et al., 1958; 
Raap and Van de Kar, 1999; Hjorth et al., 2000). Most psychotropic drugs are 
thought to act at least in part on the serotonergic system/mechanisms (Nestler, 
2002). Fluoxetine (Prozac) was the first recognised Selective Serotonin 
Reuptake Inhibitor (SSRI). These groups of drugs were far more selective than 
the original tricyclic antidepressant (TCA). 
The major classes of drugs used to treat depression are: Monoamine Oxides 
Inhibitors (MAOIs), TCAs and the psychomotor stimulants such as 
amphetamine (used until the mid 1960s) (Charney et al., 1998; Lieberman, 
2003). These agents appear to interact with neurotransmitters in a way that is 
consistent with the MAO hypothesis of depression. The suggested modes of 
action of amphetamines (partial agonist, catecholamine reuptake inhibitor, 
competitive inhibitor of MAO and displacer of presynaptic NA and dopamine) 
would be expected to increase catecholamines temporally at the receptors 
sites. Administration of long-term high dose amphetamine produces an eventual 
depletion of brain NA and dopamine and inhibition of neuronal activity in 
catecholamine neurons (Kamata and Rebec, 1984). 
The largest excitatory neurotransmitter found in the brain is glutamate, which 
may play an important role in neuropsychiatric disorders. The glutamatergic 
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system is interconnected with GABAergic and monoaminergic pathways in the 
limbic system and abnormalities of this system have been found in patients with 
affective disorders (Kim et al., 1982; Francis et al., 1989; Mauri et al., 1998; 
Levine et al., 2000; Mitani et al., 2006; Frye et al., 2007). 
Compounds targeting the glutamatergic receptors, or glutamate transporters 
useful for depression have yet to be identified but as this area develops new 
therapies and associated mechanisms will likely follow. 
 
1.5.9 TREATMENT OF DEPRESSION 
Although the concept of antidepressant drugs (AD) to treat depressive illness 
has existed since the second century (Sartorius, 2001), it was not until the late 
1950‘s that effective antidepressant treatments became widely available 
(Pinder, 2001). The main agents used in the 19th century were opium and 
bromides. Most drugs used in the treatment for depression prior to the 1950‘s 
were various forms of sedatives (Lieberman, 2003). 
In the 1920‘s opium gave way to barbiturates e.g. paraldehyde was used 
extensively for the treatment of depression (Lieberman, 2003). From the 1930‘s 
stimulants were introduced e.g. amphetamines, in an attempt to treat 
depression. During this time period shock therapy was introduced and 
metrazole which was administered to induce an unmodified convulsion. The 
knowledge that convulsions could be good for improving mental disturbances 
was not new in medicine at that time, it was first noted by Hippocrates that 
malaria-induced convulsions in insane patients was able to cure them (Fink, 
1984; Abrams, 2002). 
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Subsequently, electric shocks were then used to induce fits; this procedure is 
now commonly known as Electroconvulsive Therapy (ECT). The popularity of 
ECT dramatically decreased in the 1960s and 1970s due to the use of more 
effective treatments and as a result of a strong anti-ECT movement (Fink, 1984; 
Abrams, 2002).  
ECT has proven to show efficacy in the treatment of depression and is the only 
somatic therapy from the 1930's that remains in widespread use today in the 
treatment of mood disorders (Endler, 1988; Fink, 2000). 
Below are the lists of new generation antidepressants which are widely 
prescribed throughout the medical world. 
1.5.9.1 Tricyclic Antidepressants (TCA’s) 
Tricyclic antidepressants block the absorption (reuptake) of the 
neurotransmitters, serotonin and noradrenaline, making more of these 
chemicals available at the synapse. This action augments neurotransmission in 
limbic areas, which elevates mood in depressed patients. These 
antidepressants also affect other chemical messengers, which can lead to a 
number of side effects. 
Tricyclic Antidepressants (TCAs) are a class of antidepressant drugs first used 
in the 1950s. They are named after the drugs‘ molecular structure, which 
contains 3 rings (Figure 1-3). It was during testing for schizophrenia that TCAs 
were discovered to be antidepressants, during the late 1950s and 1960s TCAs 
were marketed for the treatment of depression (Nestler et al., 2002). 
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Figure ‎1-3: Chemical structure of the tricyclic antidepressant (imipramine). 
 
1.5.9.1.1 Mechanism of action 
The exact mechanism of action is not fully understood (Dwoskin et al., 2006). 
They are thought to exert their therapeutic effect by inhibiting the re-uptake 
pump for monoamine neurotransmitters, serotonin and noradrenaline into the 
presynaptic neuron, thus enhancing noradrenergic and serotonergic 
neurotransmission (Einarson et al., 1999). Some TCAs inhibit serotonin 
reuptake pump (e.g., clomipramine) and others are more selective for NA over 
5-HT (e.g., desipramine, maprotiline, nortriptyline, protriptyline) (Einarson et al., 
1999). Most TCAs block both serotonin and noradrenaline reuptake to some 
extent. TCAs as a secondary effect possess an affinity for adrenergic 
muscarinic and histamine H1 receptors to varying degrees. Although the 
pharmacological effect occurs immediately, often the patient‘s symptoms do not 
alter until 2-4 weeks of persistent administration (Sweetman, 2011). 
 
64 
 
1.5.9.1.2 Clinical Use 
Tricyclic antidepressants are used in numerous applications; mainly indicated 
for use in clinical depression, neuropathic pain, nocturnal enuresis and Attention 
Deficit-Hyperactivity Disorder (ADHD). The disadvantages of TCAs include 
unwanted pharmacological actions including a blockade of muscarinic 
cholinergic receptors, histamine 1 receptors, alpha1 adrenergic receptors and 
voltage sensitive sodium channels. Blockade of H1 receptors may cause 
sedation and weight gain. Blockade of M1 muscarinic cholinergic receptors 
cause the ‗anticholinergic side effects‘; dry mouth, blurred vision, urinary 
retention and constipation. These side effects necessitate starting with a low 
dose and increasing slowly (Furukawa et al., 2002). Blockade of alpha-1-
adrenergic receptors causes orthostatic hypotension and dizziness. TCA 
overdose is a significant cause of fatal drug poisoning. The severe morbidity 
and mortality associated with all TCAs except lofepramine, is well documented 
due to their ability to weakly block sodium channels in the heart and brain 
resulting in cardiovascular and neurotoxicity (Buckley et al., 1994; Cohen et al., 
2000). 
This toxicity and the perceived poor tolerability of these drugs in general have 
led to a decline in their use in the UK over the last decade (NICE, 2009). 
1.5.9.2 Monoamine Oxidase Inhibitors (MAO’s) 
This is the group of the older class of antidepressants with limited, but selective 
use for the treatment of depression (Livingston and Livingston, 1996; Berton 
and Nestler, 2006). Monoamine Oxidase Inhibitors (MAOIs) are a class of 
powerful antidepressant drugs prescribed for the treatment of depression. The 
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first antidepressant drug synthesised was an irreversible MAOI and drugs in this 
class have been available in the UK for nearly 50 years. Although recognised as 
powerful antidepressants, the MAOIs are also highly effective therapeutic 
agents for certain anxiety disorders, such as panic disorder and social phobia, 
and in smoking cessation. 
 
1.5.9.2.1  Mechanism of action 
MAOIs inhibit the activity of monoamine oxidase, an enzyme present in various 
parts of the body, thus preventing the breakdown of monoamine 
neurotransmitters and thereby increasing their availability. There are two 
isoforms of monoamine oxidase, MAO-A and MAO-B. MAO-A preferentially 
deaminates serotonin, melatonin, adrenaline and noradrenaline (Bortolato et al., 
2008). MAO-B preferentially deaminates phenylethylamine and trace amines. 
Both types equally deaminate dopamine. Both forms are inhibited by the original 
MAOIs, which are therefore non-selective. Original MAOIs are all irreversible 
enzyme inhibitors meaning they bind to MAO covalently and irreversibly and 
destroy its function indefinitely (Benedetti and Dostert, 1985). Enzyme activity 
returns only when a new enzyme has been synthesised, which can take 
approximately 2 weeks. Newer MAOIs, are reversible, notably moclobemide, 
they have the ability to detach from the enzyme to facilitate usual catabolism of 
the substrate (Robinson, 2002). 
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1.5.9.2.2 Clinical Use 
MAOIs tend to be underutilised in clinical practice now, even in hospitalised 
patients. This is due to the potential lethal dietary and drug interactions and the 
availability of safer antidepressants. All MAOIs have the potential to induce 
hypertensive crisis if foods containing tyramine (which is also metabolised by 
monoamine oxidase) are ingested (Merriman, 1999) or drugs that increase 
monoamine neurotransmission are co-prescribed (Livingston and Livingstone, 
1996). 
In the past, MAOIS were used for patients resistant to TCAs, but the newer 
reversible MAOIs (moclobemide) provide a safer alternative and are now 
occasionally used as first-line therapy, although these substances are not as 
effective as the original MAOIs (Da Prada et al., 1989). The three of the original 
MAOIs that are still available in the UK for clinical use today are phenelzine, 
tranylcypromine and isocarboxazid. MAOIs are still cited as being the most 
effective antidepressants for the treatment of atypical depression (McGrath et 
al., 1994; Nolen et al., 1994). 
 
1.5.9.3 Selective Serotonin Reuptake Inhibitors (SSRI’s) 
Selective serotonin reuptake inhibitors (SSRIs) were introduced in the late 
1980s and they have dramatically revolutionised clinical psychopharmacology. 
It is predicted that 6 prescriptions per second, around the clock, around the 
year, are written for these agents (Anderson, 2001; Ban, 2001). 
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1.5.9.3.1 Mechanism of Action 
The Selective Serotonin Reuptake Inhibitors (SSRIs) inhibit the reuptake of 
serotonin; each SSRI shares the common property of serotonin transporter 
(SERT) inhibition. SSRIs bind at the SERT and prevent 5HT from being taken 
up both at the axon and dendrites, leaving more neurotransmitter in the 
synapse and providing an antidepressant effect. While SSRIs have in common 
their high affinity for 5-HT reuptake inhibition, each has a secondary 
pharmacological action, which includes NRI (noradrenaline reuptake inhibition), 
DRI (dopamine reuptake inhibition), 5-hydroxytryptamine 2C receptor (5-HT2C) 
antagonism, muscarinic/cholinergic antagonism, sigma-1 receptor actions and 
inhibition of Nitric Oxide Synthase (NOS) and of CYP450 2D6, 34A and 1A2 
(Iversen, 2006). 
 
1.5.9.3.2 Clinical Use 
Selective serotonin reuptake inhibitors are used in the treatment of depression, 
anxiety disorders, obsessive-compulsive disorder and bulimia nervosa, via 5-
HT1A antagonism (Geddes and Butler, 2002; Cipriani et al., 2005; Cipriani et 
al., 2009). This class of antidepressants typically have fewer adverse events 
and side effects than TCAs and MAOIs. SSRIs are less cardiotoxic than TCAs, 
have fewer anticholinergic side effects (e.g. sedation) and low toxicity in 
overdose (Gunnell et al., 2005; Möller et al., 2008). Dosage titration is not 
routinely required so subtherapeutic doses are less likely to be prescribed. 
These advantages have led to their widespread use as better-tolerated first-line 
antidepressants (Bosker et al., 2004). 
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1.6 ANIMAL MODELS  
1.6.1 GENERAL CONSIDERATIONS IN MODELLING DEPRESSION 
A study by Duman (2010) reports that a basic understanding of the underlying 
disease processes in depression is currently lacking and therefore it is not 
possible to recreate the disease in animal models with precision (Duman, 
2010). 
Animal models attempt to produce quantifiable correlates of human depression 
symptoms in experimental animals. It has been reported that it is not possible to 
assess the most classical symptoms of depression in animals because most of 
these symptoms are subjective feelings. Therefore, we strive to model the 
symptoms of depression that can be easily translated to behaviours that are 
measurable in animals. Present animal models for depression differ 
considerably in the extent to which they produce features that resemble 
depressive-like behaviours and that mimic human depression. The examples of 
measures that can be evaluated in rodent behavioural models include; social 
interaction, motor responses to stress and reward-related responding. The 
rationale for these is that they reflect levels of helplessness or despair, social 
withdrawal and anhedonia, all of which measures are characteristic of human 
depression. Psychomotor, appetite and sleep alterations, are not uniformly 
useful for investigating the neurobiological mechanisms of depression as these 
behaviours are sometimes elevated, or diminished in depression (Duman, 
2010). 
The ability of animal models to produce animal aspects of depression illness 
seen in humans is generally evaluated in their reliability or reproducibility (e.g. 
69 
 
face validity), their ability to precisely predict outcome in humans (e.g. predictive 
validity) and the incidence to which they model the disease process or its 
etiology in humans (e.g. construct validity) (Willner, 1984; Willner, 1997; 
McKinney, 2001). Clinically, predictive validity is the ability of animal models to 
accurately detect treatments that are useful for depression. 
Pharmacologically, the utility of many of the models is based on their predictive 
validity. This consideration has become increasingly important as new emerging 
evidence suggest that neural plasticity is involved in antidepressant drugs 
effectiveness (Pittenger and Duman, 2007). 
This emphasizes the importance of using animal models with features that 
result from processes believed to be relevant to human depression (Duman, 
2010). 
Because of the lack of understanding for the pathophysiological basis for 
depression, models are used from poor construct validity. Although different 
animal models attempt to produce specific behavioural or physiological features 
of depression, the features in the animal models likely come about through 
processes that are very different from those operative in human depression. 
Therefore, results obtained from using animal models need to be carefully 
interpreted for their relevance. This is because there is a limitation in using 
animal models in that they are used to detect mechanisms of current 
antidepressant drugs in animals and may lack the ability to detect potentially 
novel mechanisms that actually underpin human depression (Duman, 2010). 
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1.6.2 ANIMAL MODELS OF DEPRESSION 
One of the key environmental risk factors thought to evoke depression is the 
exposure to stress (Keller et al., 2007; Kendler et al., 1999; Kessler, 1997). 
Thus, early-life adverse experience could lead to psychopathology in humans. 
Studies carried out on humans show that exposure to stress or early adversity 
in life increases the risk for depression and that stress exposure may promote 
depression in those with genetic risk factors (Agid et al., 1999, 2000; Caspi et 
al., 2003; Kaufman et al., 2006; Weiss et al., 1999). Early Life Stress exposure 
(ELS) model has been developed to investigate determinants of experience-
dependent susceptibility for developing depressive illness (Duman, 2010). 
Animal models to study neurobehavioural function permit researchers precise 
control in studies as detailed below (Table 1.3) (Hitzemann, 2000). 
Table ‎1.3: Reasons for using animals in the study neurobehavioural function.  
Adapted from (Katz, 1981). 
1 Control of and manipulation of genetic history. 
2 Short life span allows longitudinal study, within and across generations. 
3 Direct experimental manipulations of examination of the brain possible. 
4 Full control of life history. 
5 Cost effective and time effectiveness. 
 
Many studies show that exposure to stress, can reliably elicit many core 
components of depression (Duman, 2010). 
Physiologically, it appears that different types of stressors in animals activate 
different neural circuits (Duman, 2010). For example, there is a differential 
involvement of limbic pathways thought to underpin the processing of stressors 
that vary in their systemic (i.e. immune, metabolic, cardiovascular and metabolic 
which promote the adverse actions) versus cognitive/psychological nature (i.e. 
stressors which lead to excessive release of CORT) (Herman and Cullinan, 
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1997; Anisman and Matheson, 2005). Importantly, the degree of control an 
animal has when it is stressed has been demonstrated to be the key factor for 
the neurobehavioural consequences of stress exposure. For example, 
behavioural impairments and increased brain amine utilisation can be seen after 
exposure to uncontrollable stress, but are not apparent when an animal is able 
to control/predict the stress exposure (Anisman and Matheson, 2005). Greater 
unpredictability can reduce the probability of adaptive processes occurring upon 
repeated stress exposure and promotes the appearance of stress related 
effects (Willner et al., 1987; Anisman and Matheson, 2005). 
According to Van Der Staay et al. (2009) validation of a model is a scientific 
method to improve the confidence in that model, i.e. to evaluate its plausibility 
and consistency (Van Der Staay et al., 2009). Even though numerous 
definitions on validity have come into existence, the most notable one is defined 
as ― the agreement between a test score or measure and the quality it is 
believed to measure ― (Silva, 1993). Validity should not be interpreted as the 
―truth‖ of a model but an interpretation of the data arising from the model. 
Validity in this sense is a major criterion for evaluating animal models in 
practical terms (Holmes, 2003b). According to Silva (1993), no animal model 
can be valid in all situations, for all purposes. Validity is restricted to a specific 
use of the model and consequently, must always be open for discussion and re-
evaluation (Silva, 1993). 
There is no general consensus about how to rank the different categories of 
validity in the model evaluation process. We hold that the validation process 
should consider the internal validity which includes reliability and replicability, 
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face validity, predictive validity, construct validity and external validity of a 
model. The concepts of internal validity, face, predictive and construct validity 
have been elucidated in a number of publications e.g. (Willner, 1984; Willner, 
1986; van der Staay, 2006).  
 
1.6.3 VALIDITY OF ANIMAL MODELS OVERVIEW 
The following sections will develop and introduce basic concepts of animal 
models and move onto a detailed examination of animal models for depression 
to fully illustrate these concepts. 
 
1.6.3.1 Reliability and replicability, internal validity 
Reliability is a measure of the assessment instrument whereas replicability (or 
reproducibility) is a quality of the results obtained using a particular animal 
model (Van Der Staay et al., 2009). 
Reliability explains the consistency of the assessment or testing device, i.e. it 
explains the extent to which a measurement instrument yields consistent results 
each time the measurements are performed under the same experimental 
conditions (Van Der Staay et al., 2009). 
Internal validity refers to the quality of the experimental appraisal of the animal 
model, for example how well the research was designed, how variables are 
measured, what variables were included, performance of a study, how strictly 
variables were controlled and about the confidence levels of how one can be 
sure that the changes observed in the dependent variable(s) are induced by 
73 
 
experimentally manipulating the independent variable(s) and not by factors that 
might also affect the independent variable and may offer alternative 
explanations of the results obtained (Guala, 2003). 
Internal validity is a measure of a specific labs ability to obtain that result. It is 
most obviously demonstrated in studies from a given laboratory. 
 
1.6.3.2 Face validity 
Face validity is the extent of descriptive similarity between the behavioural 
disorders seen in an animal model and in the human condition that the model 
seeks to evaluate. The similarity of symptoms may be the beginning point of 
identifying a possible animal model of neurobehavioural dysfunction (Geyer and 
Moghaddam, 2002). Although face validity has been suggested to constitute a 
major or even the most important gauge for model appraisal by (Holmes, 
2003a), strong emphasis on face validity has been criticized (Sarter and Bruno, 
2003). 
 
1.6.3.3 Predictive validity 
Predictive validity is the measure of how well a test predicts the future 
performance of the test. It is also known as criterion validity (Van Der Staay et 
al., 2009). An animal model with high predictive validity predicts behaviour in 
the situation it is thought to model. It allows extrapolation of the effect of a 
particular experimental manipulation from one species to another and from the 
laboratory to the ‗Real World‘ (Epstein et al., 2006). 
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In psychopharmacology a narrower concept of predictive validity is used (e.g. 
(Sarter et al., 1992; Bourin et al., 2001; Borsini et al., 2002; Cryan and Slattery, 
2007; Whiteside et al., 2008) where it is considered to be of particular 
importance in drug development programs (Swerdlow and Sutherland, 2005). In 
this context, predictive validity refers to an animal model‘s utility to correctly 
identify the efficacy of known or putative therapeutic agents in the treatment of a 
particular disorders (Wright, 2002). 
 
1.6.3.4 Construct validity 
Construct validity is the relationship between the measurements (dependent 
variables) and of the manipulations (i.e. independent variables) with the 
theoretical hypotheses being tested (Lubow, 2005). According to Sarter and 
Bruno (2003), construct validity is the most important gauge for animal models 
because it addresses the soundness of the theory underlying the model and it 
identifies the framework for translating data generated by the model (Sarter et 
al., 1992; Sarter and Bruno, 2003). 
Epstein (2006) has reported that construct validity points to the degree of 
similarity between the mechanisms underlying the behavioural disorder being 
modelled and the mechanisms underlying specific behaviours observed in this 
model (Epstein et al., 2006). Construct validity thus is a theory which is driven 
by experimental substantiation of pathophysiological, behavioural and/or 
neuronal components of the model (Sarter and Bruno, 2003), i.e. it reflects the 
degree of fitting the theoretical rationale underlying the model with the true 
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nature of the syndrome/symptoms that the animal model mimics (Holmes, 
2003b).  
Numerous studies have defined the theory of construct validity and perhaps the 
most noted is one by Kaplan and Silva which defines a framework of 
theoretically relevant relations in the model (Silva, 1993; Kaplan and Saccuzzo, 
2008). This reflects the soundness of the theoretical rationale of the disorder 
(Wright, 2002). 
 Anxiety and depression are both mood disorders and often co-morbid. 
An effective animal model must clearly delineate between each disorder. 
1.6.4 TYPES OF ANIMAL MODELS OF DEPRESSION 
1.6.4.1 Learned helplessness 
When animals are exposed to inescapable stress (e.g. electrical footshock) for 
more than one session, this procedure may result in Learned Helplessness 
(LH). Subsequent to inescapable stress, the animals are tested for their ability 
to engage in an active avoidance task. In these models, animals are prevented 
from escaping the electrical footshock in a shuttle box chamber. Animals 
previously exposed to inescapable stress (e.g. electrical footshock) show 
decreased abilities to escape when afforded the opportunity to do so. 
Antidepressant drugs e.g. MAOIs, TCAs, SSRIs and ECT usually restores the 
ability of the animals to escape (Sherman et al., 1982; Martin et al., 1990). 
Willner (1984) found this model has a good predictive validity for the efficacy of 
antidepressant drugs (Willner, 1984). The LH model has been used to show the 
importance of the controllability of the inescapable stressor as a key 
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psychological component in inducing the behavioural problems (Anisman and 
Matheson, 2005).  
Maier (1984) concluded in his review that there is a great similarity between 
human depression symptoms (e.g. weight loss, decreased motivation, 
increases in stress hormones and decreases in motor activity) and the 
behaviours associated with the learned helplessness model in rodents. 
(Maier, 1984). 
1.6.4.2 Porsolt Test or Forced swim test 
This study was first described by Porsolt et al. in 1977 and involves placing a rat 
or mouse a chamber full of water such that the animal cannot touch the 
chamber bottom with its hind paws (Porsolt et al., 1977a; Porsolt et al., 1977b; 
Porsolt et al., 1978). 
A normal animal shows an initial struggling reaction and tries to escape by 
jumping, climbing until eventually it adopts an ‗‗immobile‘‘ posture, where it 
maintains its snout above the water line to breath. It is a 2 day test with the first 
day designated the ―exposure‖ day and on the 2nd day, termed ―test‖ day, 
where total immobility is measured.  
The exposure day primes the animal to produce immobility on the test day. 
Greater immobility is deemed to be depressive-like behaviour. It therefore 
belongs to the spectrum of tests that employ the concept of learned 
helplessness as a feature of depression. It is commonly used to screen novel 
antidepressants, since testing with known antidepressants produce less 
immobility on the test day (Porsolt et al., 1978). 
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The monoamine oxidase inhibitors, tricyclic and atypical antidepressants (e.g. 
bupropion, nefazodone, trazodone, mirtazapine) have all been shown to 
decrease the duration of immobility in rodents in a dose-dependent manner 
(Porsolt et al., 1977a; Porsolt et al., 1977b; Borsini and Meli, 1988). 
Stimulant drugs (e.g., amphetamine) may cause false positive results in the 
Porsolt test, because this drug can increase locomotor activity and therefore 
decrease immobility (Katz et al., 1981). In addition, the Porsolt test does not 
uniformly distinguish between acute and chronic antidepressant effects. Several 
studies have shown that the Porsolt test is sensitive to genetic variation as 
indicated by differences in strain efficacy of drug in rats and mice (Porsolt et al., 
1978; López-Rubalcava and Lucki, 2000). 
 
1.6.4.3 Tail suspension test 
The Tail Suspension Test (TST) is conceptually similar to the Porsolt test in that 
it suspends a mouse by its tail, while measuring the extent to which immobility 
versus active movement (Steru et al., 1985). In a stress situation, the TST 
similar to the Porsolt test is based on the adoption of a passive response.  
The TST has good predictive validity; and several studies have shown that 
acute antidepressant treatment given prior to the test decreases immobility time 
in the TST (Steru et al., 1985; Perrault et al., 1992; Cryan et al., 2005). 
Although, the TST is similar to the Porsolt test, both tests do not show 
congruous sensitivities to pharmacologic agents or to any differences in strain, 
suggesting that responding in the TST and the Porsolt test may be determined 
by non-congruous substrates (Bai et al., 2001).  
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There are limitations with the TST in comparison to the Porsolt test. The major 
drawback of the TST that, it is only used in mice and not in rats due to size and 
weight whereas the Porsolt is suitable for both types of rodents.  
The TST and Porsolt test have similar limitations, including sometimes showing 
false positive responses to psycho-stimulants (e.g., amphetamine). 
Nevertheless, the high reliability of the TST and Porsolt test has contributed to 
their sustained use and they are both considered useful for investigating 
differences between strains to stress and in assessing depression-like 
behaviour (Duman, 2010). 
None of the above mentioned models, i.e. LH, the Porsolt test, and TST 
reproduce the pathophysiology of depression, but they are useful in that they 
are sensitive to therapeutic agents in a manner predictive of their effects in 
humans. The Porsolt test and TST have been used extensively for this purpose, 
but the selectivity of these tests for monoamine-based mechanisms may limit 
their ability to detect novel mechanisms (Willner, 1991; Thiebot et al., 1992; 
Weiss, 1995; Lucki, 1997). 
 
1.6.4.4 Chronic unpredictable mild stress 
Learned helplessness, elicited by the Porsolt test, and tail suspension test 
procedures depend on short term stress exposure, but the Chronic, 
Unpredictable mild Stress (CUS) test was developed to study neural changes 
which result from stress of a more chronic nature (e.g., wet sawdust, cage 
tilting, sounds of a predator, water in the bottom of an empty cage, being placed 
79 
 
in an empty cage, during the dark phase lights will be on for a short duration, 
and moving cages).  
This procedure lasted for 28 days before behavioural tests (e.g. open field, 
elevated plus maze, Porsolt test and a tail suspension test) (Mineur et al., 
2003). The advantage of over the aforementioned stress procedures is the 
intuitive belief that frequent different stress stimuli, each varying in physiological 
effects is a more natural reflection of major life stress experienced by humans. 
Thus it is the aggregate of their effects summated over long time periods that 
cause depressive-like behavioural responding; at first these responses are mild, 
but eventually become sensitised and elicit a more robust depression.  
One of the first studies carried out on the CUS model was by Katz and 
colleagues and then developed by other researchers providing the basis for 
most of the currently used tests (Katz, 1981; Katz et al., 1981; Willner et al., 
1987; Willner, 1997).  
1.6.4.5 Sucrose preference 
Anhedonia is defined as a loss of interest or inability to experience pleasure, 
even with activities that were previously highly rewarding. Measuring alterations 
in anhedonia represents another technique to measure depression-like 
behaviour in rodents (Willner, 1984; Willner, 1991). 
Sucrose preference test is used to examine the animal‘s interest in their 
activities e.g. sexual, social, motivation, and food (Willner et al., 1987; 
Deussing, 2006). The benefit of this test prodcedure is that the behaviour to 
drink is not elicited via an aversive event, but rather elicited by the degree to 
which the animal is motivated by pleasant taste of sucrose (Willner et al., 1987). 
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Sucrose preference testing is carried out in the animal‘s home cage. For the 
task, animals are presented with a choice to drink plain water or 2-4% sucrose 
solution in water (Willner et al., 1987; Papp et al., 1991). 
Animals much prefer to drink more sucrose water than plain water, and thus any 
procedure applied to the animals prior history such as chronic (presumably 
leading to a depression-like behaviour state), would be expected to reduce the 
innate preference  of the animal for the sucrose solution. Diminished sucrose 
intake can be inferred to indicate that the animal no longer finds it as 
pleasurable (Brenes Sáenz et al., 2006; Brenes and Fornaguera, 2008). Human 
depressed patients exhibit a similar diminution in interest of pleasurable 
activities, and the sucrose-preference test models this precise symptom of 
depression (Willner et al., 1987; Papp et al., 1991; Willner, 1991; Willner, 1997). 
A number of studies have shown than chronic antidepressant treatment can 
reduce anhedonia seen in CMS rats without producing general changes in fluid 
intake, palatability, or learning capacity (Willner et al., 1992; Treit and Menard, 
1998) . 
One caveat is of course that sucrose supplies a calorie load to the animal, and 
this may produce modifications in the amount of nutritionally vital dietary 
components such as vitamins, minerals, lipids and proteins (Wooley et al., 
1972; D'Aquila et al., 1997). 
Artificial sweetness‘ such as saccharine can be used to control for these 
problems, but may have deleterious consequences of their own  (Kurre Nielsen 
et al., 2000) 
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1.6.4.6 Early-life stress 
Experimental paradigms have been developed in an effort to model Early Life 
Stress (ELS) and are used as models in which to investigate determinants of 
experience-dependent susceptibility to depressive illness (Agid et al., 1999; 
Weiss et al., 1999; Agid et al., 2000; Caspi et al., 2003; Kaufman et al., 2006). 
Stress exposure during critical periods of development can cause stable 
phenotypic changes, which are induced by the ELS models.  
ELS produce changes that are particularly replicable and involve alterations in 
neural systems that control or respond to stress such as the HPA axis; and 
include neurochemical, endocrine and behavioural changes. Changes in HPA 
axis which regulate stress systems after ELS could be relevant to 
consequences in humans after early life stress and may lead to suggest 
mechanisms that predispose to depressive illness (Heim et al., 2004; Pryce et 
al., 2005). 
1.6.4.6.1 Maternal separation 
Several studies show that parental care is evidently an important modifier of 
stress exposure during development in humans and maternal deprivation tests 
are useful in developmental animal models for predisposition of affective 
disorders/depression (Heim and Nemeroff, 2001; Kendler et al., 2002; Newport 
et al., 2002a; Holmes et al., 2005). It has been suggested that maternal 
behaviour has a role in programming emotion-related behaviour in offspring 
caused by translating the stress level in the environment into the offspring via 
parental behaviour (Zhang et al., 2006).  
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Several maternal deprivation models exist which involve repeated periods of 
separation of preweaning rats from the dams. Preweaning rats are exposed to 
daily episodes of 3–6h separation in the first 2 postnatal weeks and the 
separation can include removing the entire litter from the dam, or removal of 
individual pups from their littermates and the dam (Rüedi-Bettschen et al., 2005; 
Vazquez et al., 2005).  
Previously separated animals are then allowed to develop into adulthood, under 
normal conditions where phenotypic characteristics can be evaluated (Lovic et 
al., 2001).  
Several studies have indicated that rats separated during early life show 
behavioural abnormalities, for example, reduced social motivation, appetite and 
sleep problems, reduced pleasure, decreased motor activity, increased anxiety 
and fear responses and endocrine neurochemical changes in stress-relevant 
systems as adults (Levine, 1957; Plotsky and Meaney, 1993; Ladd et al., 2000; 
Mintz et al., 2005; Rüedi-Bettschen et al., 2005; Rüedi‐Bettschen et al., 2006). 
The behavioural changes that accompany Maternal Separation (MS) show 
similarities with symptoms of depression and the neuroendocrine alterations are 
also consistent with depression (Pryce et al., 2001; Heim et al., 2004; Pryce et 
al., 2005). Chronic antidepressant drug treatment counteracts some effects of 
maternal separation (Leventopoulos et al., 2009), but generally predictive 
validity needs further studies (Duman, 2010). 
The brain is very susceptible to experience-dependent alterations during the 
critical period of postnatal development. Newport et al. (2002) reported that 
maternal separation test in rodents target this period (Newport et al., 2002b).  
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Parental behaviour contains direct or indirect behaviour at the offspring; direct 
behaviour (arched back nursing, licking grooming and retrieval), or nest building 
and indirect behaviour which includes protecting their offspring from any threat 
conditions that might be harmful (Bornstein, 2002). 
There are positive and negative approaches to conceptualizing parenting 
behaviour. Positive behaviour is associated with the growth of litter‘s proficiency 
in life areas and behaviours control. Adverse or negative behaviour in 
comparison suggests a parent as a factor in the development of emotional-
behavioural problems, in particular anti-social behaviour and violence 
(Menendez-Patterson et al., 1982). So, these models have face validity for 
disrupted parenting behaviour in humans that can develop from a number of 
situations including father or mother depression and also likely to occur during 
critical periods of the individual‘s development (Newport et al., 2002). 
A variation of the MS procedure is a related paradigm that uses the 
quantification of levels of maternal care as it occurs naturally rather than via 
experimental manipulations (Cannon, 1939; Liu et al., 1997a; Francis et al., 
1999b).  
Champagne et al. (2003) found that the licking/grooming of pups and arched 
back nursing are important features of maternal behaviour in female rats 
(Champagne et al., 2003). These maternal behaviours, which are naturally 
occurring variations are quantified and low levels of these variations are 
considered to represent a stress condition for the offspring (Duman, 2010). 
Levels of maternal care have been shown to associate with levels of stress-
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reactivity (HPA activity and anxiety-related phenotype) in the adult offspring (Liu 
et al., 1997).  
1.6.4.6.2 Prenatal stress 
In different laboratories, prenatal stress paradigms have been used as a model 
of depression. It has been reported that maternal stress of different types, for 
example, restraint during gestation or noise exposure results in changes in the 
offspring, including changed HPA axis activity, increased symptoms of 
depression in animal models of depression and increased anxiety (Alonso et al., 
1991a; Weinstock et al., 1992; McCormick et al., 1995; Secoli and Teixeira, 
1998; Maccari et al., 2003b; Morley-Fletcher et al., 2003; Morilak and Frazer, 
2004; Smith et al., 2004). 
Prenatal stress tests have construct and face validity, but the depression-
related changes and anxiety that are induced in the dams complicate the 
interpretation as to the relative contributions of pregnancy versus the effect of 
postnatal care (Duman, 2010). 
Studies reported that chronic antidepressant treatment reverses the behavioural 
changes in Porsolt model of depression, anxiety and HPA axis alteration, which 
result from prenatal stress (Morley-Fletcher et al., 2004; Poltyrev and 
Weinstock, 2004). Weinstock, (1997) reported that changes in the rodents‘ and 
monkeys‘ HPA axis are similar to those caused by prenatal stress in humans 
which lead to behavioural abnormalities e.g. ADHD (Clements, 1991), 
depression, criminal, unsociable and inconsiderate behaviours (Meijer, 1985) 
and schizophrenic episodes (Huttunen and Niskanen, 1978). 
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1.6.5 ANIMAL MODELS OF ANXIETY 
Anxiety is adaptive when mild which helps the body to deal and cope with it, but 
may be crippling and disturbing when it is extreme (American Psychiatric, 
2000). Clinically, anxiety appears in several recognisable forms. Differences are 
made between patients who experience psychological feelings of panic, 
continuous nervousness, tension and worry; often these are accompanied by 
autonomic hyperactivity in the absence of external stressors (Schlaepfer and 
Nemeroff, 2012). 
Examples of anxiety include panic attacks which are accompanied by subjective 
feelings of terror, fear of dying and apprehension. Dyspnoea, faintness, 
sweating and trembling are somatic symptoms which occur co-morbidly in 
multiple physiological systems of these individuals (Schlaepfer and Nemeroff, 
2012). 
Most diagnostic destructions are made for patients presented with anxiety due 
to phobic disorders, PTSD and obsessive-compulsive disorder (OCD), as 
reflected in the Diagnostic and Statistical Manual of Mental Disorders, 4th 
edition (DSM-IV: American Psychiatric Association, 1994). 
In anxiety research, animals are used widely to screen new anti-anxiety drugs 
which have anxiolytic effects to treat anxiety in humans (McMillan, 2008). For 
example, anxiolytic compounds like benzodiazepine drugs have shown to 
decrease anxiety-like behaviour in rats (Treit, 1991; Treit et al., 1993). 
Furthermore, betacarbolines are used as anxiogenic agents to induce anxiety in 
humans; this compound is found to produce anxiety-like behaviour in animals 
(Ninan et al., 1982; Dorow et al., 1983). 
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Elevated Plus Maze 
The Elevated Plus Maze (EPM) is perhaps the most widely used animal anxiety 
model in use today especially for rats and mice (Walf and Frye, 2007). It 
comprises of two open arms (i.e. no enclosing walls) and two closed arms (with 
barriers on each side). Rats are curious animals and naturally explore the 
environment (White, 1959; Martin and Bateson, 1993; Cavigelli, 2005). 
However, according to (Rodgers and Cole, 1993; Padovan and Guimarães, 
2000; Adamec et al., 2004), stressors often increase anxiety-like behaviour. 
The amount to which the rat is willing to explore the open arms is a measure of 
the rat‘s intrinsic anxiety because the animal wishes to explore/escape, but will 
be vulnerable when in the open (Pellow et al., 1985; Pellow and File, 1986; 
Adamec et al., 2004). Moreover, the plus maze is a very simple test and 
provides a high degree of utility in measuring emotional reactivity to 
experimental drugs. 
 
1.7 PROGRAMMING 
1.7.1  OVERVIEW 
Mammalian foetuses are exposed to continual chemical signals from conception 
until birth, transported via the maternal blood supply. Among these signals, a 
pronounced role is played by the hormones associated with the stress 
response. Studies of human and nonhumans show that maternal stress during 
pregnancy exerts pervasive, long-lasting effects on the development of the 
foetal nervous system and may eventually affect the offspring‘s physiology and 
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behaviour (Weinstock, 2008; Baker et al., 2009; Lupien et al., 2009; Conrad, 
2011; Del Giudice, 2012; DiPietro, 2012). 
The classical approach in psychology and medicine to maternal stress has been 
to treat it as a disruptive influence on foetal development and a net risk factor 
for future pathology (Van den Bergh et al., 2005; Weinstock, 2005; Mennes et 
al., 2006).  
Conversely, the last decade has witnessed the emanation and consolidation of 
another model, based on evolutionary biology, in which foetal programming by 
maternal stress is seen as an evolved adaptive process (Matthews, 2002; 
Kaiser and Sachser, 2005; Kapoor et al., 2006; Talge et al., 2007; Kaiser and 
Sachser, 2009; Glover et al., 2010; Pluess and Belsky, 2011; Sandman et al., 
2011).  
In humans, maternal stress has been linked with poor coping behaviour under 
adversity, aggressive and antisocial behaviour, ADHD and depression in 
children and adults (Weinstock, 2008). 
Studies in a wide range of species show the major hormonal systems which 
mediate stress responses (including the autonomic nervous system (ANS) and 
HPA axis) can be altered during early life (Plotsky and Meaney, 1993; Liu et al., 
2000a; Huot et al., 2002; Read et al., 2005; McEwen, 2008). Most of the studies 
have been done with respect to the HPA axis, which can be altered or 
‗programmed‘ prenatally by nutrient restriction, exposure to synthetic 
glucocorticoids or maternal adversity and postnatally by neonatal handling, 
maternal deprivation or even infection to a certain extent (Matthews, 2002). 
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Evidence from epidemiological, clinical and experimental studies has clearly 
shown a close link between adverse effects in utero environment and the 
increased risk of psychological, neurological and psychiatric disorders in later 
life (Li et al., 2012). 
Epigenetic phenomenon play a major role in this process such that 
environmental signals can be transmitted from the mother to the foetus, 
impacting upon specific tissues in their sensitive developmental stages; 
modulating normal development trajectory, remodelling their structure and 
function and reprogramming the resiliency or susceptibility for diseases during 
postnatal life (Harris and Seckl, 2011). Such programming processes may be 
determined by factors which include gestational age, duration, mode of 
exposure and the nature of the stressor (Harris and Seckl, 2011). 
Studies have indicated that foetal stresses such as hypoxia, malnutrition, 
substances exposure (nicotine, alcohol and cocaine) and excess 
glucocorticoids (endogenous or exogenous), have a long lasting impact on the 
developing brain; altering the brain‘s ontogeny, organisation, structure and 
function; remodelling the brain‘s developmental trajectory and reprogramming 
its vulnerability or resiliency to some neurobehavioural, neuropsychological and 
neuropsychiatric disorders in later (Seckl and Meaney, 2004c; Harris and Seckl, 
2011). 
Considering the above factors it becomes evident that early-life environmental 
factors for the mother effect prenatal development and may cause permanent 
structural and functional changes. Conceptually, we now refer to this as early-
life programming (Meaney et al., 1996a).  
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The major programming factors responsible for these development changes 
include nutrients and hormones (Meaney et al., 1996a; Seckl, 1998). For 
example, highly lipophilic hormones like sex steroids can easily cross the 
placenta and the blood brain barriers. These are powerful mediators of early-life 
organizational effects (Seckl, 1998; Seckl et al., 2000).  
Prenatal exposure to different types of steroid hormones can be followed to see 
the effects of programming as in the case of early exposure to glucocorticoids 
and early-onset hypertension (Seckl, 2004). 
Animal models of maternal stress feature a wide range of species, e.g. mice, 
rats, guinea pigs and nonhuman primates. These have demonstrated that 
prenatal stress increases offspring HPA axis sensitivity, anxiety and depressive-
like behaviours, as well as cognitive deficits (Kapoor and Matthews, 2005; 
Mueller and Bale, 2007; Darnaudéry and Maccari, 2008). Similarly in 
epidemiological findings, animal models of maternal stress found a temporal 
specificity of stressor exposure and foetal sex were predictive factors (Bale et 
al., 2010).  
Studies showed that early life experiences enhanced prefrontal-dependant 
response, increased exploration behaviour, decreased levels of cortisol and 
reduced anxiety in primates (Parker et al., 2005; Katz et al., 2009).  
A study by King et al. (2009) revealed that acute prenatal maternal stress, 
following exposure to a life-threatening ice storm during the gestational period 
for fingerprint development (the second trimester) resulted in greater 
dermatoglyphic asymmetry in the children. This was most pronounced in those 
with greater maternal distress (King et al., 2009). 
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1.7.2 DEFINITIONS OF PROGRAMMING 
There are different concepts which arise with regards to programming.  Several 
studies have reported that physiological programming of early life experiences 
explains the links between prenatal environment events, changed development 
and growth of the foetus and later disease states e.g. hypertension, type 2 
diabetes, autism and depression (Csaba, 1986; Barker et al., 1993; Edwards et 
al., 1993; Seckl, 1998; Seckl and Meaney, 2004a). 
Various definitions are offered to explain programming, but the most notable 
perhaps comes from Fink (2000). He defines it as the process through which a 
stimulus or insult, when applied during a sensitive or critical period of 
development, results in a long-term or permanent effect on the structure or 
function of the organism (Fink, 2000).  
Subsequently, the concept of early life programming came into existence and it 
defines the action of an external factor during a sensitive developmental period, 
or critical period, this affects the development and organization of specific 
tissues that produces effects persisting throughout life (Fink, 2000).  
At different occasions and time points, cells and tissues are programmable and 
vulnerable to the effects of environmental challenges (Seckl and Meaney, 
2004a).  
1.7.3 MECHANISMS OF PROGRAMMING 
It is clearly understood that higher HPA axis activity confers enhanced response 
to stress and challenge, underpinning some neurobehavioural and psychiatric 
abnormalities (Seckl and Meaney, 2004c; Cottrell and Seckl, 2009; Harris and 
Seckl, 2011). The HPA axis and its key limbic regulator, the hippocampus 
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(Jacobson and Sapolsky, 1991), are particularly sensitive to hormones 
especially the glucocorticoids and their actions (Gould et al., 1991; Welberg et 
al., 2001; Gould et al., 2004; Seckl and Meaney, 2004a). 
As the function of the nervous and endocrine systems is closely integrated with 
behavioural responses, Weinstock (2001) reported that there is evidence that 
behaviour can be programmed during development (Weinstock, 2001). 
Gluckman and Hanson (2004) suggested that this process is helpful from an 
evolutionary perspective allowing organisms to adapt during a single generation 
(Gluckman and Hanson, 2004). 
Studies have reported that prenatal glucocorticoid exposure permanently 
increases basal plasma corticosterone levels in adult rats (Levitt et al., 1996; 
Welberg et al., 2001). Thus, perinatal glucocorticoid exposure increase blood 
pressure and blood glucose levels in adulthood (Seckl, 2004).  
For example studies have shown that administration of dexamethasone (a 
synthetic glucocorticoid used during obstetric practice) to pregnant rats leads to 
reduced birth weight, which reverses by day 21 (Seckl, 2001; Seckl, 2004; 
Seckl and Meaney, 2004b).  
However, both male and female adult offspring of dexamethasone-treated 
pregnancies show elevated blood pressures (Benediktsson et al., 1993). Similar 
adult hypertensive phenotypes are seen in studies on sheep exposed to 
dexamethasone during pregnancy (Dodic et al., 1998; Gatford et al., 2000). 
During the last trimester excess glucocorticoid exposure is sufficient to produce 
adult hypertension in rats (Levitt et al., 1996) and also ‗programmes‘ permanent 
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hyperglycemia and particularly, hyperinsulinemia in the adult offspring 
(Nyirenda et al., 1998). 
Studies suggest a molecular mechanism by which early life environmental 
factors may programme offspring physiology (Levine, 1957; Levine, 1962; 
Meaney et al., 1988b; Meaney et al., 1996b). Meaney et al. reported that 15 min 
of daily handling (NH) of rat pups during the first week or two of its life 
permanently increases GR density in the hippocampus and prefrontal cortex, 
but not in other brain regions (Meaney et al., 1988a). This potentiates the HPA 
axis sensitivity to glucocorticoid negative feedback; keeping plasma 
glucocorticoid levels low throughout life, a state suitable for good adjustment to 
environmental stress (Meaney et al., 1989; Meaney et al., 1992). Similar effects 
were reported with neonatal glucocorticoid exposure as well (Catalani et al., 
1993).  
The NH model appears to be of physiological relevance, since handling 
increases natural variation and maternal care-related behaviours and such 
naturally-occurring maternal behaviour also correlates similarly with 
hippocampal GR expression and the offspring HPA physiology (Liu et al., 
1997b). The long-term manifestations of some prenatal programming stimuli 
can be substantially modified by the immediate postnatal environment (Maccari 
et al., 1995a), suggesting that distinct ‗windows‘ occur. This shows that 
apparently similar early life events may produce different responses depending 
upon their degree, duration, developmental timing or sequence (Seckl and 
Meaney, 2004). 
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In other words in mothers who experience anxiety, the offspring may feel 
anxious or may be programmed to be anxious (Seckl, 2004). There are ample 
studies using rodent models of maternal stress which show substantial links 
between glucocorticoid exposure during gestation and unfavourable behavioural 
characteristics (Harris and Seckl, 2011). For example, Takahashi and 
colleagues compared prenatally stressed rats with non-stressed control rats and 
found that prenatally stressed rats exhibit impaired social behaviour and a 
reduced propensity to play (Takahashi et al., 1992a). Depressive-like 
behaviours are also altered (Smith et al., 2004; Cryan et al., 2005; Cryan and 
Slattery, 2007).  
In rodent models, prenatal stress increases immobility time in the Porsolt test 
and TST leads to anhedonia (Alonso et al., 2000; Sobrian, 2000), effecting 
anxiety as well (Häuser et al., 2009). It is reported that the offspring of 
prenatally stressed rats spend less time than controls in the open arms of an 
EPM (Vallée et al., 1997; Estanislau and Morato, 2006; Murmu et al., 2006) and 
rats from mothers that were prenatally stressed exhibit higher levels of anxiety 
than control rats in novel environments, such as the open field test (Takahashi 
et al., 1992a; Ward et al., 2000; Dickerson et al., 2005).  
A plausible alternative explanation for the increased ‗hyperemotional‘ state of 
prenatally stressed rats is altered functioning of the amygdala (Johns et al., 
2005). The amygdala mediates fear, anxiety-related behaviour, learning and 
memory and thus, is instrumental for the expression of fear-conditioned learning 
(Davis, 1992). The amygdala contains MR, GR and CRF receptors and CRF 
producing cells (De Kloet et al., 1998; De Kloet et al., 2011). 
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Indeed, CRF may be the key neurotransmitter that mediates the effect of 
prenatal stress on anxiety. First, CRF levels are elevated in the central nucleus 
of the amygdala in prenatally stressed or glucocorticoid-treated rats (Cratty et 
al., 1995; Welberg et al., 2000; Welberg and Seckl, 2001). Second, CRF 
injections directly into the amygdala increase anxiety-related behaviour in rats 
(Dunn and Berridge, 1990). 
Maternal stress during gestation can cause a range of long-term effects on the 
offspring (Weinstock, 2001). These include learning difficulties, anxiety, altered 
immune function, reduced attention, as well as changes to the cardiovascular 
responses to stress (Igosheva et al., 2007) and hyperglycemia (Lesage et al., 
2004). Male and female offspring are different in these effects, it found a 
reduction in hippocampal plasticity in male, while in the female and this effect is 
protected from prenatal restraint stress (Darnaudéry and Maccari, 2008). 
Animal studies show that programming effects can last until the second 
generation at least. For example, Drake et al. (2005) found that when pregnant 
females were treated with dexamethasone, this reduced birth weight and 
caused glucose intolerance, which were transmitted to a second generation of 
offspring by both first generation female and male offspring (Drake et al., 2005). 
Glover et al. (2010) suggested, the possibility that epigenetic changes can 
affect both oocyte and sperm  is a controversial finding in biology (Glover et al., 
2010). 
Other studies have shown how variation in the nature of maternal care can have 
long lasting effects on both function of the HPA axis and the behaviour of the 
offspring (Champagne et al., 2004; Fish et al., 2004; Cameron et al., 2005; 
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Champagne and Meaney, 2006; Diorio and Meaney, 2007; Léonhardt et al., 
2007; Meaney et al., 2007; Cameron et al., 2008; Champagne et al., 2008; 
Kappeler and Meaney, 2010) 
 
1.8 MATERNAL BEHAVIOUR 
1.8.1 DESCRIPTION OF RAT MATERNAL BEHAVIOUR 
Numerous researches have comprehensively documented maternal behaviour 
with (the influence of oxytocin, prolactin, estradiol and progesterone priming 
her, the new dam is responsive to her pups from birth onwards (J.S. Rosenblatt, 
1963). The litter sizes range from 8-16 pups and usually consist of an equal 
number of males and females. 
During birth, the dam bites open the amniotic sac, eats the placentas and 
begins cleaning her pups as others emerge (Hudson et al., 1999). Within 30 
minutes after birth, the dam retrieves all of the pups and place them in the nest 
site, licks/grooms them and will adopt a nursing posture over them. Prior to 
weaning (which normally occurs between 21 and 31 day of age), all pups 
remain with the dam. As they mature, they start eating food crumbs from around 
the mother's mouth and fur and eventually, eat food at a distance from the nest 
and drink from a water bottle. Day by day, the pups spend less time in the nest 
with the dam and eventually the dam will move away from her offspring pups 
when they approach to suckle milk. 
During the first 10 days postpartum, there are important maternal behaviours 
displayed intermittently by rat dams, including: 
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1.8.1.1  Retrieval 
Pup retrieval occurs when the dams move her pups (by mouth) from one spot to 
another and inside the nest. This behaviour is observed during the early 
postnatal days, when pups get scattered around the nest, if the dam is suckling 
for instance and suddenly moves out of the nest a few pups attached to the 
teats get pulled from the nest and drop off some distance away.  Normally dams 
retrieve their pups efficiently and quickly replace them in the nest; less maternal 
dams are slow to retrieve the pups. When the dam and pups are in the nest, 
she will frequently pick up/move pups and reposition them. This type of 
behaviour is called ‘pick-ups‘ or ‘mouthing‘ rather than true retrieval (Whishaw 
and Kolb, 2004). 
1.8.1.2 Pup licking 
An important source of stimulation for newborn pups is licking during the early 
postnatal period. A number of studies have confirmed the important effect of 
pup licking on the offspring's developing emotionality (Francis and Meaney, 
1999), physiology (Kuhn and Schanberg, 1998) and cognition (Liu et al., 
2000b). 
Pup body licking and pup anogenital licking are the two types of licking. Body 
licking is observed during nursing, before retrieval and between retrievals, 
whereas anogenital licking is observed while mothers nurse the pups (Whishaw 
and Kolb, 2004). 
Moore (1984) reported that pups show reflexive extensions of limbs during 
anogenital stimulation. This plays an important role in sexual development 
especially in male pups, because that stimulation is important to ensure pup 
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defecation and urination. It also appears that the dams consume urine and 
faeces from their pups perhaps to maintain their own nutritional requirements 
during lactation (Whishaw and Kolb, 2004). 
1.8.1.3 Nursing postures 
Hovering and crouching are the two general types of nursing postures; Hovering 
is a posture when some or all of the pups are in the nest, the dam is positioned 
over them, but the dam is actually licking the pups, self grooming, moving the 
nest material or moving pups within the litter while hovering (Whishaw and Kolb, 
2004). Meanwhile, crouching is considered to be a quiescent posture and 
usually occurs when the pups are sufficiently content. In this posture, the dam 
will stop other activities (e.g. moving the nest material, self grooming, or moving 
pups within the litter) and maintain herself in arched back position above her 
pups (Whishaw and Kolb, 2004). This posture is important helping to protect the 
pups from any environmental hazards, allowing them access to her teats for 
milk and regulating their temperature (Whishaw and Kolb, 2004). 
1.8.1.4 Nest building 
Nest building (in which the dam collects and gathers nesting materials to one 
site) is one of the maternal behaviours that is observed and recorded during a 
maternal behaviour test. Whishaw and Kolb, (2004) rated the nest building to 
five numbers; 1, no nest; 2, some material arranged in one location; 3, 
moderate, when low walls can be seen; 4, good nest, when walls are round and 
distinct; and 5, excellent nest, when walls of the nest are high and can take all 
the pups. 
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1.9 AIMS AND OBJECTIVES 
1.9.1 BACKGROUND 
Gestational Stress (GS) in rat dams causes behavioural effects (depressive-like 
behaviour, heightened anxiety-like behaviour and impaired cognitive function) 
and neuroendocrine changes such as impaired Hypothalamic-Pituitary-Adrenal 
(HPA) axis negative feedback in response to acute stress challenge, in the 
offspring at all postpartum ages tested to date). There are two possible 
mechanisms have been offered as explanations for how gestational stress 
induces these alterations in the offspring: 
1- In utero exposure of the rat foetus to circulating maternal stress 
hormones that affect the phonotype of the offspring. 
2- Reduced quality and quantity of maternal care shown by gestational 
stress dams that permanently alter the offspring. Maternal care occurs in 
nesting bouts during which the dams adopt nursing postures above 
(resembling a canopy) or beside (supine) their pups; lick and groom the 
ano-genital regions of the pups; and retrieve pups to the nest. 
1.9.2 AIMS 
1. We contend that disruptions of maternal behaviour caused by prenatal stress 
(PS) contribute to behavioural and physiological disturbances in the offspring. 
Furthermore, we speculate that impaired maternal behaviour in rats may model 
human postnatal depression and therefore, antidepressant agents should act to 
reinstate normal maternal behaviour in prenatally-stressed dams. Obviously, 
intrinsic changes in neurochemical and hormonal systems in both mother and 
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pup underlie PS effects; however, some of these disrupt mother-pup 
interactions and this contributes to the programming of offspring behaviour and 
physiology. Such interactions constitute a potentially valuable target for 
therapeutic intervention, but a number of issues need to be clarified and a 
detailed analysis of maternal behaviour following PS has to be made initially.  
2. The change in maternal care following GS in the rat dam represents a form of 
postpartum depression, as it correlates with higher immobility scores in the 
Porsolt test. Administration of known antidepressant drugs to the dams should 
reduce these immobility times and simultaneously elicit increased maternal 
care. 
1.9.3 OBJECTIVES  
1- Is a period of stress during pregnancy sufficient to induce symptoms in 
the mother rat that model depressive states? We hypothesize that 
restraint stress; performed on a daily basis for the last half of the 
pregnancy should increase immobility (a measure of depressive-like 
behaviour) of the dams in a forced swim task. 
2- If changes in rat maternal behaviour model human postnatal depression 
then antidepressant administration should act to normalize maternal 
behaviour in the rats. Using either a Serotonin Specific Reuptake 
Inhibitor (SSRI) such as sertraline, or a Tricyclic Antidepressant (TCA) 
such as imipramine, should reinstate normal maternal behaviour and act 
to offset the enduring effects of PS on the progeny. Antidepressants are 
efficacious in human depression and therefore they should ameliorate or 
diminish the impaired maternal behaviour of the rat.  
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3- To contribute further to the data suggesting that GS effect on maternal 
behaviour in the rat dam represents a novel and far more valid, model of 
human depression, than existing paradigms (such as olfactory 
bulbectomy). Moreover, to our knowledge, this is the first model that 
specially addresses post-partum depression, a condition that is poorly 
identified and one for which effective treatments have yet to be 
determined. In particular, if the model has predictive validity for 
antidepressant actions then this feature can be used to assess novel 
pharmacotherapies. Moreover, if the model shows predictive validity for 
antidepressant drugs, then it can replace current procedures such as the 
olfactory bulbectomy technique, which is invasive and has greater 
severity levels for the animals. 
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2. MATERIALS AND METHODS 
2.1 ETHICAL APPROVAL 
This project was carried out at the University of Bradford Biological Services 
Unit (BSU). All experiments were carried out in accordance with the UK Animals 
(Scientific Procedures) Act 1986, under Home Office project licence No. 
40/3415 and personal licence No. 40/10095 (Ali M. Alrumaih), following 
approval from the local ethics committee (see appendix). Housing, handling and 
testing of the animals were conducted according to Home Office regulations for 
investigations on live animals. These studies were funded by a Framework 
(FP7) European Union Grant (MOODINFLAME).  
 
2.2 HOUSING AND HUSBANDRY 
Lister hooded rats, male and female, were purchased from Harlan (UK) or 
Charles River (UK) for breeding. The change in supplier was due to an 
unexpected shortage of breeding stock from the primary source (Harlan, UK). 
Animals weighed between 120-260 grams upon arrival. The males and females 
were left to acclimatise in a designated holding room in the facility for one week, 
to overcome any transportation stress.  
Male and Female rats were housed in groups of five (same sex) in standard, 
polycarbonate cages. The rats had free access to food (Harlan, UK), consisting 
of 18% protein in a compacted pellet and had ad libitum tap water. The bedding 
was Grade 6 woodchip, with additional sizzlenest nesting, plastic enrichment 
products and aspen chew blocks (Datesand LTD, Manchester). Housing 
conditions were strictly regulated; temperature was maintained at 22±1⁰C, with 
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52±2 % humidity. The light/dark cycle was on from 7am until 7pm and off from 
7pm. Cages were cleaned once a week by BSU animal technicians. However, 
when pups were born, cleaning of the cages was carried out by the 
experimenter, at appropriate times to reduce the impact of stress on the Dam 
and her litter. 
 
2.3 MATING 
Three female rats (12 weeks old, approximately 150g) were placed overnight 
with adult males (n=2) for the purpose of mating. The males and females 
remained together overnight and the females were checked the next morning 
for the presence of sperm (by smear test) or a vaginal plug. 
 
2.4 SMEARING 
To assess if mating had occurred each female rat underwent a vaginal smear 
test on the morning following being housed with a male(s). 
The female was smeared using a small dropper with a rounded tip containing 
approximately 100 µl of warm water. The dropper tip was gently introduced into 
the opening of the vagina and the water was pumped into the vagina and 
immediately sucked back into the dropper by depressing one releasing a rubber 
bulb on the opposite end of the dropper. The sample was then aliquoted onto a 
glass slide. Using a microscope (Zeiss-Standard 20, Germany) at 400X 
magnification, slides were examined for the presence of sperm. If smears 
screened positive for sperm, females were re-housed in a new cage. Females 
giving a negative smear were returned to the mating cage. 
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Females with positive smears were designated as gestational day 0. 
A few females had mucous plugs covering the vaginal opening indicating 
mating had occurred and were transferred to new cages without being smeared. 
 
2.5 HOUSING OF PREGNANT RATS 
Pregnant rats were group housed (n=5) into a fresh cage (60 × 80 × 20 cm3; 
Techniplast, UK) as detailed before. 
The pregnant rats were left undisturbed until gestation day 10, at which time 
each animal was randomly assigned into either a control (non-stressed) or 
experimental (stressed) condition (Figure 2-1). Once they were assigned as 
control or stressed and had undergone the relevant procedure, animals were re-
housed from the group cages into single cages, for the remainder of their 
gestational period. It is important to note that each pregnant Dam was assigned 
to a new cage, and identified only by a coded cage card such that all testing 
could be conducted in a ‛blind‘ fashion. For each separate behavioural test 
another lab member would assign which animals were to be tested. The 
experimenter only had sight of the coded card and was unaware of which 
group, drug or day of gestation/postnatal time. All testing was done in a similar 
manner. 
Note too that for the purposes of clarity in the reminder of this dissertation the 
word ‘Dam‘ with a capital ‘D‘ refer to the Dams in our studies. Use of ‘dam‘ 
indicates animal mothers in other studies. 
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2.6 GESTATIONAL STRESS 
2.6.1 PROCEDURE  
For gestational days 10-20, pregnant rats were randomly assigned to be either 
a control or stressed animal (Figure 2-1). The females assigned as stressed 
were transferred from the maternity room to a procedure room and individually 
placed into clear perspex restrainer tubes (99mm x 320mm ,500gm model-
AH002D, VetTech Solutions LTD), for 1h which usually occurred between 
(08:00 and 09:00 am). This chronic restraint stress technique was selected in 
view of its effectiveness in inducing overt neurobehavioural changes as 
reported in previous studies (Barlow et al., 1978; Chapman and Stern, 1979; 
Ward and Weisz, 1984; Kinsley and Svare, 1986; Vallée et al., 1997; Smith et 
al., 2004; Darnaudéry and Maccari, 2008).  
Each restrainer consists of a ventilated tube with one end sealed by an 
adjustable rubber blocker used to increase/decrease the horizontal length of the 
restraining area (useful for setting the restraint space according to the size of 
the rat) (Figures 2-2, 2-3). The animal was transferred into the restrainer 
through the open end of the tube, which was then shut with a guillotine-type 
door, restricting the rat in the confined space (Figures 2-2, 2-3). It should be 
noted that the animal was not immobilized by the restrainer, but confined to a 
tight space and visible at all times. The consensus opinion is that restraint 
increases the animals‘ degree of fear and sense of vulnerability, without causing 
physical discomfort or harm. The animal can turn around, groom and scratch, 
but generally remains motionless and appears lethargic. Urine drains out 
through the various ventilation openings that perforate the tube. Faeces tend to 
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collect within the tubes and the high degree of defecation is taken as a signal of 
the animal‘s heightened emotionality. 
The females were placed into the restraint chamber during normal lighting and 
room conditions for 60 minutes (Figures 2-2, 2-3). During the restraint period, 
the rats were continually observed for any unusual behaviour, ensuring strict 
adherence for their welfare.  
Once the procedure was completed, the Dams were returned to their single 
cages, restraining devices were washed and cleaned and the Dams were 
observed for 30 minutes for any subsequent abnormalities or behavioural 
disturbances. 
The gestation period usually lasted for 21-22 days. Control, pregnant females 
were left undisturbed throughout their gestation periods (Figure 2-1), other than 
routine husbandry and weight monitoring. 
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Figure ‎2-2: Pictures showing open restrainers and 
the restraining area after adjusting the rubber 
blocks. 
Figure ‎2-3: Picture showing pregnant rats 
undergoing restraint. 
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2.7 PRENATAL PORSOLT  
2.7.1 PROCEDURE 
 
Between days 17-20 of gestation, randomly selected control and stressed Dams 
underwent a Porsolt swim challenge (Figure 2-4) to assess immobility times. 
The test was conducted over two days; it consisted of an initial exposure day 
(day 17) for 15 minutes and, an experimental day for 5-10 minutes (day 18). On 
each occasion the water depth was adjusted for the size of the Dam such that 
the hind limbs could touch the bottom of the water chamber when fully extended 
and the animal could reach the water surface with its snout to breath. The 
overall chamber dimensions were 260X280X295mm (Height X Width X 
Diameter) (Figure 2-4). Pregnant rats were placed in the water chamber for the 
appropriate times and the total duration of immobility was recorded. The initial 
struggling activity that rats exhibit is eventually replaced by a periods of total 
immobility, which reflects learned helplessness‘. The animals then cycle 
between active and passive states in an irregular fashion. The duration of 
immobility in stressed and control rats was recorded by the experimenter using 
a digital timer. The water temperature was maintained at 20-22⁰C these 
temperatures minimize immobility times and thus measures of immobility 
represent a more robust outcome (Smith et al., 2004). 
The procedure induces a fear-response, but this is minimised by employing a 
short duration exposure transient (Butler et al., 1990; Vallée et al., 1997; Korte, 
2001; Korte et al., 2007). All test sessions were recorded using Logitech® HD 
Webcam cameras C510 connected to computers and, immobility times also 
were recorded from the live images displayed on the computer monitors. This 
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technique reduces influences caused by the experimenters‘ presence (Figure 2-
10). The camera was positioned 90cm above the chamber. After completion of 
the experiment, the animal was immediately placed into a bucket, under a heat 
lamp to aid drying and reduces hypothermia (Figure 2-5). The water in the 
Porsolt chamber was replaced after each test. Once the animals were 
completely warmed and dried, they were then transferred to their home cages 
and routinely monitored for residual signs of distress (e.g. lack of grooming, 
failure to feed, restlessness, timidity, or lethargy) for 60 minutes. 
These animals were administered the peritoneal antidepressant or vehicle 
following birth, but neither they nor their progeny were used or tested in any 
further behavioural procedure. Tissues were harvested at weaning from the 
Dams; however, the pups were discarded. The exposure of the control Dams to 
the significant stress of the prenatal Porsolt test confounds any results, after 
birth because the control group is no-longer stress free and therefore results 
might be compromised. 
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Figure 2-4: Picture showing water chamber used in Porsolt test.  
 
 
Figure 2-5: Picture showing experimental animal under the heat lamp.  
Pregnant dam or offspring were kept for ten minutes to be dried completely. 
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2.8 EXPERIMENTAL GROUPS 
2.8.1 MOTHERS 
After the birth, the females were left for one day to acclimatise (day 0) and on 
day 1, litters were cross-fostered and culled to 5 males and 5 females. Different 
coloured bedding for stressed and control Dams assisted in coding the 
gestational treatment and with assessment of nest parameters (size, shape, 
quality and area of bedding) since the bright coloured material stands out from 
the typical brown materials. (1) a 20 grams brown colour, Grade 6 woodchip, 
with Sizzlenest nesting, plastic enrichment products and aspen chew blocks, all 
from Datesand LTD, Manchester and 5 grams of yellow 511 sizzle nest bedding 
from [SCA packaging stabox (The Netherlands)] for control (Figure 2-6) or (2) a 
20 grams brown bedding and 5 grams of orange 048 sizzle nest bedding which 
[SCA packaging stabox (The Netherlands)] for stressed groups (Figure 2-7). 
Control and stressed Dams were assigned to receive either vehicle (saline) or 
drug (sertraline /imipramine) on the day of birth. 
This created 4 experimental conditions: 
1. Control (C) + Vehicle (0.9% Saline) - This group (n=20) were left undisturbed 
during gestation and were given daily vehicle injections on postnatal days 1-10 
(Figure 2-6). 
2. Control (C) + Drug (imipramine hydrochloride-15mg/kg from Sigma Aldrich® 
or sertraline hydrochloride-10mg/kg from Tocris Bioscience) - These groups 
(n=13 imipramine) or (n=13 sertraline) (Figure 2-6), consisted of mothers that 
were left undisturbed during gestation and were given daily drug injections of 
either imipramine HCL or Sertraline HCL on each of postnatal days 1-10. 
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3. Prenatal Stress (PS) + Vehicle (0.9% Saline) - This group (n=20) consisted of 
prenatally stressed mothers that were given daily vehicle injections on postnatal 
days 1-10 (Figure 2-7).  
4. Prenatal stress (PS) + Drug (imipramine hydrochloride-15mg/kg from Sigma 
Aldrich® or sertraline hydrochloride-10mg/kg from Tocris Bioscience - these 
groups (n=11 imipramine) or (n=11 sertraline) consisted of mothers that were 
stressed prenatally and administered imipramine HCL-15mg/kg or Sertraline 
HCL-10mg/kg on each of postnatal days 1-10 (Figure 2-7).  
All injections were given as 1ml/kg intraperitoneally dissolve in 0.9% saline. 
Drug doses were selected based on a wide survey of the literature, and 
represent mid-range concentrations. It is important in terms of animal usage 
and cost to test dose-response curves for this type of gestational work, and the 
current protocol methods existing research groups in the field. 
Figure ‎2 7: Picture showing stressed mother with brown and 
orange sizzle bedding. 
Figure ‎2 6: Picture showing control mother with brown 
and yellow sizzle bedding. 
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2.8.2 WEANING 
At 21-22 days postnatally entire litters were re-housed into new cages for use in 
assessing prenatal stress and/or antidepressant effects on offspring behaviours. 
Offspring were tested in the elevated plus maze or the Porsolt swim test 
between 40-50 days of age, but each animal was tested only in one condition. 
Immediately following testing these offspring were killed and tissues were 
harvested. 
Initially, the entire litters were transferred into the weaning cage, and the coded 
numbering system identifying gestation condition and postnatal drug treatment 
was copied onto the cage tags. As the offspring grew into juvenile and early 
adulthood (50-60 days of age), the male and female litters were devolved into 2 
new cages. The same coding was maintained and the experimenter remained 
blinded to group identification. For a given Run, there would be similar, but not 
identical numbers of cages for offspring groups. 
Any behavioural testing which entailed progeny of any or all 4 experimental 
groups was established as follows: an unblended lab confederate identified the 
cage numbers that would be used to draw subjects from, ensuring that the 
appropriate experimental groups and sample sizes were evenly represented as 
much as possible. Furthermore, offspring were routinely selected from all cages 
such that individual litters, representing only a single Dam, were never over-
represented in the behavioural tests. 
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2.8.3 OFFSPRING 
The male and female offspring of stressed and control Dams formed 4 
experimental conditions: 
1. Control–Vehicle (CV) - This group consisted of the offspring (n= 79; Male = 
39; Female = 40) born of mothers which were left undisturbed during gestation 
and had received daily injections of vehicle (0.9% Saline) on postnatal days 1-
10 (Figure 2-6). 
2. Control – Drug (CD) - This group consisted of the offspring (n=98; Male = 51; 
Female = 47) born of mothers which were left undisturbed during gestation and 
had received daily injections of imipramine hydrochloride-15mg/kg (Sigma 
Aldrich®) or sertraline hydrochloride-10mg/kg (Tocris Bioscience) on postnatal 
days 1-10 (Figure 2-6). 
3. Prenatal stress – Vehicle (SV) - This group consisted of the offspring (n= 78; 
Male = 41; Female = 37) born of mothers which were stressed during gestation 
and had received daily injections of vehicle (0.9% Saline) on postnatal days 1-
10 (Figure 2-7).  
4. Prenatal stress – Drug (SD) - This group consisted of the offspring (n= 80; 
Male = 41; Female = 39) born of mothers that were stressed during gestation 
and had received daily injections of imipramine hydrochloride-15mg/kg (Sigma 
Aldrich®) or sertraline hydrochloride-10mg/kg (Tocris Bioscience) on postnatal 
days 1-10 (Figure 2-7). 
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2.9 POSTNATAL PORSOLT MOTHERS 
2.9.1 PROCEDURE 
Selected Dams were assessed using the Porsolt procedure at specific times 
following birth. The test was carried out over two days as before and consisted 
of the Dam being placed in the water chamber for 10 minutes as the exposure 
day and for 5 minutes on the experimental day 24hr later.  
All parameters were observed as per the prenatal Porsolt test and immobility 
times were again recorded for each of the exposure and experimental days 
(Figure 2-8). Rats were only tested with the Porsolt procedure once, i.e. a 
pregnant Dam tested prenatally was not subjected to a postnatal Porsolt test. 
The Porsolt test was always administered to naive rats. 
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2.10 OFFSPRING PORSOLT  
2.10.1 PROCEDURE  
Selected offspring (males and females) were subjected to the Porsolt test at 40-
50 days of age. The test was carried over 2 days, as before.  
All parameters of the test were done as per the prenatal Porsolt test procedure. 
 
Figure ‎2-8: Schematic diagram of the Porsolt video recording system. 
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2.11 ELEVATED PLUS MAZE (EPM)  
2.11.1 APPARATUS 
The elevated plus-maze is comprised of two open arms without walls (10cm in 
width) and two closed arms (10cm in width) enclosed by walls (8.5cm) in height. 
These walls extended from a shared central point (10cm²) (Figure 2-9). Each 
arm is 44cm long. The apparatus is constructed from clear plexiglas and 
elevated to a height of 72cm above floor level. The floor of each arm is covered 
with a rubber mat to assist animals to walk without slipping. Rats are curious 
animals and will explore their environment (White, 1959; Martin and Bateson, 
1993; Cavigelli, 2005); however, stressors often increase anxiety-like behaviour 
(Rodgers and Cole, 1993; Padovan and Guimarães, 2000; Adamec et al., 
2004). The amount to which the rat is willing to explore open arms is a measure 
of the rat‘s intrinsic anxiety (Pellow et al., 1985; Pellow and File, 1986; Adamec 
et al., 2004). 
All test sessions were recorded using a Logitech® HD Webcam camera C510 
connected to a computer, to minimise the influence caused by the presence of 
an experimenter and this was placed (90cm) above the apparatus.  
 
2.11.2 PROCEDURE 
On days 4 and 10 post-birth, selected Dams underwent anxiety assessment. 
The Dam was transported to the procedure room and placed on the centre point 
(facing an open arm) of the EPM. Rats from each condition were selected 
randomly for testing. In between each animal tested, the EPM was wiped 
cleaned with 70% ethanol (Sigma Aldrich®). 
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Entry into the open arms and closed arms was counted as defined by when the 
whole head and body of the rat were in that arm. However, if the rat fell from the 
platform, the trial time was stopped and resumed once the rat was replaced in 
the same position prior to the fall. The recordings were scored some later point 
by two individuals to ensure consistency. Times spent in the middle, central 
point, time spent in each arm and number of arm entries were recorded. The 
entire test trial lasted 5 minutes and each animal was exposed to the EPM only 
once. 
 
Figure ‎2-9: Picture showing the elevated plus maze with dimensions for open arms, closed arms 
and the height used for testing rat mothers and their offspring.  
Underneath the maze we positioned soft padding material to eliminate harm to any rat that fell off 
the maze. 
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2.12 MATERNAL BEHAVIOURS ASSESSMENT 
On the second day after parturition, mothers were observed and recorded using 
a Logitech® HD Webcam camera C510 connected to a computer to preserve 
images of maternal behaviours of Dams that could be closely inspected at a 
later point. Electronic recordings also eliminated any interference or confounds 
caused by the presence of an experimenter, on any of the Dam‘s behaviours. 
The maternal behaviours were sampled for 30 min on any of postnatal days 1-
10.  The maternal cage was placed in a rack with the camera positioned above 
it.  
The Dam was given 10 min to acclimatise to the new cage position. The 
recordings were carried out in the maternity holding room to minimize 
behavioural disturbances caused by cage transport, and external noises. To 
eliminate observational bias, the maternal behaviours from the videos were 
scored by two independent assessors blinded to the animal‘s treatment 
conditions. The following are descriptions of the various maternal behaviours 
examined; 
Licking/Grooming Pups (LG): whether the mother was L/G the body or 
anogenital region of pups. 
Arched Back Nursing (ABN); whether a Dam was nursing her pups with her 
back clearly arched and legs spread as in a canopy position or lying supine to 
suckle the pups (Figure 2-10, 2-11). 
Behavioural measures were taken as the total time when the animal engaged in 
the particular behaviour during a 30 minute observation period. Scores from 
both observers were averaged to give an aggregate total time value. 
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Figure ‎2-10: Picture showing Arched back nursing (ABN). 
 
Figure ‎2-11: Picture showing an example of supine nursing. 
122 
 
No contact; when the mother was absent from the nest (Figure 2-12). 
 
Retrieval of pups; where the mother picked/moved her pups by mouth from one 
spot to another in the cage (Figure 2-13). 
 
 
         Figure ‎2-12: Picture showing mother absent from her nest. 
          Figure ‎2-13: Picture showing the mother retrieving a pup. 
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Nest building: whether a Dam was engaged building the nest or changing the 
architecture of the existing nest (Figure 2-14). 
 
Time in the nest: total time that the mother spent inside the nest or in close 
contact with her pups. 
 
 
 
 
 
 
Figure ‎2-14: Picture showing mother were building her nest. 
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2.13 ASSESSMENT OF MATERNAL NESTING 
Every morning from PND2-10 cages were inspected for nest construction and 
pictures were taken.  
In order to score nesting behaviour the following parameters were observed: 
i- Cages were arbitrarily divided into 5 quadrants to ascertain the position of the 
nest as: 1) Top Left; 2) Top Right; 3) Bottom Right; 4) Bottom Left; 5) ; and 
Centrally Located nest (Figures 2-15 and 2-16). 
ii- Amount of nesting materials used over a 10 day period. 
iii-Frequency of nest moves. 
 
 
 
 
Figure ‎2-15: Picture showing the quadrant divisions. 
1 as top left, 2 as top right, 3 as bottom right, 4 as bottom left, and 5 as central of the cage 
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2.14  STATISTICAL ANALYSIS 
All statistical analyses were carried out using the statistical package StatView® 
(SAS Institute.) and Excel® program to produce graphs. 
We have the prenatal condition as one variable (Control or Stressed) and 
another variable for treatment (Vehicle or Drug), where appropriate Day of 
testing appears as a repeated-measures variable, for instance maternal 
behaviours was examined on select postnatal days to determine if either 
prenatal condition or postnatal treatment effects emerged or diminished as the 
pups grew. 
Significant main and/or interaction effects were examined using a posteriori 
tests using Bonferroni-corrected f-tests maintaining the experiment-wise alpha 
level equal to p<0.05. 
Figure ‎2-16: Diagram illustrating the Cage specifications. 
it shows 1 as top left, 2 as top right, 3 as bottom right, 4 as bottom left, and 5 as 
central of the cage ,numbers 1 and 2 assigned as the distance from water and food 
hopper wither closed or far. 
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Data for Dams and offspring were managed the same, save to note that for the 
offspring prenatal condition and postnatal drug treatment refers to the mothers 
of the offspring.  
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CHAPTER THREE:    
RESULTS 
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3. RESULTS 
3.1 EFFECTS ON WEIGHTS 
3.1.1 EFFECT OF PRENATAL STRESS ON RAT GESTATIONAL WEIGHTS 
Figure 3-1 shows the effects of prenatal stress on Dam weights for gestation 
days 11-19. A repeated measures ANOVA showed that non-stressed Dams 
gained significantly more weight over the 8 days in comparison to the stressed 
Dams (F(7,364)=2.82, p<0.045). 
 
Figure ‎3-1: Mean Cumulative weight gain (g) during gestational days 11-19, for control and gestationally-
stressed Dams.  
Data shown are Means ± SEM. 
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3.1.2 POSTNATAL DAMS WEIGHTS AND THE EFFECTS OF SERTRALINE 
Figure 3-2 depicts postnatal Dams‘ weight measured over postnatal days 1-10. 
An ANOVA on the postnatal Dams‘ weights revealed no effect of prenatal 
condition with (F(1,200)=0.01, p<ns). As can be seen in Figure 3-2  below, the 
weight over days 1-10, in aggregation shows that stressed Dams have a slower 
weight gain than that of the control Dams. A similar ANOVA examining the 
effects of drug treatment (sertraline, 10mg/kg) on postnatal weight gain of 
Dams, revealed a significant effect of sertraline with (F(1,200)=7.62, p<0.01).  
An ANOVA examining the interaction between drug treatment (sertraline, 
10mg/kg) and prenatal condition revealed a significant interaction with 
(F(8,200)=3.20, p<0.002). 
As can be seen in Figure 3-2, all Dams showed modest weight gains over 
postnatal days 1-10, but the magnitude of this effect was reduced in all animals 
administered sertraline. 
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Figure ‎3-2: Mean postnatal cumulative weight gain (g) of Dam’s days, 1-10 after giving birth. 
Data represent the mean weight gain (cumulative) for Dams who had undergone gestational restraint stress, 
and non-stressed controls. Sertraline (10mg/kg) or vehicle (saline). 
Data shown are means ± SEM for each group of Dams. 
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3.1.3  POSTNATAL DAM WEIGHTS AND THE EFFECTS OF IMIPRAMINE 
Figure 3-3 depicts postnatal Dams‘ weight measured on postnatal days 1-10. 
An ANOVA on the postnatal Dams weights showed no effect of prenatal 
condition with (F(1,43)=0.49, p<ns). As can be seen in Figure 3-3 below, the 
weights over days 1-10, in aggregation show that stressed Dams have a slower 
weight gain than that of the control Dams. A similar ANOVA examining the 
effects of drug treatment (imipramine, 15mg/kg) on postnatal weight gain of 
Dams, revealed a significant effect of imipramine with (F(1,43)=20.12, 
p<0.0001). An ANOVA examining the interaction between drug treatment 
(imipramine 15mg/kg) and prenatal condition revealed a significant effect on 
Dam weights with (F(8,344)=5.67, p<0.0001). 
In contrast to the sertraline treatment, those Dams receiving imipramine showed 
negative weight gain over postnatal days 1-10 and only achieved basal weight 
levels at 10 days. This effect was slightly more pronounced in the stressed  
Dams. 
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Figure ‎3-3: Mean postnatal cumulative weight gain (g) of Dams from days 1-10. 
For those which had undergone gestational restraint stress and non-stressed controls on 
imipramine (15mg/kg) or vehicle (saline).  
Data shown are Means ± SEM. 
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3.1.4 OFFSPRING WEIGHT AND THE EFFECTS OF SERTRALINE 
Figure 3-4 shows litter weights measured from postnatal day 1-10. An ANOVA 
on the postnatal litter weights revealed a main effect of prenatal condition with 
(F(1,40)=3.56, p<0.05). As can be seen in Figure 3-4 below, the aggregated 
weight over days 1-10, shows that litters from stressed Dams have a slower 
weight gain than litters from the control Dams. A similar ANOVA examining the 
effects of sertraline (10mg/kg) postnatally on Dams‘ litter weights, revealed no 
significant effect of sertraline on litter weight gains with (F(1,40)=1.31, p<ns). An 
ANOVA examining the interaction between drug treatment (sertraline, 10mg/kg) 
for Dams postnatally and their prenatal condition revealed no significant 
interaction with (F(8,320)=2.51, p<ns). 
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Figure ‎3-4: Mean pups cumulative weight gain (g) from days 1-10. 
From stressed and non-stressed Dams on either drug sertraline (10mg/kg) or vehicle 
(saline).  
Data shown are Means ± SEM. 
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3.1.5 OFFSPRING WEIGHTS AND THE EFFECTS OF IMIPRAMINE 
Figure 3-5 shows litter weights measured from postnatal day 1-10. An ANOVA 
on the postnatal litter weights revealed no effect of prenatal condition with 
(F(1,44)=2.649, p<ns). As can be seen in Figure 3-5 below, litter weight over 
days 1-10 show that stressed Dams‘ litters have a slower weight gain than 
those litters from control Dams. A similar ANOVA examining the effects of 
imipramine (15mg/kg) administered postnatally to the Dams revealed a 
significant effect of imipramine on litter weights with (F(1,44)=9.37, p<0.003). An 
ANOVA examining the interaction between drug treatment (imipramine, 
15mg/kg) for Dams postnatally and prenatal condition revealed a significant 
effect interaction with (F(8,352)=14.46, p<0.0001). 
Again, it is obvious that litters from Dams administered imipramine showed 
diminished weight gains for most of postnatal days 1-10, although by postnatal 
day 10, there was a tendency for all litters to be similar in weight. 
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Figure ‎3-5: Mean pups cumulative weight gain (g) from days 1-10. 
From stressed and non-stressed Dams on either imipramine (15mg/kg) or vehicle (saline).  
Data shown are Means ± SEM. 
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3.2 PRENATAL PORSOLT TEST IN PREGNANT DAMS 
Figure 3-6 shows the immobility times recorded from pregnant Dams on 
gestation Day 17 (Exposure day-15 minutes) and Day 18 (Experimental day 5-
10 minutes). An ANOVA comparing Control and Stressed Dams on the Day 17 
immobility data revealed a significant effect with (F(1,39)=4.02, p<0.05).         
A similar ANOVA for the Day 18 immobility data showed no significant effect 
with (F(1,39)=2.09, p<ns). The data are illustrated in Figure 3-6 below. 
Overall, there was a tendency for stressed Dams to show greater immobility in 
the Porsolt test, an effect that achieved statistical significance for gestational 
day 17. 
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Figure ‎3-6: Shows the Prenatal Porsolt data from control and stressed Dams at Days 17 and 18 
of gestation (Exposure Day and Experimental Day).  
Data shown are Means ± SEM. 
*Significantly different, P<0.05, Bonferroni t-test. 
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3.3 POSTNATAL PORSOLT DATA FOR DAMS AND THE 
EFFECTS OF IMIPRAMINE 
 
Postnatal Porsolt testing was done on Dams at postnatal day 9 (Exposure day -
10 min) and day 10 (Experimental day-5 min). An ANOVA on the data for the 
Exposure Day revealed no significant effect of prenatal condition with 
(F(1,33)=0.006, p<ns). An ANOVA on these data revealed no significant effect 
of postnatal drug treatment (imipramine 15mg/kg) on immobility times with 
(F(1,33)=1.1, p<ns). An ANOVA examining the prenatal condition by postnatal 
imipramine (15mg/kg) interaction revealed no significant effect on immobility 
times with (F(1,33)=1.13, p<ns). 
Figure 3-7 shows that stressed Dams given imipramine (15mg/kg) exhibited 
higher immobility times, but this was not significant in comparison with the other 
groups.  
An ANOVA on the data for the Experimental Day revealed no significant effect 
of prenatal condition on immobility times with (F(1,33)=1.05, p<ns). An ANOVA 
on these data revealed a significant effect of postnatal imipramine (15mg/kg) 
treatment on immobility times with (F(1,33)=4.28, p<0.05. An ANOVA 
examining the prenatal condition X postnatal imipramine (15mg/kg) interaction 
revealed no significant effect on immobility times with (F(1,33)=0.26, p<ns). 
Figure 3-7 shows that stressed Dams who had been given imipramine and 
exhibited reduced immobility times in comparison with non-drug treated groups. 
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           Figure ‎3-7: Shows data for the control and stressed Dams following birth.  
           Dams were treated with imipramine (15mg/kg) administered daily following birth.  
           Data shown are Means ± SEM. 
            *significantly, different from same group animals were given saline, p<0.05, Bonferroni t-test. 
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3.4 OFFSPRING PORSOLT AND THE EFFECTS OF 
IMIPRAMINE  
 
Figure 3-8 illustrated the data obtained for the Porsolt test in offspring of 
gestationally-stressed and control rat Dams. After giving birth, Dams were 
treated with saline (vehicle) or imipramine (15mg/kg) daily for 10 days. Offspring 
were weaned on postnatal days 20-21 and tested at 40-50 days of age. Panel A 
shows immobility times for male and female offspring recorded at the initial test 
( the Exposure Day), while Panel B reveals the immobility times recorded for the 
second day of testing (the Experimental Day). Note that the Exposure Day trial 
is 10min in duration, while the Experimental Day trial test is only 5min. 
An ANOVA on the data for the Exposure Day revealed a significant effect of 
prenatal condition on immobility times with (F(1,127)=25, p<0.0001), which 
shows that offspring of stressed Dams exhibited lower immobility times in 
comparison to those offspring of control Dams. There was also a significant 
effect of postnatal drug treatment on immobility times with (F(1,127)=4.5, 
p<0.04), this significant effect was not altered by postnatal imipramine 
treatment, although imipramine itself decreased immobility times in both control 
and stressed offspring. Moreover, there was no significant effect of gender 
(male or female) with (F(1,127)=2.45, p<ns. There was no significant effect of 
prenatal condition X postnatal drug treatment X gender immobility times 
interaction for these data (F(1,127)=0.23, p<ns). 
An ANOVA on the data for the Experimental Day as shown in Panel B, revealed 
a significant effect of prenatal condition on immobility times with (F(1,127)=14.4, 
p<0.0002), which showed that offspring of stressed Dams exhibited lower 
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immobility times in comparison to those of offspring from control Dams.  
However, there was no significant effect of postnatal drug treatment on 
immobility times with (F(1,127)=1.65, p<ns). Moreover, there was a significant 
effect of gender (male or female) with (F(1,127)=3.5, p<0.05, which showed that 
males and females of prenatally-stressed Dams exhibit lower immobility times in 
comparison to those of offspring from control Dams. There was a significant 
effect of prenatal condition X postnatal drug treatment interaction for these data 
with (F(1,127)=6.4, p<0.01). There was no significant effect of prenatal 
condition X postnatal drug treatment X gender immobility times interaction for 
these data with (F(1,127)=0.46, p<ns), this showed that imipramine treatment 
decreased immobility times in gestationally stressed offspring. 
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A. Exposure Day (10min) 
 
B. Experimental Day (5min) 
 
Figure ‎3-8: Immobility times for the Porsolt task recorded from the offspring (male and 
female) of gestationally stressed or control rat Dams following postnatal drug or 
vehicle treatment of the Dams immediately after birth. 
Offspring were tested on 2 consecutive days (Exposure and Experimental Days) after 
they had reached adolescence (40-50 day old). 
Data shown are Means ± SEM. 
* Significantly differences between offspring of control and gestationally stressed 
Dams and significant differences between vehicle and imipramine-treated animals, 
p<0.05, Bonferroni t-test. 
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Figure 3-9 shows the immobility times for offspring of control and prenatally-
stressed Dams subjected to the Porsolt test at 40-50 days of age, but removing 
the variable of offspring gender. An ANOVA on the data for the Exposure Day 
revealed a significant effect of prenatal condition on immobility times with 
(F(1,131)=24.82, p<0.0001), which showed offspring‘s of prenatally-stressed 
Dams exhibit lower immobility times in comparison to those offspring from 
control Dams. Moreover, there was a significant effect of postnatal drug 
treatment on immobility times with (F(1,131)=4.5, p<0.004), which shows that 
postnatal imipramine treatment decreased the immobility time in offspring from 
prenatally-stressed and control Dams. There was no significant effect of 
prenatal condition X postnatal drug interaction for these data with 
(F(1,131)=1.14, p<ns). 
Figure 3-9 shows that offspring of stressed Dams exhibited lower immobility 
times in comparison with those of offspring of control Dams. This difference was 
not altered by postnatal imipramine treatment, although imipramine itself 
decreased immobility time in both control and stressed offspring. 
An ANOVA on the data for the Experimental Day Porsolt procedure (Panel B) 
revealed a significant effect of prenatal condition with (F(1,131)=14.22, 
p<0.0002), which showed that offspring of prenatally-stressed Dams exhibited 
lower immobility times compared to control Dams. An ANOVA on these data 
showed no significant effect of postnatal drug treatment with (F(1,131)=1.54, 
p<ns). An ANOVA examining the interaction between prenatal condition and 
postnatal drug treatment showed a significant effect with (F(1,131)=6.33, 
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p<0.01), showing imipramine reduced immobility times and effect that was 
evident only for the offspring of stressed Dams. 
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A. Exposure Day (10min) 
 
B. Experimental Day (5min) 
Figure ‎3-9: Offspring immobility times (from gestationally stressed or control Dams postnatally treated with 
Imipramine 15mg/kg or Vehicle (saline) after giving birth.  
The immobility of the offspring was assessed in two consecutive Exposure and Experimental Days when the 
offspring were 40-50 days old. Data shown are Means ± SEM. 
*Significantly differences between offspring of control and gestationally stressed Dams and significant 
differences between vehicle and imipramine-treated animals, p<0.05, Bonferroni t-test. 
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3.4.1 OFFSPRING PORSOLT AS STRESSED AND CONTROL  
 
Figure 3-10 (Panel A) shows the immobility times for offspring of control and 
prenatally-stressed Dams and considering only gender and prenatal condition 
as orthogonal variables. In this instance, the postnatal drug treatment has been 
removed from the analysis for illustration purposes. An ANOVA on the data for 
the Exposure Day (Panel A) revealed a significant effect of prenatal condition 
on offspring immobility times with (F(1,66)=6.71, p<0.012), which means that 
females of prenatally-stressed Dams exhibited lower immobility times in 
comparison to males of prenatally stressed or Control Dams. There was no 
significant effect of gender immobility times with (F(1.66)=0.9, p<ns). Moreover, 
there was no significant effect of gender immobility times X prenatal condition 
interaction for these data with (F(1,127)=0.07, p<ns).  
Figure 3-10 (Panel B) shows the immobility times for data obtained for the 
experimental day. An ANOVA on the data revealed no significant effect of 
prenatal condition on offspring immobility times with (F(1,66)=0.62, p<ns). 
There was no significant effect of gender immobility times with (F(1.66)=2.72, 
p<ns). Moreover, there was no significant effect of gender immobility times X 
prenatal condition interaction for these data with (F(1,127)=0.002, p<ns).  
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A. Exposure Day (10min) 
B. Experimental Day (5min) 
 
Figure ‎3-10: Immobility times for the Porsolt task recorded from the offspring (Males and female) of 
gestationally stressed or Control rat Dams on the Exposure and Experimental Days when offspring were 40-50 
days old. 
Data shown are Means ± SEM. 
*Significantly different, p<0.05, Bonferroni t-test. 
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3.5 EFFECTS OF GESTATIONAL STRESS ON POSTNATAL 
ANXIETY IN DAMS 
3.5.1 EFFECTS OF IMIPRAMINE 
3.5.1.1  Time to enter 
The Elevated Plus Maze (EPM) test was performed on groups of rats on 
postnatal days 4 and 10. The Dams were treated either with imipramine 
(15mg/kg) or Vehicle (saline) once daily following birth. Figure 3-11 shows the 
initial times for the Dams to enter the open arm (Days 4 and 10 - 5 minutes) 
trial. In Day 4 (Panel A), an ANOVA on these data revealed no significant effect 
of prenatal condition with (F(1,6)=0.23, p<ns). Furthermore, there was no 
significant effect of postnatal drug treatment on times to enter the open arms 
with (F(1,6)=0.13, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed a significant effect with 
(F(1,6)=5.82, p<0.05). This shows that control Dams given imipramine 
postnatally spent more time in, in comparison with those treated with vehicle 
and vice versa happened in stressed Dams. 
In Day 10 (Panel B), an ANOVA on these data revealed no significant effect of 
prenatal condition with (F(1,6)=0.01, p<ns). Furthermore, there was no 
significant effect of postnatal drug treatment on times to enter the open arms 
with (F(1,6)=0.01, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed a significant effect with 
(F(1,6)=5.7, p<0.05), which shows that control Dams were given imipramine 
postnatally spent more time in comparison with those treated with vehicle and 
vice versa happened in stressed Dams. 
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A. Open arm (Day 4) 
 
B. Open arm (Day 10) 
‎3-11: Effects of gestational stress and postnatal drug treatment on initial times to 
enter the open arms on days 4 and 10 of the elevated plus maze test. 
Data shown are Means ± SEM. 
*Significantly different, p<0.05, Bonferroni t-test. 
151 
 
 Figure 3-12 shows the initial times for the Dams to enter the closed arms (Days 
4 and 10-5 minutes) trial.  
In Day 4 (Panel A), an ANOVA on these data revealed no significant effect of 
prenatal condition with (F(1,6)=1.22, p<ns). Furthermore, there was no 
significant effect of postnatal drug treatment on times to enter the closed arms 
with (F(1,6)=0.07, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed a significant effect with 
(F(1,6)=7.83, p<0.03), which shows that control Dams given the vehicle 
postnatally spent more time in, in comparison with those treated with 
imipramine, however, vice versa happened in stressed Dams. 
In Day 10 (Panel B), an ANOVA on these data revealed no significant effect of 
prenatal condition with (F(1,6)=0.05, p<ns). Furthermore, there was no 
significant effect of postnatal drug treatment on times to enter the closed arms 
with (F(1,6)=0.42, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed no significant effect with 
(F(1,6)=0.03, p<ns). 
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Figure ‎3-12: Effects of gestational stress and postnatal drug treatment on initial times to enter the 
closed arms on days 4 and 10 of the elevated plus maze test. 
Data shown are Means ± SEM. 
*Significantly different, p<0.05, Bonferroni t-test. 
A. Closed arm (Day 4) 
B. Closed arm (Day 10) 
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3.5.1.2 Licking and Grooming 
Figure 3-13 shows the amount of time the Dams spent licking and grooming in 
the open arms. In day 4 (Panel A), an ANOVA on these data revealed no 
significant effect of prenatal condition with (F(1,6)=1.16, p<ns). Furthermore, 
there was no significant effect of postnatal drug treatment on L/G with 
(F(1,6)=1.16, p<ns). An ANOVA examining the prenatal condition by postnatal 
drug interaction revealed no significant effect with (F(1,6)=2.27, p<ns). 
Figure 3-13 (Panel B) shows the amount of time for the Dams spent licking and 
grooming in the open arms day 10. An ANOVA on these data revealed no 
significant effect of prenatal condition with (F(1,6)=1.71, p<ns). Furthermore 
there was no significant effect of postnatal drug treatment on L/G in the open 
arms with (F(1,6)=1.71, p<ns). An ANOVA examining the prenatal condition by 
postnatal drug treatment interaction revealed no significant effect with 
(F(1,6)=1.71, p<ns). 
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A. Open arm (Day 4) 
 
 
B. Open arm (Day 10) 
 
Figure ‎3-13: Effects of gestational stress and postnatal drug treatment on time spent grooming in 
the open arms for Dams tested in the elevated plus maze on postnatal days 4 and 10. 
Data shown are Means ± SEM. 
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Figure 3-14 shows the amount of time the Dams spent licking and grooming in 
the closed arms. In day 4 (Panel A), an ANOVA on these data revealed a 
significant effect of prenatal condition with (F(1,6)=5.24, p<0.05), which shows 
stressed Dams spent more time grooming in the closed arms in comparison 
with control Dams. Furthermore, there was no significant effect of postnatal 
drug treatment on L/G with (F(1,6)=0.06, p<ns). An ANOVA examining the 
prenatal condition X postnatal drug treatment interaction revealed no significant 
effect with (F(1,6)=0.15, p<ns). 
Figure 3-14 (Panel B) shows the amount of time for the Dams spent licking and 
grooming in the closed arms day 10. An ANOVA on these data revealed no 
significant effect of prenatal condition with (F(1,6)=1.58, p<ns). Furthermore, 
there was no significant effect of postnatal drug treatment on L/G at the closed 
arms with (F(1,6)=2.05, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed no significant effect with 
(F(1,6)=0.24, p<ns). 
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A. Closed arm (Day 4) 
 
B. Closed arm (Day 10) 
  
Figure ‎3-14: Effects of gestational stress and postnatal drug treatment on time spent grooming in 
the closed arms for Dams tested in the elevated plus maze on postnatal days 4 and 10. 
Data shown are Means ± SEM. 
*Significantly different, p<0.05, Bonferroni t-test. 
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3.5.1.3 Total Time 
 
Figure 3-15 (Panel A) shows the total time that Dams spent in the open arms 
Day 4. An ANOVA on these data revealed no significant effect of prenatal 
condition with (F(1,6)=2.33, p<ns). Furthermore, there was no significant effect 
of postnatal drug treatment on total time with (F(1,6)=0.04, p<ns). An ANOVA 
examining the prenatal condition X postnatal drug treatment interaction 
revealed no significant effect with (F(1,6)=4.43, p<ns). 
Figure 3-15 (Panel B) shows the total time that Dams spent in the open arms 
Day 10. An ANOVA on these data revealed no significant effect of prenatal 
condition with (F(1,6)=0.05, p<ns). Furthermore, there was no significant effect 
of postnatal drug treatment on total time with (F(1,6)=0.19, p<ns). An ANOVA 
examining the prenatal condition X postnatal drug treatment interaction 
revealed no significant effect with (F(1,6)=0.48, p<ns). 
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A. Open arm (Day 4) 
B. Open arm (Day 10) 
 
Figure ‎3-15: Effects of gestational stress and postnatal drug treatment on total time in the open arms the 
elevated plus maze for Dams tested on postnatal days 4 and 10. 
Data shown are Means ± SEM. 
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Figure 3-16 (Panel A) shows the total time that Dams spent in the closed arms 
on Day 4. An ANOVA on these data revealed no significant effect of prenatal 
condition with (F(1,6)=2.20, p<ns). Furthermore, there was no significant effect 
of postnatal drug treatment on total time with (F(1,6)=0.05, p<ns). An ANOVA 
examining the prenatal condition X postnatal drug treatment interaction 
revealed no significant effect with (F(1,6)=4.3, p<ns). 
Figure 3-16 (Panel B) shows the total time for that Dam spent in the closed 
arms Day 10. An ANOVA on these data revealed no significant effect of 
prenatal condition with (F(1,6)=0.05, p<ns). Furthermore, there was no 
significant effect of postnatal drug treatment on total time with (F(1,6)=0.19, 
p<ns). An ANOVA examining the prenatal condition X postnatal drug treatment 
interaction revealed no significant effect with (F(1,6)=0.5, p<ns). 
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A. Closed arm (Day 4) 
 
B. Closed arm (Day 10) 
Figure ‎3-16: Effects of gestational stress and postnatal drug treatment on total time in the closed arms the 
elevated plus maze for Dams tested on postnatal days 4 and 10. 
Data shown are Means ± SEM. 
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3.5.2 OFFSPRING ELEVATED PLUS MAZE AND THE EFFECTS OF 
SERTRALINE  
3.5.2.1 Time to enter  
a) Open arms 
Figure 3-17 (Panel A) shows the initial times for the offspring to enter the open 
and closed arms for EPM. This test lasted for 5 minutes.  
Each group was randomly selected from Dams who had undergone restraint 
stress or were unstressed controls and had been treated with either sertraline 
(10mg/kg) or vehicle (saline) postnatally from day 1-10. 
An ANOVA on the data for times to enter the open arms revealed no significant 
effect of prenatal condition with (F(1,192)=0.1, p<ns). An ANOVA on the data 
for times to enter the open arms revealed no significant effect of postnatal drug 
treatment with (F(1,192)=0.4, P<ns). There was no significant effect of gender 
times to enter open arms with (F(1,192)=0.03, P<ns). An ANOVA examining the 
prenatal condition X postnatal drug treatment interaction revealed no significant 
effect with (F(1,192)=0.01, p<ns). An ANOVA examining the prenatal condition 
X gender times to enter interaction revealed no significant effect with 
(F(1,192)=1.2, p<ns). An ANOVA examining postnatal drug treatment X gender 
interaction revealed no significant effect with (F(1,192)=0.2, p<ns). An ANOVA 
examining the prenatal condition X postnatal drug treatment X gender times to 
enter in the open arms interaction revealed no significant effect with 
(F(1,192)=0.6, p<ns).  
162 
 
b) Closed arms 
Figure 3-17 (Panel B) shows the initial times for the offspring to enter the closed 
arms for EPM.  
Each group was randomly selected from Dams who had undergone restraint 
stress or were unstressed controls and had been treated with either sertraline 
(10mg/kg) or vehicle (saline) postnatally from day 1-10. 
An ANOVA on the data for times to enter the closed arms revealed no 
significant effect of prenatal condition with (F(1,192)=0.01, p<ns). An ANOVA 
on the data for times to enter the closed arms revealed no significant effect of 
postnatal drug treatment with (F(1,192)=0.33, P<ns). There was no significant 
effect of gender times to enter the closed arms with (F(1,192)=0.01, P<ns). An 
ANOVA examining the prenatal condition X postnatal drug treatment interaction 
revealed no significant effect with (F(1,192)=3.34, p<ns). An ANOVA examining 
the prenatal condition X gender times to enter the closed arms interaction 
revealed no significant effect with (F(1,192)=0.6, p<ns). An ANOVA examining 
postnatal drug treatment X gender times to enter the closed arms interaction 
revealed no significant effect with (F(1,192)=0.4, p<ns). An ANOVA examining 
the prenatal condition X postnatal drug treatment X gender times to enter the 
closed arms interaction revealed no significant  effect with (F(1,192)=0.04, 
p<ns).  
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Figure ‎3-17: Shows offspring time to enter the open and closed arms. 
Behaviour of offspring during the elevated plus maze (EPM). These were born of Dams which had been 
left undisturbed during gestation (Control), or who had been subjected to gestational stress. At birth 
Dams were treated with once daily injections of saline or sertraline (10mg/kg) up to and including 
postnatal day 10.   
Data shown are Means ± SEM. 
 
A. Open arm 
 
B. Closed arm 
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3.5.2.2 Licking and Grooming  
 
Figure 3-18 (Panel A) shows the amount of times the offspring spent licking and 
grooming in the open arms.  
 
a) Open arms 
An ANOVA on these data revealed no significant effect of prenatal condition 
with (F(1,192)=0.25, p<ns). An ANOVA on these data revealed a significant 
effect of postnatal drug treatment with (F(1,192)=3.5, p<0.05), showing that 
offspring of Dams either control or prenatally-stressed which had been treated 
with sertraline had less time spent grooming in comparison with those which 
had been treated with vehicle. Furthermore, There was no significant effect of 
gender with (F(1,192)=1, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment interaction revealed no significant effect with 
(F(1,192)=0.25, p<ns). ANOVA examining the prenatal condition X gender L/G 
in the open arms revealed no significant effect interaction with (F(1,192)=0.14, 
p<ns). Moreover, an ANOVA examining the drug treatment X gender L/G in the 
open arms interaction revealed no significant effect with (F(1,192)=1, p<ns). An 
ANOVA examining the prenatal condition X postnatal drug treatment X gender 
L/G in the open arms interaction revealed no significant effect with 
(F(1,192)=0.14, p<ns).  
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b) Closed arms 
Figure 3-18 (Panel B) shows the amount of times the offspring spent licking and 
grooming in the closed arms. 
An ANOVA on these data revealed a significant effect of prenatal condition with 
(F(1,192)=3.6, p<0.05), which shows overall the control Dams spent more times 
licking and grooming in comparison with prenatally-stressed Dams. An ANOVA 
on these data revealed no significant effect of postnatal drug treatment with 
(F(1,192)=0.001, p<ns). There was no significant effect of gender L/G in the 
closed arms with (F(1,192)=1.4, p<ns). Furthermore, an ANOVA examining the 
prenatal condition X postnatal drug treatment interaction revealed a significant 
effect with (F(1,192)=5.6, p<0.02), which shows offspring from control Dams 
that were given vehicle spent more times licking and grooming in comparison 
with those of offspring from stressed Dams that were given sertraline 
postnatally.  Moreover, An ANOVA examining the prenatal condition X gender 
L/G in the closed arms interaction revealed no significant effect with 
(F(1,192)=2.75, p<ns). An ANOVA examining the drug treatment X gender L/G 
in the closed arms interaction revealed no significant effect with (F(1,192)=0.15, 
p<ns). An ANOVA examining the prenatal condition X postnatal drug treatment 
X gender L/G in the closed arms interaction revealed no significant effect with 
(F(1,192)=0.45, p<ns). 
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A. Open arm 
 
B. Closed arm 
 
Figure ‎3-18: Shows offspring time spent grooming in the open and closed arms. These were born of Dams 
which had been left undisturbed during gestation (Control), or who had been subjected to gestational stress. At 
birth Dams were treated with once daily injections of saline or sertraline (10mg/kg) up to and including 
postnatal day 10.al Times spent in open and closed arms 
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3.5.2.3 Total Times spent in open and closed arms 
Figure 3-19 (Panel A) shows the total time that offspring spent in open or closed 
arms. 
a) Open arms 
An ANOVA on these data revealed no significant effect of prenatal condition 
with (F(1,192)=0.25, p<ns). An ANOVA on these data revealed no significant 
effect of postnatal drug treatment with (F(1,192)=2.83, p<ns). Furthermore, 
there was a significant effect of gender with (F(1,192)=10.743, p<0.001), which 
showed the total time to spend for females was higher than males. An ANOVA 
examining the prenatal condition X postnatal drug treatment interaction 
revealed no significant effect with (F(1,192)=0.46, p<ns). Moreover, an ANOVA 
examining the prenatal condition X gender total times in the open arms 
interaction revealed no significant effect with (F(1,192)=0.11, p<ns). An ANOVA 
examining the drug treatment X gender total times in the open arms interaction 
revealed no significant effect with (F(1,192)=1.18, p<ns). An ANOVA examining 
the prenatal condition X postnatal drug treatment X gender total times in the 
open arms interaction revealed no significant effect with (F(1,192)=0.55, p<ns).  
168 
 
a) Closed arms 
Figure 3-19 (Panel B) shows the amount of time that offspring spent in the 
closed arms. 
An ANOVA on these data revealed a significant effect of prenatal condition with 
(F(1,192)=24.32, p<0.0001), which showed that offspring of control Dams 
exhibited more amount of time to spend in the closed arms in comparison to 
those from prenatally-stressed Dams. An ANOVA on these data revealed a 
significant effect of postnatal drug treatment with (F(1,192)=14.52, p<0.0002), 
showing that offspring of Dams treated with sertraline spent more amount of 
time in the closed arms in comparison to those treated with vehicle. 
Furthermore, there was a significant effect of total times on gender in the closed 
arms with (F(1,192)=5.4, p<0.02), which showed females spent less total 
amount of time in the closed arms in comparison with males.  An ANOVA 
examining the prenatal condition X postnatal drug treatment interaction 
revealed a significant effect with (F(1,192)=17.15, p<0.0001), which showed 
offspring of control Dams were either given vehicle or sertraline spent more 
amount of total time times in comparison with those offspring of prenatally-
stressed Dams. An ANOVA examining the prenatal condition X gender total 
times in the closed arms interaction revealed no significant effect with 
(F(1,192)=0.07, p<ns). Moreover, an ANOVA examining the drug treatment X 
gender interaction revealed no significant effect with (F(1,192)=0.17, p<ns). An 
ANOVA examining the prenatal condition X postnatal drug treatment X gender 
total times in the closed arms interaction revealed no significant effect with 
(F(1,192)=0.2, p<ns). 
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A. Open arm 
 
B. Closed arm  
‎3-19: Shows offspring amount of total time spent in the open and closed arms. 
Behaviour of offspring during the elevated plus maze (EPM). These were born of Dams 
which had been left undisturbed during gestation (Control), or who had been subjected 
to gestational stress. At birth Dams were treated with once daily injections of saline or 
sertraline (10mg/kg) up to and including postnatal day 10.   
Data shown are Means ± SEM. 
*Significantly different, p<0.05, Bonferroni t-test. 
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3.6 MATERNAL BEHAVIOUR: EFFECTS OF GESTATIONAL 
STRESS AND TREATMENT WITH IMIPRAMINE 
3.6.1 ARCHED BACK NURSING (ABN)  
Maternal behavioural assessments were made on groups of rats over postnatal 
days 3, 5 and 7. The Dams had been treated either with imipramine (15mg/kg) 
or vehicle (saline) once daily following birth. Figure 3-20 shows the amount of 
time the Dams spent in Arched-Back Nursing (ABN) position. An ANOVA on the 
data revealed a significant effect of prenatal condition with (F(1,32)=5.7, 
p<0.03), showing that stressed Dams spent less time in ABN compared to 
control Dams. ANOVA revealed no significant effect of postnatal drug treatment 
on time ABN with (F(1,32)=1.3, p<ns). An ANOVA examining the interaction 
between postnatal drug treatment and prenatal condition revealed no significant 
effect with (F(1,32)=1.27, p<ns). ANOVA revealed no significant change in ABN 
over postnatal days 3, 5 and 7 with (F(1,32)=2.27, p<ns). Furthermore, an 
ANOVA examining the prenatal condition X day of testing interaction revealed 
no significant effect with (F(1,32)=0.3, p<ns). An ANOVA examining the 
postnatal drug treatment X postnatal days interaction revealed no significant 
effect with (F(1,32)=2.04, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment X day of testing interaction revealed no significant 
effect with (F(1,32)=2.07, p<ns). 
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Figure ‎3-20: Arched-Back nursing times for Dams that experienced gestational stress or for 
controls, and subsequently administered imipramine (15mg/kg) or vehicle, once daily following 
birth.  
Data shown are Means ± SEM. 
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3.6.2 SUPINE NURSING 
Figure 3-21 shows the amount of time that Dams spent in a supine nursing 
position. An ANOVA on the data revealed no significant effect of prenatal 
condition with (F(1,32)=0.35, p<ns). ANOVA revealed no significant effect of 
postnatal drug treatment on time spent in a supine nursing position with 
(F(1,32)=0.64, p<ns). An ANOVA examining the postnatal drug treatment X 
prenatal condition interaction revealed no significant effect with (F(1,32)=0.145, 
p<ns). However, ANOVA on these data did show a significant effect of testing 
day (3, 5 and 7) on supine nursing times with (F(1,32)=4.5, p<0.02) and this 
shows that all Dams spent more time in a supine nursing position as the infants 
aged. An ANOVA examining the prenatal condition X day of testing interaction 
revealed no significant effect with (F(1,32)=0.332, p<ns). An ANOVA examining 
the postnatal drug treatment X postnatal days interaction revealed no significant 
effect with (F(1,32)=0.62, p<ns). An ANOVA examining the prenatal condition X 
postnatal drug treatment X day of testing interaction revealed no significant 
effect with (F(1,32)=0.31, p<ns). 
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Figure ‎3-21: Supine nursing times for Dams that experienced gestational stress or for controls, 
and subsequently administered imipramine (15mg/kg) or vehicle, once daily following birth.  
Data shown are Means ± SEM. 
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3.6.3 LICKING/GROOMING PUPS (LG) 
 
Figure 3-22 shows the amount of time that Dams spent Licking and Grooming 
(LG) their pups. An ANOVA on the data revealed no significant effect of 
prenatal condition with (F(1,32)=2.51, p<ns). ANOVA revealed no significant 
effect of postnatal drug treatment on L/G with (F(1,32)=0.28, p<ns). An ANOVA 
examining the postnatal drug treatment X prenatal condition interaction 
revealed no significant effect with (F(1,32)=0.21, p<ns). ANOVA did reveal a 
significant effect of testing day (3, 5 and 7) on Dams L/G their pups with 
(F(1,32)=10.9, p<0.0002) and this shows that all Dams spent more time L/G 
their pups as the litters get older. An ANOVA examining the prenatal condition X 
day of testing interaction revealed no significant effect with (F(1,32)=0.01, 
p<ns). An ANOVA examining the postnatal drug treatment X day of testing 
interaction revealed no significant effect with (F(1,32)=1.8, p<ns). An ANOVA 
examining the prenatal condition X postnatal drug treatment X day of testing 
interaction revealed no significant effect with (F(1,32)=0.04, p<ns). 
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Figure ‎3-22: Licking/Grooming times for Dams that experienced gestational stress or for controls, 
and subsequently administered imipramine (15mg/kg) or vehicle, once daily following birth.  
Data shown are Means ± SEM. 
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3.6.4 PUP RETRIEVAL 
 
Figure 3-23 shows the amount of time the Dams spent engaged in retrieving 
their pups. An ANOVA on the data revealed no significant effect of prenatal 
condition with (F(1,32)=2.38, p<ns). ANOVA revealed no significant effect of 
postnatal drug treatment on pup retrieval with (F(1,32)=1.58, p<ns). An ANOVA 
examining the interaction between postnatal drug treatment and prenatal 
condition revealed no significant effect with (F(1,32)=0.4, p<ns). ANOVA 
revealed no significant effect on pup retrieval over postnatal days (3, 5 and 7) 
with (F(1,32)=0.314, p<ns). An ANOVA examining the prenatal condition X day 
of testing interaction revealed no significant effect with (F(1,32)=2.05, p<ns). An 
ANOVA examining the postnatal drug treatment X day of testing interaction 
revealed a significant effect with (F(1,32)=4.14, p<0.02) and this shows that 
Dams treated with imipramine spent more time retrieving pups in comparison 
with Dams administered vehicle. An ANOVA examining the prenatal condition X 
postnatal drug treatment X day of testing interaction revealed a significant effect 
with (F(1,32)=4.25, p<0.02), which shows that stressed Dams administered 
imipramine exhibited markedly enhanced pup retrieving on postnatal days 5 and 
7. 
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Figure ‎3-23: Time spent by Dams engaged in actual pup retrieval during the 30 minute observation 
period.  
Data shown are Means ± SEM. 
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3.6.5 TIME SPENT IN THE NEST 
 
Figure 3-24 shows the amount of time the Dams spent in the Nest. An ANOVA 
on the data revealed no significant effect of prenatal condition with 
(F(1,32)=2.54, p<ns). ANOVA revealed no significant effect of postnatal drug 
treatment on time spent in the nest with (F(1,32)=0.002, p<ns). An ANOVA 
examining the postnatal drug treatment X prenatal condition interaction 
revealed no significant effect with (F(1,32)=0.08, p<ns). ANOVA did reveal a 
significant effect of test day (3, 5 and 7) on Dams time spent in the nest with 
(F(1,32)=6.28, p<0.005) and this shows that all Dams spent more time in the 
nest as the litters get older. An ANOVA examining the prenatal condition X 
postnatal days interaction revealed no significant effect with (F(1,32)=0.052, 
p<ns). An ANOVA examining the postnatal drug treatment X postnatal days 
interaction revealed a significant effect with (F(1,32)=2.8, p<0.05), which shows 
that stressed Dams treated with imipramine spent less time in the nest 
compared to control Dams and this time enhanced on postnatal days 5 and 7. 
An ANOVA examining the prenatal condition X postnatal drug treatment X day 
of testing interaction revealed no significant effect with (F(1,32)=0.32, p<ns). 
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Figure ‎3-24: Time spent in Nest for Dams that experienced gestational stress or for controls, and 
subsequently administered imipramine (15mg/kg) or vehicle, once daily following birth.  
Data shown are Means ± SEM. 
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3.6.6 TIME SPENT OUT OF THE NEST 
 
Figure 3-25 shows the amount of time the Dams spent out of the nest. An 
ANOVA on the data revealed no significant effect of prenatal condition with 
(F(1,32)=2.70, p<ns). ANOVA revealed no significant effect of postnatal drug 
treatment on time spent out of the nest with (F(1,32)=0.01, p<ns). An ANOVA 
examining the postnatal drug treatment X prenatal condition interaction 
revealed no significant effect with (F(1,32)=0.104, p<ns). ANOVA revealed a 
significant effect of test day (3, 5 and 7) on Dams time spent out of the nest with 
(F(1,32)=6.4, p<0.005) and this shows that all Dams spent less time out of nest 
as the litters get older. An ANOVA examining the prenatal condition X day of 
testing interaction revealed no significant effect with (F(1,32)=0.042, p<ns).  
An ANOVA examining the postnatal drug treatment X day of testing interaction 
revealed a significant effect with (F(1,32)=2.8, p<0.05), which shows that 
stressed Dams treated with imipramine spent more time out of the nest in 
comparison with vehicle-treated Dams. However, stressed Dams administered 
imipramine exhibited less time out of the nest on postnatal days 5 and 7. An 
ANOVA examining the prenatal condition X postnatal drug treatment X day of 
testing interaction revealed no significant effect with (F(1,32)=0.33, p<ns). 
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Figure ‎3-25: Time spent out of Nest for Dams that experienced gestational stress or for controls, 
and subsequently administered imipramine (15mg/kg) or vehicle, once daily following birth.  
Data shown are Means ± SEM. 
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3.6.7 TIME SPENT IN NEST BUILDING 
 
Figure 3-26 shows the amount of time the Dams spent nest building. An 
ANOVA on the data revealed a significant effect of prenatal condition with 
(F(1,32)=5.1, p<0.04), showing that stressed Dams spent more time overall  
nest building compared to control Dams. ANOVA revealed no significant effect 
of postnatal drug treatment on Dams time spent nest building with 
(F(1,32)=0.47, p<ns). An ANOVA examining the postnatal drug treatment X 
prenatal condition interaction revealed no significant effect with (F(1,32)=0.49, 
p<ns). ANOVA revealed no significant effect of test day (3, 5 and 7) on Dams 
time spent nest building with (F(1,32)=0.150, p<ns). An ANOVA examining the 
prenatal condition X day of testing interaction revealed no significant effect with 
(F(1,32)=0.36, p<ns). An ANOVA examining the postnatal drug treatment X day 
of testing interaction revealed a significant effect with (F(1,32)=6.26, p<0.02) 
and shows stressed Dams spent more time for nest building in comparison to 
control Dams. However, stressed Dams treated with imipramine exhibited less 
time nest building on postnatal days 5 and 7. An ANOVA examining the 
prenatal condition X postnatal drug treatment X day of testing interaction 
revealed a significant effect with (F(1,32)=7.81, p<0.01) and shows that 
prenatally stressed Dams and treated with imipramine spent less time nest 
building as the litters get older and this was similar to stressed Dams given 
vehicle.  
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Figure ‎3-26: Nest Building times for Dams that experienced gestational stress or for controls, and 
subsequently administered imipramine (15mg/kg) or vehicle, once daily following birth.  
Data shown are Means ± SEM. 
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3.6.8 DAMS SELF GROOMING INSIDE THE NEST 
Figure 3-27 shows the amount of time the Dams spent grooming themselves in 
the nest. An ANOVA on the data revealed no significant effect of prenatal 
condition with (F(1,32)=0.09, p<ns). ANOVA revealed no significant effect of 
postnatal drug treatment on time spent self-grooming in the nest with 
(F(1,32)=0.93, p<ns). An ANOVA examining the postnatal drug treatment X 
prenatal condition interaction revealed no significant effect with (F(1,32)=0.34, 
p<ns). ANOVA revealed a significant effect on Dams times spent self grooming 
inside the nest over postnatal days (3, 5 and 7) with (F(1,32)=17.76, p<0.0001) 
and this shows that Dams increased their self-grooming in the nest as the litters 
get older. An ANOVA examining the prenatal condition X day of testing 
interaction revealed no significant effect with (F(1,32)=0.38, p<ns). An ANOVA 
examining the postnatal drug treatment X day of testing interaction revealed a 
significant effect with (F(1,32)=4.74, p<0.016) and this shows stressed Dams 
treated with imipramine spent more time self grooming in nest in comparison 
with control administered vehicle. However, stressed Dams administered 
imipramine exhibited more time self grooming on postnatal days 5 and 7. An 
ANOVA examining the prenatal condition X postnatal drug treatment X day of 
testing interaction revealed no significant effect with (F(1,32)=1.34, p<ns). 
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Figure ‎3-27: Self Grooming times in Nest for Dams that experienced gestational stress or for 
controls, and subsequently administered imipramine (15mg/kg) or vehicle, once daily following 
birth.  
Data shown are Means ± SEM. 
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3.6.9 DAMS SELF GROOMING OUT OF THE NEST 
Figure 3-28 shows the amount of time the Dams spent grooming themselves 
outside of the nest. An ANOVA on the data revealed no significant effect of 
prenatal condition with (F(1,32)=2.29, p<ns). ANOVA revealed no significant 
effect of postnatal drug treatment on self grooming times outside of the nest 
with (F(1,32)=0.023, p<ns). An ANOVA examining the postnatal drug treatment 
X prenatal condition interaction revealed no significant effect with (F(1,32)=2.5 
p<ns). ANOVA revealed no significant effect of test days (3, 5 and 7) on Dams 
times spent self grooming outside the nest with (F(1,32)=1.19, p<ns). An 
ANOVA examining the prenatal condition X day of testing interaction revealed 
no significant effect with (F(1,32)=0.09, p<ns). An ANOVA examining the 
postnatal drug treatment X day of testing interaction revealed no significant 
effect with (F(1,32)=0.152, p<ns). An ANOVA examining the prenatal condition 
X postnatal drug treatment X day of testing interaction revealed no significant 
effect with (F(1,32)=0.66, p<ns). 
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Figure ‎3-28: Self Grooming times out of Nest for Dams that experienced gestational stress or for 
controls, and subsequently administered imipramine (15mg/kg) or vehicle, once daily following 
birth.  
Data shown are Means ± SEM. 
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4. DISCUSSION 
4.1 EFFECTS ON WEIGHTS  
4.1.1 EFFECT OF PRENATAL STRESS ON RAT GESTATIONAL WEIGHTS 
 
Normal weight gain during the course of pregnancy in the rat was profoundly 
reduced by concurrent gestational stress. 
In our study, we found that stressed Dams gained an average weight between 
1-3 grams/day (normal weight gain between 5-6 g) which is consistent with 
other research findings (D'Mello and Liu, 2006; Darnaudéry and Maccari, 2008; 
Pawluski et al., 2011). Previous work has shown that different stress paradigms 
e.g. restraint stress (Ward and Weisz, 1984; Alonso et al., 1991a; Vallée et al., 
1997), noise and light stress (Freide and Weinstock, 1984), tail and foot shocks 
(Takahashi et al., 1992a), saline injections (Drago et al., 1999) and immersion 
in cold water (Velazquez-Moctezuma et al., 1993), can result in significant 
decreases in gestational weight (Darnaudéry et al., 2004; Van den Hove et al., 
2005; van den Hove et al., 2010). In our experiments we have used females 
weighing between 120-260 grams at the time of conception and it is highly likely 
that the use of heavier and older females may mask the effect of restraint stress 
on weight gain during pregnancy in such studies (Pawluski et al., 2011). That is, 
slow weight gain in much more likely to be noticeable in young, primiparous 
females, than in older and multiparous females (Ronca et al., 2001; Schroeder 
et al., 2006). 
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4.1.2 POSTNATAL DAMS WEIGHTS AND THE EFFECTS OF SERTRALINE 
 
Significant weight differences were also seen postnatally in groups treated with 
sertraline.  All Dams showed modest weight gains over postnatal days 1-10, but 
the magnitude of this effect was reduced in all animals administered sertraline 
(Figure 3-2). Previous studies have revealed that the SSRIs can cause weight 
loss (perhaps) because they have anorectic properties (Moses and Wurtman, 
1984; Yen and Fuller, 1992; Clifton and Lee, 1997; Kalia et al., 2000). 
Hypophagia is one of the main side effects which is known to accompany 
increased serotonin (5-HT) neurotransmission (whether by administration of 5-
HT or its precursors) (Barrett and McSharry, 1975; Rezek and Novin, 1975; 
Sugrue MF, 1978; Meister, 2007), by 5-HT releasing agents (Pinder et al., 1975; 
Wurtman and Wurtman, 1977; Meister, 2007), 5-HT receptor agonists (Rezek 
and Novin, 1975; Aulakh et al., 2012), or by antagonism of 5-HT breakdown 
(Barrett and McSharry, 1975). Other evidence suggests that serotonergic 
neurons regulate food consumption in animals (Garattini et al., 1988; Nielsen et 
al., 1992; Meister, 2007) since 5-HT receptor antagonists (Speight and Avery, 
1972; Silverstone and Schuyler, 1975; Weischer ML, 1979) or synthesis 
inhibitors (Breisch et al., 1976; Meister, 2007) produce hyperphagia. 
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4.1.3 POSTNATAL DAMS WEIGHTS AND THE EFFECTS OF IMIPRAMINE 
 
Dams receiving imipramine showed negative weight gain over postnatal days 1-
10 and only achieved basal weight levels at 10 days postnatally (Figure 3-3), 
i.e. they initially lost weight regardless of whether they were stressed or 
controls.  A similar finding has been reported previously (Broitman and Donoso, 
1978; Hughes and Pither, 1987). This may indicate that the drug has an 
anorectic effect which diminishes food intake (Broitman and Donoso, 1978; 
Mogensen et al., 1994). However, it blocks the re-uptake of serotonin and 
noradrenaline and we might expect hyperphagia in rather than hypophagia 
(Tucker and File, 1986). Studies suggest that serotonergic axons have the 
binding sites for imipramine (Palkovits et al., 1981). Chronic treatment with 
imipramine elevates brain serotonin and its metabolite 5-HIAA in rats (Sugrue, 
1983) leading to a disturbance in brain serotonin function and possible 
dysregulations of appetite, and may be involved in the pathogenesis and 
aetiology of eating disorders (Kaye, 2008). 
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4.1.4 OFFSPRING WEIGHT AND THE EFFECTS OF SERTRALINE 
The weights of litters from stressed and control Dams were measured to 
evaluate the effects of restraint stress carried out during the gestation period 
and any indirect effects of maternal sertraline treatment.  Pups weight (based 
on 10 pups per litter), were measured at various points during the first 10 
postnatal days.  
Offspring from stressed Dams had a slower weight gain in comparison to the 
control Dams (Figure 3-4). The low weight gain for stress exposed pups was 
due to the prenatal stress which may affect Dam‘s behaviour leading to neglect 
Dams for the pups and/or the effect of postpartum depression which may be 
induced by prenatal stress.  
However, previous reports show that exposure to SSRI‘s through breast milk 
does not affect infants‘ weight (Hendrick et al., 2003) and thus we believe that 
our mothers engage in less productive feeding. 
Our findings show no significant sertraline effects on stressed and control 
exposed pups and there was no significant interaction between the drug 
treatment and prenatal condition. SSRI‘s are the recommended drug of choice 
during breastfeeding (di Scalea and Wisner, 2009; Sharma, 2011).  
Other studies have found that in humans, females who breast feed, and take 
fluoxetine, show no changes in platelet 5HT (Epperson et al., 2003). Some 
studies suggest that antidepressant drugs can pass into breast milk, but only in 
small amount (Weissman et al., 2004; Davanzo et al., 2011).  
However, the drug‘s milk/plasma (M/P) ratio indicates the estimated 
concentration of a drug in breast milk. Sertraline, fluoxetine and paroxetine have 
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M/P ratios of <1.0 which is classed as a low concentration, while fluvoxamine, 
citalopram and escitalopram exceed this range (Davanzo et al., 2011; Gorman 
et al., 2012). However, this is not a measure of absolute amount, as this is 
influenced by several factors including peak milk concentration, dosing 
schedule, body weight and genetic variability in metabolism which can cause 
changes in the concentration of an antidepressant in the body (Gentile et al., 
2007; Davanzo et al., 2011). 
The monoamines have a well-documented ontogeny for whole brain mnervation 
synapse formation and transmitter content. At birth, both NA and DA are clearly 
present and much of their ascending pathways are present and functioning. i.e. 
Both ventral and dorsal bundles of the NA neurons of the locus coeruleus and 
sub coeruleus which ascend to hypothalamus, limbic areas and frontal cortex 
are present.  
In addition, the nigro-striatal, meso-accumbens and meso-cortical DA systems 
also are well described. However, the 5-HT system is much less existent. 
Transmitter levels are low in the median and dorsal the raphé nuclei and the 
ascending pathways are sparse and less pronounced. Indeed the hypothalamic 
projections of the raphé are only visible following incubation in high-5HT buffers. 
The rapid growth differentiation of 5-HT projection sites begins at approximately 
10-14 days postnatally and culminates in adult levels by about 4 weeks 
postnatally. This anatomical evidence would suggest that 5-HT drugs in milk 
would not be expected to have profound effects in neonatal pups, but rather that 
our results follow maternal behaviour changes. 
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There are conflicting data, which show that maternal stress affects lactation in 
both human and animals and when mothers have depressive disorders this can 
cause the diminished breastfeeding and might decrease milk production  
(Dewey, 2001; Hatton et al., 2005; Kalueff et al., 2008).  
It has been hypothesized that there are two mechanisms explaining the relation 
between lactogenesis and stress; 1) The release of oxytocin, prolactin and 
progesterone hormones decrease following; these hormones regulate 
production and expression (Larsen and Grattan, 2012).  
Studies suggested that the oxytocin secretion can be induced via 5-HT 
receptors in the central of serotonergic neurons (Raap and Van de Kar, 1999). 
2) Mothers maternal behaviour could cause inadequate breastfeeding leading to 
impair the lactogenesis (Dewey, 2001).  
Studies suggest that depression may increase the difficulties women 
experience at start of breastfeeding period (Misri et al., 1997; Henderson et al., 
2003; Lau et al., 2007; Dennis and McQueen, 2009).  
Psychological bonds between mothers and infants are reinforced by 
breastfeeding. However, maternal separation may affect this relationship. A 
study carried out on rats reported that the sucking pattern was affected by 
maternal separation, due to the decreased interactions between dams and their 
pups (Brake et al., 1982). 
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4.1.5 OFFSPRING WEIGHT AND THE EFFECTS OF IMIPRAMINE 
Our data show that offspring from stressed Dams treated with imipramine had a 
slower weight gain in comparison to the offspring of controls Dams. As  
previous work shows there is a significant retardation of body weight in stress-
exposed pups (Broitman and Donoso, 1978).  
There was a significant interaction between prenatal condition and drug 
treatment postnatally; it is obvious that litter weights from Dams administered 
imipramine showed diminished weight gains over postnatal days 1-10, after 
which there was a tendency for all litters to be similar in weight (Figure 3-5). 
Low birth weights have been reported in others studies associated with prenatal 
stress (Geber, 1973; Herrenkohl, 1979; Pollard, 1984; Schneider, 1992b; 
Fameli et al., 1995; Cabrera et al., 1999; Drago et al., 1999; Fonseca et al., 
2002; Patin et al., 2002; Lesage et al., 2004; Consoli et al., 2005). 
Prenatal stress causes different abnormalities: disturbances in corticosterone 
levels and locomotor activity (Koehl et al., 1997; Van Reeth et al., 1998; Koehl 
et al., 1999), dysfunctions in the serotonergic, noradrenergic and dopaminergic 
systems (Takahashi et al., 1992b; Day et al., 1998) and behavioural 
impairments (e.g. reduced sexual behaviour and increased anxiety-like 
behaviour) (Ward, 1983; Rhees et al., 1999). Noradrenaline and serotonin 
physiology in the CNS are modified by tricyclic drugs caused by an inhibition in 
their reuptake at synaptic sites (Ross and Renyi, 1975). Given that Dams 
treated with imipramine show impaired weight gain affect after giving birth, 
regardless of prenatal condition, three possible explanations might be offered 
for the observed effects in the pups. 
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1- The mother is experiencing an anorectic effect of the imipramine, fails to 
consume enough nutrients to maintain or gain weight and likely is unable 
to produce sufficient quantity or quality of milk for suckling pups. 
2- The drug may produce subtle alterations in maternal behaviour that 
appear normal but are actually ineffective. For instance, the Dams 
nursing postures may appear correct, but she may shift her positions 
such that the pups fail to attach to the teats sufficiently to feed. 
3- The drug may pass into the pups via the mother‘s milk and directly cause 
an effect on feeding. Neurochemically, imipramine could alter NA or 5-HT 
(although the paucity of functioning 5-HT synapses in the forebrain 
suggests this may be tenuous), although we might reasonably anticipate 
hyperphagia and weight gain instead. If it is a drug-transfer issue then we 
would suggest a NA-based action if the imipramine to cause the pups to 
be more sedate and soporific and thus unable to feed sufficiently for the 
immediate few days following birth. Regardless of the explanations, that 
proves accurate, by 10 days postnatally the groups differences are 
absent, reflecting some form of rectification on weight occurs, or 
tolerance develops to this effect of the drug. 
Another study carried by Vallée et al. (1996) suggested that prenatal stress on 
dams causes disruption in glucose regulation through a lower food intake, 
leading to an effect on body weight comparing with a control group (Vallée et 
al., 1996). 
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Studies on pregnant mice have reported no difference in pups weight who had a 
reduction in food and water intake for stressed dams (following heat or restraint 
stress) (Kinsley and Svare, 1986).  
In general pup weights from prenatal stressed dams are consistently lower than 
in non-stressed dams at birth (Morley‐Fletcher et al., 2003). However, other 
studies have reported a decline in body weight after birth following prenatal 
stress in comparison to control rats (Pollard, 1984; Cabrera et al., 1999). 
Our procedure included examining litter sizes, sexing and the cross-fostering 
pups within their prenatal condition. Thus all control and stressed Dams receive 
approximately equal numbers of pups, with equality in male and female 
numbers.  
For the present work and in a previous report (Smith et al., 2004) we have not 
seen an initial weight difference between litters. The difference emerges after 
birth and resolves by 10 days postnatally. The presence of imipramine is 
probably not relevant since the same ―emergence-resolution‖ pattern occurs 
with imipramine (present result) and without imipramine (Smith et al., 2004). 
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4.2 PRENATAL PORSOLT 
4.2.1 PRENATAL PORSOLT TEST IN PREGNANT DAMS 
 
Our findings show that stressed Dams show greater immobility in the Porsolt 
test on gestational day 17 (Exposure day) (Figure 3-6). Between 10-20 percent 
of women experience stress and suffer from stress-related disorders during 
pregnancy, yet our knowledge of how stress impacts the brain and behaviour of 
the mother during pregnancy is very limited (Pawluski et al., 2011). Our findings 
indicate that depressive-like behaviours are present before the litters arrive. 
Animal models of depression and stress related psychiatric diseases are still 
undergoing development to create an effective model for use. The nature in 
research/diagnosis for depression entails emotional and cognitive disruptions 
and considerable difficulty arises as animals do not exhibit these traits (without 
inference by researchers).  
Most behavioural studies on depression focus on symptoms, such as sleep 
disturbances, cognitive deficits, lack of motivation or anhedonia (Brummelte, 
2008; Weinstock, 2008). These can be modelled in animals and are, but for 
mood in particular we struggle because we must infer from the rats‘ behaviours 
that mood is disrupted. 
Researchers use the Porsolt test as a model of depressive-like behaviour 
(Lucki, 1997; Galea et al., 2001; Cryan et al., 2002; Smith et al., 2004; Cryan et 
al., 2005; Dalla et al., 2005). This was first developed by Porsolt (Porsolt et al., 
1977a; Porsolt et al., 1977b; Porsolt et al., 1978) and measures the active 
(swimming or struggling) and passive (floating) behaviour of rats or mice in a 
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container filled with water at a certain temperature (See Methods, page 114). 
The Porsolt test is a widely used test of antidepressant efficacy (Porsolt et al., 
1978) and depressive-like behaviour (Galea et al., 2001; Smith et al., 2004; 
Dalla et al., 2005; Hinojosa et al., 2006). This test is a very popular method in 
depression-related research because it is relatively quick, valid and has the 
possibility for high-through-put testing (Porsolt et al., 1978). 
Observations on the time animals spend immobile following treatment with 
antidepressants show that passive behaviour is significantly reduced. This 
passive behaviour (immobility) is interpreted as depressive-like behaviour 
(Kudryavtseva et al., 1991; Lahmame et al., 1997).  
The advantage of the Porsolt test in animals for antidepressant 
treatment/assessment is that observable effects occur within minutes after 
treatment. Antidepressant effects in humans with the same drugs take weeks 
for symptoms to abate. The Porsolt is still one of the best models for assessing 
antidepressants. However, this test has moderate construct and no face validity 
and its overall application is questionable.  
As mentioned earlier ―floating‖ or Immobility in the forced swimming test is 
considered to be a depressive-like behaviour (Porsolt et al., 1978). It may also 
represent a strategy to conserve energy in a potentially fatal situation (West, 
1990). 
Studies have indicated that struggling and swimming behaviours in the rats are 
regulated by noradrenaline and serotonin, respectively (Detke et al., 1995) and 
these are explicitly involved in depression and antidepressant action.  
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In addition we found that immobility times in the stressed Dams were increased 
both on the exposure day and the experimental day compared to controls (See 
Figure 3-6); these findings replicate previous research findings, that stressed 
pregnant females has exhibit greater Immobility during gestation (Frye and 
Walf, 2004; Szymañska et al., 2009). 
Prenatal restraint stress in rats was used in the present study to create model of 
depression and the procedure for restraint stress is described in the method 
section (Page 105). The predictive and construct validity of this model was 
already reported (Koehl et al., 1999; Rao et al., 1999; Lemaire et al., 2000; 
Morley-Fletcher et al., 2003; Morley-Fletcher et al., 2004). In accordance with 
previous results, the present study shows that prenatally stressed rats displayed 
a prolonged immobility time in the Porsolt test prior to birth (Smith et al., 2004; 
Szymańska et al., 2009) suggesting that maternal depressive-like behaviour 
begins before litters delivered. 
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4.3 POSTNATAL PORSOLT (IMIPRAMINE) 
Our data have shown that control and stressed Dams had a lower immobility 
times compared with non-drug treated groups. We have used the Porsolt test 
because it is widely accepted and the most reliable model for depressive-like 
behaviour in rodents (Borsini and Meli, 1988; Cryan et al., 2005). 
Craft and colleagues (2010) found that postpartum female rats do not spend 
signiﬁcantly more time immobile than virgin controls during the ﬁrst postpartum 
week. However, they suggested that there are three differences between 
postnatal dams and virgin controls: postnatal dams defecate more than 
controls; spend less time swimming; and show less diving in comparison with 
controls dams (Craft et al., 2010). 
Work conducted by Smythe‘s group  (Smith et al., 2004) addressed the role of 
gestational stress on postpartum depression. In this study they have focussed 
on gestational stress and/or exposure to high levels of corticosterone during 
postpartum.  
Smith et al. (2004) found that gestational stress (restraint stress 1h/daily, days 
10–20) induces depressive-like behaviour and changes maternal care in the 
postpartum dam, thus suggesting that prenatal stress could be used as a model 
of postpartum depression (Smith et al., 2004).  
These results are in line with a later study by O'Mahony et al. (2006), who used 
1 week of chronic restraint stress (3×daily) during pregnancy and found higher 
immobility scores in the Porsolt test after birth (O'Mahony et al., 2006).  
Another study by Misdrahi et al. (2005) reported that chronic mild stress in mice 
causes increased corticosterone and estrogen levels in late-term pregnancy 
203 
 
which likely contributes to depressive-like behaviours postpartum (Misdrahi et 
al., 2005). While gestational or postnatal maternal stress may have elements 
that potentially serve to model postnatal depression, there are confounding 
variables for both: 
1- Gestational stress when the pregnant dam is subjected to chronic 
application of some aversive stimuli (e.g. restraint, noise, cold, shock), 
has the benefit of not directly interfering with mother-pup interactions at 
any point (Weller et al., 1988; F. Champagne, 2000; Weinstock, 2001; 
Smith et al., 2004; Champagne and Meaney, 2006). Thus, by its nature 
the source of stress is removed prior to delivery and the dam is not 
handled during the postnatal period which would entail removing the 
mothers from their litters (Meaney et al., 1988b; Wakshlak and Marta, 
1990; Smythe et al., 1996). This might produce an enforced effect of 
maternal separation, which by itself may impair/diminish maternal 
behaviours (Kuhn and Schanberg, 1998; Lehmann et al., 2000; 
Matthews and Robbins, 2003; Weaver et al., 2007). Loss of heat 
regulation in the nest might also occur and nest temperatures are known 
to affect HPA axis programming and maternal behaviour. We have not 
included maternal separation as a variable in our study because it has 
complex features that render it difficult to interpret (Kuhn et al., 1990; 
Huot et al., 2002; Kalinichev et al., 2002; Matthews and Robbins, 2003; 
Aisa et al., 2007). For instance acute and chronic maternal separation 
markedly affects the mother-pup interactions and it has greater impact on 
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fear and anxiety measures, rather than depression (Kalinichev et al., 
2002). 
2- The benefit of using a postnatal stress regime to induce mood alterations 
in the dams and investigate subsequent mother-pup interactions is that 
we can be certain that the development, gestational length and birth of 
the infant are completely natural. That is, we do not have to consider if 
both the mother and infants have been affected by a gestational stress 
regime. There are a priori reasons to be circumspect that the gestational 
stress affect the developing foetus; clearly the smaller litter size and 
slightly elevated pup mortality, speak concretely to this concern; whereas 
these are statistically insignificant, they repeatedly appear in our own 
work and that of others (Guo et al., 1993; Cabrera et al., 1999; Yorty et 
al., 2004). Obviously there is some direct foetal effect of maternal stress 
during gestation that impacts on the pups that cannot possibly be 
attributed to postnatal environment or maternal behaviour. The other 
repeated effect of gestational stress that is readily apparent but not often 
included in studies, is the almost immediate (seen within 12-24h of birth) 
increase in ultrasonic vocalisations (USV) emitted by stress-exposed 
pups (Bell et al., 1971; Williams et al., 1998a; Morgan et al., 1999; 
Branchi et al., 2001; Drugan et al., 2009). The presence of USV appears 
to precede any influence of postnatal maternal behaviours. 
Either gestational stress or postnatal stress elicit enduring alterations in the 
offspring readily measured in the post-weaning days such as affective 
alterations, HPA axis dysregulation and assorted behavioural changes involving 
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cognition, nociception and reward recognition (Boyle et al., 2005). For these 
maternal behaviour is of paramount importance, but we must cognisant of 
potential influences of maternal stress on either foetal physiology, development, 
differentiation and vitality as contributing factors to the range of changes seen in 
stress-exposed offspring as adults (and that interact/affect/contribute to any 
effects seen in the adult offspring due to maternal behaviour influences). 
Our data for the experimental day show that there was a significant effect of 
postnatal imipramine treatment on immobility times such that prenatally-
stressed Dams treated with imipramine exhibited a lower immobility times in 
comparison with Dams treated with vehicle. This effect means that imipramine 
restore normal behaviour caused by prenatal stress. This effect has been 
observed previously prenatally (Alonso et al., 1999; Frye and Wawrzycki, 2003; 
Morley-Fletcher et al., 2004).   
All major classes of antidepressants are sensitive to the Porsolt test, including 
tricyclic, selective serotonin and noradrenaline reuptake inhibitors, atypical 
antidepressants and monoamine oxidase inhibitors (Koe et al., 1983; Kulkarni 
and Mehta, 1985; Borsini and Meli, 1988; Cesana et al., 1993; Nixon et al., 
1994; Bourin et al., 1996; Redrobe et al., 1996; Da-Rocha et al., 1997; Sánchez 
and Meier, 1997).  
The immobility in the Porsolt test was considered as a model of depression 
(Porsolt et al. 1977a, 1977b) and thought to represent the psychomotor 
retardation (PR) shown by many depressed patients. Sobin and Sackeim (1997) 
have defined PR as a decreasing of motor and mental activity and this give us 
an important symptom of a major depression (Sobin and Sackeim, 1997). 
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There has been much advancement in behavioural studies for depression the 
most notable one being the behavioural immobility assessed by the Porsolt test. 
It provides adaptive disengagement from the persistent stress of swimming and 
with active escape forms part of the search-waiting coping strategy (Thierry et 
al. 1984).  
Alternatively immobility may reflect a specific state of the mammalian defence 
repertoire known as ―arrested flight‖ that is related with the psychological 
construct of ―entrapment‖ in clinical depression (Dixon 1998; Gilbert and Allan 
1998). Gilbert and Allan (1998) suggested that the defeat and entrapment 
scales may be a good set of tools to predict high stress mothers who are in risk 
for depression (Gilbert and Allan, 1998).  
Subjects will actively persist in escape-directed behaviours for longer periods of 
time if antidepressant treatments are given between the two exposure times. 
Conversely, in mice, one exposure is sufficient to generate a stable immobility 
readout that can be countered by acute pre-treatment with antidepressant 
agents (Borsini and Meli, 1988; Borsini et al., 2002; Cryan et al., 2002).  
Another study by Buccafusco and colleagues (2009) reported that the Porsolt 
test and tail suspension procedures are viewed as simple screening test for 
antidepressants rather than a model of depression, because the dependent 
variable (immobility) is a direct reaction to the test itself and does not persist 
outside the test situation (Buccafusco et al., 2009) i.e. it takes construct validity. 
There is no obvious induction of a ‘depressive state‘, although there are 
elements of construct validity (stressful inducing conditions and decreased 
behavioural output). Prior exposure to the aversive stress which constitutes a 
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learned helplessness procedure (model of depression) causes long lasting 
changes in animals, in that they are subsequently less able to learn appropriate 
escape responses (Telner and Singhal, 1984; Vollmayr and Henn, 2001; 
Buccafusco et al., 2009).  
It has been reported that long-lasting and frequent stress is probably required to 
produce a lasting change that could be construed as a ―depressive state‖ 
(Buccafusco et al., 2009). 
Previous studies by Borsini et al. (1989) and Piras et al. (2010) have 
demonstrated and confirmed the validity of Porsolt test over 2 days. The 
exposure to a pre-test swim session facilitates the development of immobility, 
and amplifies the effects of antidepressants during the test session performed 
24h later (Borsini et al., 1989; Piras et al., 2010).  
Studies report that the Porsolt test results are sensitive to monoamine 
alterations (Porsolt et al. 1977). To summarize, we can consider that ―The 
Porsolt test represents a very specific cluster of stress-induced behaviours (e.g. 
freezing, aggression, eating) that have no direct, empirical relation to 
depression symptoms in humans, but which are nonetheless exquisitely 
sensitive to monoaminergic manipulations (Porsolt et al., 1977b; Holmes and 
Rodgers, 2003; Petit-Demouliere et al., 2005; Duarte et al., 2006). The Porsolt 
test is a useful tool to study neurobiological and genetic mechanisms underlying 
stress and antidepressant responses using a range of mutational techniques in 
mice such as use of chemical mutagens to induce random mutations and then 
studying the resulting phenotypes (Porsolt 2000; Lucki et al. 2001; Nestler et al. 
2002). 
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In a more recent study by McCormick and Green (2012) confirms that the 
Porsolt is a widely used to model depressive symptomatology in rodents 
(McCormick and Green, 2012). Others have argued, however, that the test may 
be better characterized as a measure of passive behavioural reactivity to stress 
(Holmes, 2003b). Although the face and construct validity of the Porsolt test is 
questioned (Mosier, 1947; Cronbach and Meehl, 1955; Willner, 1984; Hendrie 
and Weiss, 1994; Willner, 1997; Townsley and Johnson, 2008), the test has had 
success as a screen for antidepressants and has predictive validity (Palanza, 
2001; O'Neil and Moore, 2003).  
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4.4 OFFSPRING PORSOLT (IMIPRAMINE) 
Our study of offspring from prenatally-stressed or control Dams, administered 
vehicle or imipramine from postnatal day 1-10 revealed some interesting data 
for the Porsolt test. Note again that these offspring were tested between 40-50 
days of age. We find that offspring of stressed Dams show enhanced immobility 
in the test and that maternal treatment with imipramine had some effect to 
reduce this response and that the effect is reduced by treating the mother with 
imipramine.  
If we accept that: 1) enhanced immobility of the stress-exposed offspring 
reflects a genuine depressive-like state of the animal; and 2) that the 
imipramine administered to the Dams over postnatal days 1-10, does not pass 
through the mothers‘ milk in any significant quantity, then we may reasonably 
conclude that the drug alters maternal behaviours, tending to normalities and 
the depressive-like behaviour of the offspring is almost entirely the result of 
gestationally-induced modifications of maternal behaviour. 
Our findings show that there is a significant effect of postnatal maternal drug 
treatment on offspring immobility times. These differences were not uniquely 
expressed in the offspring of stressed Dams, as imipramine decreased 
immobility times in both stressed and control offspring.  
Our results suggest that gestational stress produces a depressive-like 
behavioural effect in the offspring and this behaviour is modifiable with anti-
depressant treatment. We suggest that gestational-stress effects observed in 
the offspring are not directly affected by the in-utero stress exposure, but rather 
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are a result of secondary alterations in maternal behaviour that programme fear, 
anxiety and depressive-like tendencies of the offspring. 
Although the face, predictive and construct validities of the Porsolt model of 
depression have been reported (Koehl et al., 1999; Rao et al., 1999; Rhees et 
al., 1999; Lemaire et al., 2000; Morley-Fletcher et al., 2003; Morley-Fletcher et 
al., 2004) only imipramine and tianeptine (on a few parameters) reverse stress-
induced increases in immobility.  
Based on current and previous data, we suggest that prenatally stressed rats 
show depressive-like behaviour in the Porsolt test, i.e. prolonged immobility 
behaviour. Furthermore, as indicated above imipramine is expected to affect 
these immobility times, and our present findings with imipramine are in 
agreement with past research (Szymańska et al., 2009).  
In contrast to the significant action of all antidepressants in rats subjected to 
prenatal stress in the Porsolt test, fluoxetine, mirtazapine and tianeptine had no 
effect, while imipramine showed only a tendency to decrease immobility in 
control animals. In line with our results Morley-Fletcher et al., 2003, 
2004 showed that imipramine did not change and tianeptine even enhanced 
immobility times in unstressed rats.  
To recapitulate, gestational stress produces offspring that show evidence of 
depressive-like behaviour via heightened immobility times in the Porsolt test. 
This depressive-like behaviour responds to anti-depressant drugs as per animal 
models/screens in which naive rats are subjected to chronic, uncontrollable 
stress i.e. antidepressant act to reduce evidence of depressive-like behaviour 
as revealed by diminished immobility times. Thus, gestational stress produces a 
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―learned helplessness‖ response identical to that produced in normal rats 
subjected to a chronic stress regime. Our study now provides important 
information regarding this phenomenon.  
Gestational stress elicits depressive-like behaviours of the offspring via subtle 
alterations of maternal behaviour and these variant maternal behaviours are 
also somewhat modifiable by selective antidepressant drugs. 
Our data also reveal differences between female and male offspring, such that 
females from prenatally-stressed Dams‘ exhibit lower immobility times 
compared to males equivalents. Previous including studies show that prenatal 
stress produces gender-specific effects e.g. sexual behaviour, reproduction and 
the HPA axis is disrupted more in females than in males (Weinstock et al., 
1992; McCormick et al., 1995). Moreover behavioural responses including e.g. 
exploration, locomotion, anxiety and depressive-like behaviours reported can be 
gender specific (Braastad, 1998). 
Prenatally stressed rats show increased anxiogenic-like behaviour, expressed 
as a decrease in the time spent in the illumined areas of an open field (Vallée et 
al., 1997). The avoidance of anxiogenic environments is in line with data 
showing decreased exploration in the open arms of the elevated plus-maze 
(Fride and Weinstock, 1988; Zurita et al., 2000; Maccari and Morley-Fletcher, 
2007).  
Like the immobility-induced behaviour, studies have also found that the prenatal 
stress-induced anxiogenic-like behaviour is reduced by major antidepressant 
drug types (Morley‐Fletcher et al., 2003; Morley-Fletcher et al., 2004). Another 
study (Zienowicz et al., 2006) reported that fluoxetine increases anxiety in some 
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patients during the first few days of treatment and in experimental animals 
following a single injection (Belzung et al., 2001; Calatayud and Belzung, 2001; 
Zienowicz et al., 2006). Fluoxetine administered for 3 weeks had no effect in 
control rats, but produced anxiolytic behaviour in the offspring of prenatally 
stressed animals (Zienowicz et al., 2006). 
Numerous studies show that different types of stressors applied during the 
gestational period induces abnormalities in biological and behavioural functions 
of dams and their offspring (Becker and Kowall, 1977; Barlow et al., 1978; 
Power and Moore, 1986; Peters, 1988; Maccari et al., 1995b; Weinstock, 1997). 
Among those dysfunctions are depression, anxiety and changes in HPA axis 
activity (Alonso et al., 1991c; Weinstock et al., 1992; McCormick et al., 1995; 
Maccari et al., 2003a; Morley‐Fletcher et al., 2003; Smith et al., 2004).  
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4.5 EFFECTS OF GESTATIONAL STRESS ON POSTNATAL 
ANXIETY IN DAMS 
4.5.1 EFFECTS OF IMIPRAMINE 
Elevated plus maze (EPM) behaviour of control and gestationally-stressed 
Dams were assessed at 4 and 10 days postnatally. Our data showed no 
differences between stressed and control dams in times to enter the open arms 
of the EPM. Furthermore, our data show that stressed dams groom longer in 
the closed arms on day 4, although this effect is not significant by day 10.  
According to Leveleki et al. (2006) stress is one of the unavoidable etiological 
factors of a variety of anxiety disorders (e.g. separation anxiety, generalized 
anxiety, social phobia, acute stress disorder, Post-Traumatic Stress Disorder 
(PTSD) (Bassuk et al., 1986; Cox et al., 1991; Rafferty and Shinn, 1991; 
Pynoos et al., 1999; Lieb et al., 2000; Coupland, 2001; Dierker and Merikangas, 
2001; Jetty et al., 2001; Hunt et al., 2002; Kearney et al., 2003; Leveleki et al., 
2006).  
Acute stressors have also been reported to be effective on the behaviour 
exhibited by animals on the EPM; for example, immobilization, forced swim, 
electric shock, surgical stress and saline injection and predator exposure, all 
enhance anxiety (File, 1996; Hogg, 1996; File, 2001; Mackenzie et al., 2010). 
The intent of this assessment was to ascertain whether or not the augmented 
depressive-like behaviour seen in Dams following gestational stress might be 
generalized to other fear-associated responses. If such effects were present, 
would they be sensitive to anti-depressant drugs suggesting that any co-
morbidity was primarily depression in original. 
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Several studies on anxiety tests suggest that first trial exposure causes an 
unconditioned fear response, but 2nd trial exposure causes a learning 
avoidance (Rodgers et al., 1996; File et al., 1998; Pawlak et al., 2012). 
The elevated plus-maze (EPM) test is the most widely accepted test procedure 
to measure anxiety level in animals (Pellow et al., 1985; Rodgers and Dalvi, 
1997; Carobrez and Bertoglio, 2005).  
The advantage of the test is that it can measure the territory discrimination 
ability (Patin et al., 2005). The elevated plus-maze is assumed to gauge 
unconditioned anxiety-like behaviour or, expressed in more specific behavioural 
terms, unconditioned avoidance behaviour, which has been extensively used as 
an animal model for anxiety. 
It is based on the test-induced conflict between aversion of being exposed to an 
open and elevated platform and the motivation to explore a novel environment. 
As a consequence, the less anxious the subject, the more they explore the 
open arms.  
Prenatal stress causes an increase in closed arms exploration in the EPM test 
in the offspring showing that controls rats are less anxious than prenatally 
stressed rats (Fride et al., 1986b; Fride and Weinstock, 1988; Weinstock et al., 
1988; Wakshlak and Weinstock, 1990; Vallée et al., 1997). 
Our findings replicate that to same extent, although to our knowledge the first to 
assess gestational stress on the behavioural responses of the mothers. 
Studies examining the offspring of stressed/control mothers reveal that in rats 
and primates prenatal stress followed by increased anxiety-like behaviours 
(Schneider et al., 1992; Clarke and Schneider, 1993; Clarke et al., 1994; 
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Welberg et al., 2000; Coe et al., 2003). There are sex-dependent changes 
evident as prenatal stress appears to produce an i.e. anxiogenic response in 
females and anxiolytic response in males (Luine et al., 2007).  
Prenatal Stress appears to masculinize the female performance in anxiety tests 
and this would be consistent with others who report that prenatal stress induces 
masculinization of the female offspring in morphology (O‘Connor et al., 2003; 
Sachser and Kaiser, 1996).  
Traditional anxiety models do not consistently detect any anxiolytic effect of 
antidepressant drugs (File and Johnston, 1987; Pellow and File, 1987; Cole and 
Rodgers, 1995; Rodgers et al., 1997). These models e.g. EPM, conditioned 
freezing, light/dark transition, fear-potentiated startle, social interaction and 
conflict test models are widely used to screen the treatment of several anxiety 
disorders such as PD (J.C. Ballenger J.A. den Boer, 1994), OCD (Piccinelli et 
al., 1995) and GAD (Rickels et al., 1993; Tyrer and Tyrer, 1994).  
For our study we have used the tricyclic drug imipramine. Our findings revealed 
that there was a significant interaction between prenatal condition and postnatal 
drug treatment which shows that stressed dams treated with imipramine 
entered the open arms faster both days 4 and 10. It  was the first drug shown to 
improve anxiety (Klein and Fink, 1962), an observation confirmed by several 
controlled clinical assays (Liebowitz et al., 1988; J.C. Ballenger J.A. den Boer, 
1994).  
These studies made clear that only chronic administration of imipramine is 
effective. According to studies by Pohl et al. (1988) and Liebowitz (1989), in the 
first week of treatment, imipramine may even worsen anxiety (Pohl et al., 1988; 
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Liebowitz, 1989). In our current study it is clearly evident that our groups of 
animals given imipramine regardless of prenatal condition strongly support the 
above mentioned statement.  
The total time spent in the closed arms is much higher on the 1st trial compared 
to the 2nd trial. The most likely explanation for this is that the initial exposure led 
to habituation of the animals to the closed and open arms.  
According to Kahn et al. (1986) chronic, but not acute, imipramine 
administration has additionally been shown to ameliorate GAD, to an extent 
comparable to benzodiazepine anxiolytic (Kahn et al., 1986). In contrast, open-
arm aversion does not undergo habituation. It is quite obvious that the drug 
imipramine does have an effect on the open arm exploration.  
Accordingly it has been reported that repetitive testing in the elevated plus-
maze has been reported to either increase (Treit et al., 1993) or cause no 
change (Pellow et al., 1985; File et al., 1993) in avoidance performance i.e. 
changes in time spent in open arms or latencies to enter the open arms.  
Literature reviews report that social stress paradigms lead to both increased 
depressive and anxiogen-like behaviours (Keeney and Hogg, 1999; Berton et 
al., 2006; Schmidt et al., 2007; Krishnan and Nestler, 2010). However, to get a 
better understanding of the underlying mechanisms of each disorder separately, 
animal models producing either a depressed or anxious phenotype are required 
(Slattery et al., 2012).  
When we discuss anxiety as a phenomenon, we need to address other 
pathological conditions that are related to anxiety. Pathological anxiety consists 
of heterogeneous classes including, obsessive–compulsive disorder (OCD), 
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panic disorder (PD), post-traumatic stress disorder, phobias and generalized 
anxiety disorder (GAD) (American Psychiatric Association, 1994; Teixeira et al., 
2000). Researchers have attempted to correlate animal tests with particular 
types of clinical anxiety for example, OCD (Rapoport et al., 1992), PD (Fontana 
and Commissaris, 1988; Fontana et al., 1989; Hendrie and Weiss, 1994; Viana 
et al., 1994; Griebel et al., 1995; Jenck et al., 1995; Molewijk et al., 1995) , post-
traumatic stress disorder (Adamec and Shallow, 1993; Rasmusson and 
Charney, 2006) and phobia (Zangrossi and File, 1992; Zangrossi and File, 
1994). 
Researchers and the scientific communities have tried to correlate animal 
models of anxiety and anxiety disorders based on pharmacological responses 
of animals used clinically to treat human anxiety disorders. The most common 
anxiolytic used nowadays are the Benzodiazepines (BDZs).  
However, the effectiveness‘s of BDZs in the treatment of PA and GAD is limited 
now because low-dose SSRIs have been shown to have an anxiolytic profile 
rather than being antidepressant. The distinction may well come down to acute 
arousal/worry eliciting anxiety while if this state of arousal persists for some 
enduring time then depression may emerge. 
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4.6 OFFSPRING ELEVATED PLUS MAZE AND THE EFFECTS 
OF SERTRALINE 
Our data show that gestational-stress exposed offspring spent less time than 
control animals in the open arms of the EPM. This effect has been observed 
previously (Estanislau and Morato, 2005; Fride and Weinstock, 1988). Our 
findings have also show that offspring of stressed Dams spent less time in the 
closed arms and less time grooming in closed arms compared to offspring from 
control Dams.  
Females spent less time in the closed arms compared to males. Previous 
studies have reported that after prenatal stress, females are more anxious than 
males (Bowman et al., 2004; Gué et al., 2004). Furthermore, Depressive-like 
behaviour and anxiety can be seen in adult females more than males (Bowman 
et al., 2004; Richardson et al., 2006).  
Patin et al. (2005) reported that anxiety-like behaviour increase in male rats 
after two months of age, whereas, Lordi et al. (2000) reports this happens after 
three months of age. Studies carried out to detect the intrinsic anxiety-like 
behaviour of rats‘ suggests that differences in males and females can be seen 
at 60 days of age in the EPM and open field tests (Masur et al., 1980; Johnston 
and File, 1991; Imhof et al., 1993; Fernandes et al., 1999).  
Our results point towards a trend of the sertraline treated offspring rats to show 
less anxiety-like behaviour in the elevated plus maze than control rats. This may 
be because of the actions of serotonin on the amygdala (Davis, 1992). 
Anxiety-like behaviour increases during juvenile period after prenatal stress 
(Vallée et al., 1997). Other studies have reported an increase in anxiety-like 
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behaviour of prenatally-stressed rats in the elevated plus maze test between 
postnatal days 60-90 (Patin et al., 2005; Lordi et al., 2000).  
Baker et al. (2008) found that anxiety-like behaviour could not be detected in 
stressed/control rats at days 30-31 (Smith and Morrell, 2007; Baker et al., 
2008). However, our EPM was carried out between days 36-44.  
Gestational stress carried out on rhesus monkeys showed that offspring 
between days 90-145 exhibit signs of anxiety e.g. irritability, less exploration, 
clinging to companions and less social interactions (Schneider, 1992a; Clarke et 
al., 1994). 
Studies report that prenatal stress lead to an increased anxiety-related 
behaviour in primates and rats (Welberg et al., 2000; Coe et al., 2003). 
There are only a few behavioural studies measuring anxiety following TCAs and 
SSRI‘s treatment. In general, fluoxetine decrease anxiety as revealed by 
increased open arm exploration seen in treated rats (Konka and Bailey, 2010). 
This observation is corroborated with our current study. Meanwhile, that same 
study showed that control rats spent longer times in the closed arms of the EPM 
in comparison with fluoxetine treated rats, suggested that they were spending 
more time in the open arms. But, our study showed that sertraline treated rats 
spent more time in the closed arms compared controls.  
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4.7 MATERNAL BEHAVIOUR: EFFECTS OF GESTATIONAL 
STRESS AND TREATMENT WITH IMIPRAMINE 
Maternal behaviour is defined as those behaviours exhibited in preparation for 
arrival and care of the newborn. Ultimately these behaviours prepare dams for 
situations requiring protection, nursing and feeding of her infants. 
Grota and Ader (1969) defined maternal behaviour of rats as ―specific 
behaviours considered by observer to be maternal in character‖. Examples of 
rat maternal behaviours include: Arched Back Nursing (ABN), supine nursing, 
licking and grooming of the pups (L/G), pup retrieval, time in the nest, time out 
of the nest, nest building and Dams‘ self grooming. 
Maternal behaviour has been extensively studied in the rodent, particularly the 
rat. From the moment each pup emerges from the birth canal, the mother 
attends to each with vigorous licking and cleaning, and deposits each under her 
flank for warmth.  
Once all the pups have been delivered, the mother groups them together and 
adopts a nursing posture, allowing the pups‘ equal opportunity to attach to an 
available teat. By 4-12 hours after birth, the pups will be clean, grouped and 
have visible ‘milk-bands‘ in their abdomens showing that they have fed. 
Routinely, the dam will select a pup and lick around the genitor-anal region to 
stimulate urination and defecation. Her presence in the nest maintains the nest 
temperature at approximately 30-34 ⁰C. She may adopt supine or canopied type 
nursing positions and often sleeps in a supine position, allowing the pups to 
feed. The pups have little ability to crawl, but do paddle in an effort to find a teat. 
Once attached, they maintain a strong grip.   
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Lactation requires additional energy substrates and this demand necessitates 
the dams feeding quite frequently. They will walk away from the nest to locate 
food and water, and a few pups will be dragged out of the nest and detach from 
the teat. Upon her return to the nest, the dam may re-organise the structure, or 
move the pups to a new location and build a new nest. In any event she will 
search for pups (by sight and sound), dig in the bedding and retrieve all of them 
within approximately 10 minutes. She will leave the nest if she becomes over-
heated and lay in a remote spot on her back to dissipate heat. Once she has 
cooled, she may groom herself, feed or return to the nest.  
Normal dams give have litters of 8 to 16 pups and the number of males and 
females are almost equal (Wiesner and Sheard, 1933). Pups stay with their 
dam until postnatal day 22 and 30, when the pups are self-sufficient at feeding. 
The dam and her pups normally spend the majority of time in the nest, although 
this time decreases through postpartum period (Whishaw and Kolb, 2004). 
Our data overall, showed that stressed Dams spent less time in an arched-back 
nursing position (active posture) and relatively more time in a supine posture. 
Traditionally this has been viewed as being ―less nurturant‖ because the dam is 
not expending extra energy or effort for her pups‘ benefit.  
Combined with findings that stressed mothers frequently shift their nest 
positions, thereby disrupting the contiguity of pup care, the data suggest 
strongly that these stressed Dams are less interested in their litters. Rather, 
they seem to be more defensive and guarded, perhaps shifting the nest 
positions in some virtual attempt to avoid detection from a predator, or being 
exposed to foreign male rats. She minimizes her energy expenditure towards 
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the pups, presumably maintaining greater energy reserves to ensure her own 
health and possibly to maximize her chances to escape should the need arise.  
Rats dams generally start building the nest during pregnancy; the architectural 
features of the nest vary in shape and quality, and we found some differences 
between stressed and control Dams for this. 
Our study documented distinctive patterns of nest location and construction for 
the various groups; control with vehicle, control with drug, stressed with vehicle 
and stressed with drug. In general we were able to distinguish among different 
types of nests and match these with the corresponding group by the quality of 
the structure. Although our sample size provides limited data they suggest that 
nesting behaviour largely reflects the Dam‘s behaviour. For example, non 
stressed Dams nests showed competent nest building and the pups were neatly 
encased by a deep nest wall. All the pups were observed in the centre of the 
nest with a clear, even distribution of nesting material around them. Meanwhile, 
stressed Dams‘ nests appeared to have incomplete walls and the nests 
themselves were loose and dispersed over a larger portion of the cage. The 
pups were not packed together compared to non stressed mothers‘ nests (see 
appendix). 
Our data show that all Dams spent less time in a supine position, less 
licking/grooming and less presence in the nest as the litters got older. Licking 
and grooming can be observed (e.g. during nursing, before and between 
retrieval) (Whishaw and Kolb, 2004). However, during the active phase (light 
off) rat dams spend up to 50% of their time L/G either themselves or their pups 
(Bolles, 1960). Our results are at odds in other studies where there were no 
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differences between stressed dams and non stressed in time spent ano-genital 
licking offspring (Melniczek and Ward, 1994). 
Our data show there was an interaction between the postnatal drug treatment 
and day of testing (3, 5 and 7), suggesting that stressed Dams treated with 
imipramine spent more time retrieving pups, more time L/G inside the nest, less 
time in the nest and less nest building especially on PND5 and PND7. 
We found for the Porsolt test that prenatally stressed Dams exhibited 
depressive-like behaviour, which may explain changes in the Dam‘s maternal 
behaviour. 
Stressed Dams showed less arched back nursing of their pups. Arched-back 
nursing times were diminished in the Dams treated with imipramine, an effect 
that can be seen by postnatal days 5 and 7.  
Studies report that desipramine is the active metabolite of imipramine; however, 
desipramine is highly selective for the noradrenaline transporter in the rat 
(Owens et al., 1997; Cryan et al., 2005). Possibly we do not see a drug 
response until day 5 because imipramine must be metabolised to desipramine 
at diminished concentrations, and a response is delayed. Thus the effects of 
imipramine cannot be seen in first three postnatal days.  
Stressed Dams treated with imipramine spent more time in a supine position 
compared with stressed Dam treated with vehicle; moreover, control Dams 
treated with imipramine also spent more time in this posture as the pups got 
older.  
We found that stressed Dams exhibited more self-directed behaviours such as 
licking/grooming themselves in comparison to the non-stressed controls. Our 
224 
 
interpretation for this is either the Dam is more easily distracted or fearful and 
less inclined to devote energies towards excessive pup care. 
Numerous studies have revealed that rat offspring emotive and cognitive 
behaviours can be affected by prenatal stress (Sontag, 1966; Chapman and 
Stern, 1979; Stern and Lonstein, 2001; Smith et al., 2004). Studies have found 
that prenatally stressed dams spend less time caring their pups than 
themselves (Whishaw and Kolb, 2004).  
Francis et al. (1999) found that the offspring‘s behaviour and HPA stress 
responses were correlated with spontaneous differences in L/G and ABN of the 
dams. Those offspring from dams which exhibiting more L/G and ABN showed 
less anxiety, and appeared to produce modest HPA responses to acute stress 
challenge in comparison to offspring receiving less spontaneous L/G and ABN 
from their dams (Francis and Meaney, 1999).  
Furthermore, changes in the offspring‘s behaviour could be predicted by the 
levels of ABN and L/G seen as early as 3 days postnatally.  
Retrieval of pups is a measure of the ―motivation‖ of the dams and it is 
suggested that responsive dams retrieve pups quickly and efficiently, whereas 
less or non responsive dams retrieve pups much slower (Whishaw and Kolb, 
2004). 
Kristal (1990) suggested that several systems coordinate maternal behaviour 
including: 
(1)The sensory and cognitive system; (2) motivation and reward system; (3) 
learning and memory system; (4) emotion and stress system; and (5) motor 
output system. This means, maternal behaviour can be affected from 
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neurotransmitters and hormones release during prenatal and postnatal periods 
that have direct or indirect impact (Kristal, 2009).  
Our data lead us to suggest a rational for why stressed Dams show reduced 
maternal care of their infant. Gestational stress elicits depressive-like behaviour 
altering maternal care over postnatal days. It was suggested previously that 
prenatal stress could be used to model of human postnatal depression (Smith et 
al., 2004). Our present data corroborate and extend this finding by showing that 
some stress-induced changes in maternal behaviour are modified by 
antidepressants. 
Beck (1994) reported that certain factors may trigger PPD in women, for 
example, prenatal stress, child care stress, support and prior life stress (Beck, 
1994). Andrews-Fike (1999) suggested that women who have any of those 
factors should be under observation during the postpartum (Andrews-Fike, 
1999). Treatment of PPD is difficult because antidepressants are seen unsafe 
or unnecessary (Murray and Kelly, 2002). As an illness it still goes 
unrecognised by health care workers and other family members. 
Failure to identify and treat PPD may have serious consequences for mother 
and child. For instance PPD disturbs mother-infant interactions and leads to 
slower social and emotional development in children (Field et al., 1990; Stein et 
al., 1991) and may impair cognitive development and thus educational 
attainment.  
For instance, depressed mothers show greater impatience and dissatisfaction 
with their infants. During face-to-face interactions, depressed mothers appear to 
be more insistent that their babies react to play, talking and facial expressions 
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(Cohn et al., 1990). The babies appear over-whelmed by this assault of noise 
and visual stimuli and react by withdrawing, crying or turning away from the 
mothers. Mothers interpret this avoidant response in a negative manner, 
express exasperation and desist with further contact. They identify the baby‘s 
withdrawal as ‛I haven‘t bonded with my child‘. The baby learns that to avoid 
this excessive demand for attention, it needs to avoid eye-contact or become 
agitated and cry. Thus the baby begins to reinforce the mothers‘ errant 
perception of bonding and the aberrant interactions persist. 
One of predisposing factors or predictive sign of postpartum depression is 
anxiety. Women assessed with elevated anxiety during the postnatal period 
have a greater incidence of postpartum depression (Dalton, 1971; Hayworth et 
al., 1980; Bridge et al., 1985). However, our data do not show any consistent 
effects of gestational stress on Dams‘ anxiety-like behaviour levels. Anxiety-like 
behaviour during gestation may serve as stressor.  
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5. General Discussion 
In humans, the development of affective disorders (e.g. depression, bipolar 
disorders, etc) can result from early life adverse experience such as inadequate 
parental care, abuse, or nutritional deprivation (Bifulco et al., 1997; Harris et al, 
1990; Bifulco et al., 2002; Lenze et al., 2008). 
The main aim of our investigation was to determine if disruptions of maternal 
behaviour following prenatal stress exposure might contribute to the behavioural 
and physiological consequences seen in the offspring. Furthermore, we 
explored the notion that impaired maternal behaviour in rats might model 
human postnatal depression, and therefore, whether or not antidepressant 
drugs would act to restore normal maternal behaviour in prenatally-stressed 
Dams or otherwise alter them. 
If impaired maternal behaviour of the dam represents a form of postpartum 
depression, then we expected to see higher immobility times in the Porsolt test. 
If these higher immobility times are valid constructs of rat postnatal depression 
then immobility times should be reduced by administration of antidepressant 
drugs. Moreover, if the impaired maternal behaviour is the result of a 
depressive-like state in the dams, then these behavioural alterations should be 
ameliorated by antidepressant drugs. Thus, we assessed the effects of prenatal 
stress, and postnatal antidepressant treatment on dam‘s maternal behaviour, 
immobility scores in the Porsolt test, and examined the offspring to ascertain if 
reinstating or normalising maternal behaviour would prevent gestational stress 
influences on them.  
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Fundamentally, it was essential to establish the initial premise that gestational 
stress impairs maternal behaviour. Rat maternal behaviour is dominated by 
characteristic features including retrieval and nesting of the pups, arched-back 
and supine nursing, ano-genital licking and grooming, and in line with Meaney‘s 
group regarding spontaneous variations in maternal behaviour, high-nurturant 
mothers and low-nurturant mothers can be identified. High-nurturant mothers 
produce offspring which have reduced HPA axis hormone activation in acute 
stress challenge tests, are less anxious and show better cognitive skills.  
The particular maternal behaviours that appear to have paramount importance 
for programming the offspring with less responsive HPA axis and fear 
responses are arched-back nursing (ABN) and licking/grooming (L/G).  
In our initial report (Smith et al., 2004) we observed that gestational stress 
exposure during last 10 days of the pregnancy reduced the amount of ABN and 
L/G exhibited by dams. In the present study, we again see gestational stress 
effects on maternal behaviour as evidenced by: Stressed Dams spent 
significantly less time in arched back nursing postures, and more time in a 
supine position. However, when in the nest, they spent the same amount of 
time licking and grooming their pups as control Dams did. However, stressed 
Dams did not spend as much time in the nest. 
The lower time spent by the stressed Dam in the nest is indicative itself of a 
lower level of care. Thus, gestational stress lead to a reduction in the care given 
by the Dams to their offspring compared to non-stressed control Dams. 
We also found that prenatal stress resulted in a slight but non-significant 
retardation of both the mothers‘ pregnancy weight gain, and that of the litters. 
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Such effects were absent after 9-10 days postnatally. The initial diminished 
postnatal weight gain of the litters again reflects that stressed dams were less 
attentive to nursing their pups, and devoted less time for it (Barlow et al., 1978; 
Herrenkohl and Whitney, l976; Rhees and Fleming, 1981; Williams et al., 
1998b; Smith et al., 2004). 
There were no effects of prenatal stress on gestation duration, litter size nor on 
pup postnatal mortality in agreement with our previous report (Smith et al., 
2004; Baker et al., 2008). 
The Dams treated with antidepressant drugs (sertraline or imipramine) from 
postnatal days 1-10 had a lower weight gain in comparison to control dams that 
had been treated with vehicle. Treatment with sertraline of dams had no 
significant effect on litter weight gain or pup survival. However, Dams 
administered imipramine showed diminished weight gains throughout the 
treatment period. 
In terms of behavioural changes we found that there was a tendency for 
stressed Dams to show greater immobility in the Porsolt test measured on 
gestational days 17 and 18. 
Previous work shows that chronic restraint and chronic mild stress increases 
immobility times in the Porsolt test, and our results agree with these (Platt and 
Stone, 1982; Harro et al., 1999; Häidkind et al., 2003; Darnaudéry et al., 2004; 
Smith et al., 2004; O‘Mahony et al., 2006). However, there was a significant 
effect of postnatal imipramine treatment on Dams‘ immobility times such that 
Dams administered imipramine exhibited reduced immobility times in 
comparison with the vehicle treated groups. In general, immobility was 
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decreased by antidepressant drugs, an effect previously established (Porsolt et 
al., 1977b; Porsolt et al., 1978; Barros and Ferigolo, 1998; Morley-Fletcher et 
al., 2004; Buccafusco et al., 2009; Gutiérrez-García and Contreras, 2009; 
Hesham El Refaey, 2011).  
Our results also showed that offspring of stressed Dams exhibited variable 
immobility times in comparison with control offspring and the offspring of 
stressed Dams treated with imipramine generally exhibited reduced immobility 
times. Other studies have found that offspring of prenatally-stressed dams show 
increased immobility times (Alonso et al., 1997; Alonso et al., 2000; Morley-
Fletcher et al., 2003). Hence, we suggest that the effect of imipramine on Dams‘ 
maternal behaviour may help to reduce abnormalities in offspring behaviour 
caused by prenatal stress.  
A good animal model is unique to a particular illness or pathological state. Since 
our intent was exploring the relationship between gestational stress and 
postnatal depression, we examined maternal behaviour in the EPM. If 
gestational stress merely results in a variety of affective changes then its utility 
as a model is questionable. Thus our rational for testing the intrinsic anxiety 
state of the Dams was to exclude a general effect on the Dams.  
Overall, there were no differences between total time spent in the closed and 
open arms of the EPM. In general, anxious rats avoid the open arms and thus 
our Dams showed little evidence of anxiety-like behaviour (Wakshlak and 
Marta, 1990; Poltyrev et al., 1996; Vallée et al., 1997; Prut and Belzung, 2003; 
Rimondini et al., 2003; Darnaudéry et al., 2004).  
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The implications of prenatal stress are broad. Retrospective analysis of 
emotionally disturbed youths and their maternal influences indicates that stress 
experienced by the mother during pregnancy contributes both physiological and 
psychological towards the development of childhood psychopathology (Ward, 
1991; Huizink et al., 2004). Similarly, retrospective studies have found 
associations to exist between prenatal stress and depression, psychosis, 
hyperactivity and alcoholism (Weinstock, 1997; Weinstock, 2001).  
Environmental insults during gestation, illness, stress, fear, abuse, or even pre-
existing depression places mothers at risk for developing postnatal depression. 
Depressed mothers disengage from their infants, and report less bonding with 
them. The longer-term impact on the children is often harsh and places them at 
greater risk for health problems, social isolation, poorer socio-economic 
achievement, and numerous psychopathologies. And yet the relationship 
between the mother and child remains unexplored in terms of hormonal and 
physiological systems that trigger and sustain appropriate maternal care and 
mother-child bonding: what has remained elusive is a biological test system that 
might give us answers to these important questions; the gestational stress 
model of postnatal depression may afford us this opportunity.   
Given that we are proposing rat gestational stress as a putative model for 
human postnatal depression it is worthwhile to re-visit the concepts and 
principles that govern model specifications.  
An animal model should reflect the behaviour or illness seen in a human 
condition, and meet the same criteria as much as possible given the animals‘ 
unique overt profile and behavioural repertoires. Thus, externally-observable 
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behaviours or symptoms in humans should mirror those in rats and vice-versa. 
The underlying physiological dysfunctions should be almost identical, insofar as 
the affected structures show evolutionary autology. 
Finally, we should be able to modify the rat‘s physiology a similar manner as we 
do in humans administered treatments for their affliction. The effectiveness of 
these treatments in humans should be equally effective at altering the 
behaviour, or physiological functioning of the rat in its performance under model 
conditions.  
These principles are encompassed in the concepts of face, construct and 
predictive validities respectively. Many researchers focus only on construct 
validity in which it is expected that the illness and its underlying pathology are 
genuinely represented in the animal in structures analogous to those of the 
human. Stress has long been accepted to be a preceding or permissive factor 
that promotes and underpins major clinical depression. Animal stress models 
rely on the theoretical and historically empirical work of Martin Seligman 
originating some 40 years ago. His rational was that human depression had as 
its foundation an underlying component of personal ineffectiveness and mis-
guided belief that internal/external conditions were imposed and immutable. As 
often expressed in clinically-depressed patients, they were ‘helpless‘ to amend 
their circumstances, because they perceived that the ‘locus of control‘ over their 
lives resided externally, beyond their influences.  
The abundant literature detailing stress effects on animals confirmed that 
chronic stress procedures performed in various animal species inevitably 
increased passivity and helplessness. Animals will stop struggling, remain 
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motionless and show acceptances of their circumstances, even through 
opportunities to escape or avoid the aversive situation are made available to 
them. Thus every animal or rat model of depression measures the degree to 
which animals become passive following exposure to chronic aversive stimuli. 
The Porsolt task is a simple and reliable, assessment of passivity (i.e. time 
spent immobile) that meets and corroborates Seligman‘s ideas. 
A key to understanding the relationship between learned helplessness and 
human depression is also provided through the pioneering efforts of Aaron Beck 
(1961). His investigations with depressed patients confirmed that depressive 
people express openly that they are unhappy, feel unable to alter their 
circumstances, and that external factors govern their lives. Patients with a 
history of life-stressors (death in the family, frequent switching of schools, 
moving house, birth of children, separation), are much more likely to suffer a 
major depressive illness at least once in their lives. 
There is widespread agreement that the Porsolt task sufficiently measures 
passive states in rats, and that these passive states are elicited by preceding 
stress. Stress also produces alterations in monoamines and endocrine systems 
in rats that are largely identical to physiological measures recorded from 
depressed subjects. Thus following stress passivity is seen as a genuine 
measure of a depressed affective state of the rat. Therefore, the Porsolt test 
measures the intrinsic mood (depression) of the rat and our use of it here to 
measure the learned helpless state of our gestational stressed dams confers 
construct validity to our gestational stress model of postnatal depression. 
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Arguably the most important feature of an animal model is its utility to identify 
and test existing treatments or novel treatments to investigate the physiological 
and biological constituents of a particular disease or illness. If the model has 
construct validity then correspondingly, the existing therapies used to treat 
human patients should alter the animal in a predictable fashion indicative of 
reduced impairment. Thus for the Porsolt test, stress elicits greater immobility, 
or passivity, and since our construct defines this immobility as ‘depression‘, then 
known antidepressant drugs should diminish this immobility response. 
Conceptually this logic appears unassailable, and indeed there are hundreds of 
studies that confirm antidepressants act to reduce immobility of rats exposed to 
the Porsolt, or equivalent tasks, albeit with some variation according to the 
antidepressant class, dose, preceding stimuli used to invoke stress, and the test 
parameters of the Porsolt itself (water temperature, depth, duration of test). 
However, it is worth noting that in human depression, antidepressant 
effectiveness is on the order of 60-65%, i.e. some 35% of depression is largely 
refractory to conventional treatments. Parsimoniously we must regard the 
variations in responsiveness to antidepressants as expected, given the variation 
of human responsiveness. In the present work we have seen that reductions of 
maternal behaviours caused by stress were somewhat ameliorated by 
antidepressant treatment (imipramine) and that elevated immobility times 
recorded in the Porsolt test also showed signs of abatement. Together these 
findings would confirm or at least provide positive support that the gestational 
stress model of postnatal depression has some predictive validity. 
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Neither the construct or predictive validities render the gestational stress model 
of postnatal depression particularly compelling, nor have we advanced the 
science in the field in any particularly novel manner. However, the often 
overlooked feature of face validity may well represent the significant 
improvement for the field of stress and depression research that our proposed 
model offers. The concept of face validity entails examining both the 
circumstances that predispose the animal and human that leads them to 
acquire pathological condition. If the outward behavioural manifestations of an 
illness in rats and humans are identical or closely-resemble, one another, we 
can claim that on appearances the rat is depressed.  
A different model may offer insight to this issue, for example, the overt motor 
impairments and motor-initiation deficiencies seen in Parkinson disease are 
faithfully replicated by various lesions targeting the substantia nigra in the rat. 
The lesioned rat serves as a model for the symptomatology of PD, and has 
construct validity (PD patients have degeneration of the substantia nigra), and 
predictive validity as both lesioned rat and PD patient respond to drugs that 
mimic the transmitter action of the missing neurons. But in no way does the 
lesioned rat have PD, and Parkinson‘s patients have not suffered some 
extraneously produced insult of the substantia nigra. The lesioned rat does not 
have the illness, and its behavioural perturbations have been manufactured 
using artificial means. 
In our opinion the gestational stress model of postnatal depression may 
represent the first rat model that sufficiently satisfies face validity criteria. We 
believe the evidence to date from our work, and that of others, collectively 
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supports the contention that the gestational stress model has construct and 
predictive validities insofar as human depression can be theorized to involve 
‘learned helplessness‘ and that antidepressants can be claimed to ameliorate 
depressive symptoms for many patients. Women with postnatal depression 
disengage from their infants, and in many instances report that they feel less 
attached to their babies. They provide basic and adequate care for their infants, 
or indeed allow other family members to undertake maternal care in a 
secondary fashion.  
Gestational-stressed rat dams also show less inclination to expend more energy 
or effort for their pups‘ nurturance leading to very similar conclusions that both 
human and rat have divested themselves of excessive maternal care. Based on 
this argument by visual inspection we would conclude that as the human is 
suffering from postnatal depression, then too the gestationally-stressed rat dam 
is exhibiting a rodent equivalent to postnatal depression. Thus from overt and 
obvious similarities between human and rat, we arrive at the logical position that 
the rat is depressed and ergo the rat gestational stress model of postnatal 
depression satisfies the necessary conditions to possess face validity. 
The addition of face validity is of enormous value for research purposes. First, 
the rat can be used to model human postnatal depression without relying on 
some extreme, artificial stimulus to initiate the disorder. Admittedly restraint-
stress during gestation is an artificial manipulation that has been applied in the 
present work. But stress has many natural causes both in humans and rats, and 
these natural sources of stress/distress (e.g. cold, nutritional deprivation, 
exposure to predators) should also produce similar effects on rat maternal 
238 
 
behaviour as does restraint. The point is that we do not have to artificially 
manipulate the animal in order for it to mimic the human disorder. As such we 
can investigate the underlying physiological changes that occur in these 
stressed dams and expect identical or near identical physiological changes in 
the human. 
Second, the existence of face validity lends considerable support and 
justification for the already-accepted construct validity. If the construct validity is 
genuine and based on the overt behaviour rather than matching physiological 
markers, and a posteriori explanations such as learned helplessness, then the 
explanation of the construct is of less importance. Learned helplessness may or 
may not be the underlying issue for depression, but if we satisfy face validity, 
then whatever the name used for the construct is less bothersome. 
Gestationally-stressed rat Dams show postnatal depressive-like behaviour, 
regardless of whether or not ‘depressive-like behaviour‘ is accounted for by 
some nominal description termed ‘learned helplessness‘. 
There is still much work to undertake to explore the areas discussed above, and 
perhaps none as essential as ensuring that natural or similarly natural stimuli 
actually elicit the maternal behaviour changes seen following restraint stress in 
rat Dams. Still we feel that the compelling nature of the apparent existence of 
face validity propels this particular model to the top of pile.  
Finally, it is often reported by researchers that face validity offers little to 
researchers, because it simply adds the confounding difficulty that we 
anthropomorphisis our animals, and give them human features. Because of this 
we begin to search for those features and become distracted from the task at 
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hand. We believe that this is a fallacious argument; surely the essential point of 
creating an animal model is to replicate as precisely as can be possible all 
aspects of a human disorder. We do not confer upon the animal human 
characteristics, we recognise in the animal, as its behavioural and physiological 
repertoire permit, the features that match those seen in human pathological 
states.  
Models which claim face validity are derided for engaging in anthropomorphical 
mis-direction, perhaps because face validity is almost non-existent for most 
animal models. It may reflect some dissonance that critics engage with; since 
they cannot obtain a model with face validity, its value and importance is not 
only minimized, but its inclusion or addition to a speculative model is denoted 
pejoratively as merely an anthropomorphical confound. 
Finally, on this point, we fail to appreciate or comprehend the criticism of face 
validity based on this anthropomorphic argument. It is simply contradictory to 
ignore the obvious fact that both construct and predictive validities are also 
based on ascribing to the animal, or rat, the expected theory or explanation for 
a given pathological state in humans. Of course ‘learned helpless‘ explains the 
aberrant thought patterns of depressed humans, because the rat in that 
situation has also learned to be helpless. Antidepressants have some efficacy in 
the treatment of human clinical depression; ergo we expect learned helpless 
behaviour of the rat to be relieved following antidepressant treatment. We 
interpret the animal responses in light of how humans respond, and this is 
simply another form of anthropomorphising the rat and giving it human 
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characteristics. This criticism cannot be used to disavow the value of face 
validity without having a similar outcome for construct and predictive validities. 
Although a conclusive case for the gestational stress model of postnatal 
depression in the rat will require further proof and empirical study, we believe 
our present research adds significant evidence in its support. Whether or not 
the model will bear up under intensive scrutiny remains to be seen, but its 
potential utility in postnatal depression research could be of enormous value to 
researchers, clinicians and patients. It is our hope that other research groups 
begin examining and refining the model to accelerate its validation. 
  
Suggestions for progressing the work and 
possible ideas for development 
It is expedient to be circumspect with these data, or indeed any behavioural 
data. We acknowledge that our sample sizes are relatively small, and we base 
the issue of predictive validity using only single doses of either imipramine or 
sertraline. However, the best science can offers itself for inspection and 
replication. It is essential that extramural and independent corroboration. One 
key element in human postnatal depression is the often unrecognised impact 
the children. This we feel must an integrated be area for investigation in parallel 
with the research on maternal behaviours and therapies for postnatal 
depression. In order to ascertain if early-life adversity carries across 
generations, i.e. is a veritable epigenetic trait or if early intervention strategies 
with depressed women alters these putative generative occurrences. As such 
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future efforts should examine the rat gestational-stress model for generational 
effects, by carrying out intervention strategies (such as antidepressants), and 
adoption/cross-fostering of stress-exposed offspring to non-stressed controls, 
and vice-versa. In this way we may begin to explore and prevent the incidence 
of familial depression associated with postnatal depression. 
 
Conclusion 
Our findings confirm that Dams show depressive symptoms following 
gestational stress, and that administration of antidepressants to the Dams 
reduced depressive-like behaviour and increased maternal care. 
We propose that rat gestational stress is a putative model for human postnatal 
depression. Prenatal stress effects on maternal behaviour in the rat Dam 
represent a novel, and innovative model for human postnatal depression. It had 
been a goal of the present work to study both maternal behaviour and its 
modification by gestational stress as one approach by some of our team 
experimental (in relation to our breeding/methodologies), while team having 
offspring assessments done in parallel studies by a second team. The current 
research was structured and extended by one team only, because of staff 
movements and turnover. This is certainty by not to say that the results 
obtained the one team approach are unduly impacted by this, and indeed the 
majority of labs working in this field appear to manage work by establishing a 
single team. But a disappointment in these overall findings is the inevitable loss 
of the breath and range of data by not possessing the recourses to 
comprehensively measure everything that is occurring. This is principally a 
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feature of the limited data collected for the offspring e.g. infant vocalisations, 
and dedicated study of how pups contribute directly to any perturbations of their 
mothers behaviours. Hopefully we can identify the mechanism of transmission, 
and develop strategies to truncate or prevent the regenerative cycle that 
contributes to the familial expression of postnatal depression. 
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Total Pregnant Non Pregnant
1 20 17 3 0
2 20 16 4 1
3 20 18 2 0
4 20 18 2 2
5 30 25 5 1
8 40 37 3 2
Total 150 137 19 6
3 (embryo resorption)
4 (embryo resorption)
2 (embryo resorption)
 Eaten pups (stressed))
Eaten pups (stressed)
Table summarizing the breeding success, and distribuation of Dams and
their litters total numbers of animal were used
*Run#
Dams
Mortality in Dams
141
Mating
Prenatal
Nots *Pups Number
127
110
* Two runs (6+7) were terminated due to unspecified infection and prolonged, abnormal pregnancies.
* Cull to 10/mother.
No obvious difference in litter size. Birth numbers always permitted both control + stressed. Litters to be cross-fostered and culled to 10 
pups/Dam. Overt differences in live births between the stressed and non-stressed Dams would ha
During gestation (stressed)
86
167
210
841
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Offspring Porsolt for Females only 
Figure below shows the immobility times for offspring (Females) of control and 
prenatally-stressed Dams. The offspring (Females) selected for this test were 
chosen randomly from Dams who had undergone restraint stress or were left 
undisturbed, during gestation and had been treated either with imipramine 
(15mg/kg) or vehicle (saline) once daily on postnatal Days 1-10. Offspring, 
females were underwent Porsolt testing between days 40-50 of age.  
An ANOVA on the data from Exposure Day (Panel A), revealed a significant 
effect of prenatal condition on females offspring immobility times with 
(F(1,62)=16.7, p<0.0001), which showed that female offspring of prenatally-
stressed Dams exhibited lower immobility times in comparison with control. 
Moreover, there was a significant effect of treatment on females immobility 
times with (F(1,62) =3.8, p<0.05), showed that female offspring of stressed 
Dams were treated by imipramine exhibited lower immobility times in 
comparison with those from control Dams.  There was no significant effect of 
females immobility times X prenatal condition interaction for these data with 
(F(1,62)=2.04, p<ns). An ANOVA on the data of Experimental Day (Panel B) 
revealed a significant effect of prenatal condition on females immobility times 
with (F(1,62)=10, p<0.002), showing that a female of prenatally-stressed Dams 
exhibited lower immobility times in comparison with control Dams. Moreover, 
there was no significant effect of treatment on females immobility times with 
(F(1,62)=2.2, p<ns). There was a significant effect of females immobility times X 
prenatal condition interaction for these data with (F(1,62)=5.3, p<0.02), showing 
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imipramine reduced immobility times and effect that was evident only for female 
of stressed Dams. 
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A. Exposure Day (10min) 
 
B. Experimental Day (5min) 
 
Figure: Immobility times for the Porsolt task recorded from female’s offspring of gestationally stressed and 
Control rat Dams on the Exposure and Experimental Days, when offspring had reached 40-50 days old.  
Data shown are Means ± SEM. 
* Significantly different, p<0.05, Bonferroni t-test. 
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Offspring Porsolt for Males only 
Figure below shows the immobility times for offspring (Males) of control and 
prenatally-stressed Dams. The offspring (Males) selected for this test were 
chosen randomly from Dams who had undergone restraint stress or were left 
undisturbed during gestation and the Dams had been treated either with 
imipramine (15mg/kg) or vehicle (saline) once daily on postnatal Days 1-10. 
Offspring, males were underwent Porsolt tests between days 40-50.  
An ANOVA on the data of Exposure Day (Panel A) revealed a significant effect 
of prenatal condition on males immobility times with (F(1,65)=8.7, p<0.004), 
which showed that male offspring of prenatally-stressed Dams exhibited lower 
immobility times in comparison with offspring of control Dams. Moreover, there 
was no significant effect of treatment on males immobility times with 
(F(1,65)=2.02, p<ns). There was no significant effect of males immobility times 
X prenatal condition interaction for these data with (F(1,65)=0.184, p<ns). 
An ANOVA on the data of Experimental Day (Panel B) revealed a significant 
effect of prenatal condition on males immobility times with (F(1,65)=4.5, 
p<0.04), showing that male offspring of prenatally-stressed Dams exhibited 
lower immobility times in comparison with male offspring of control Dams. 
Moreover, there was no significant effect of treatment on males immobility times 
with (F(1,65)=0.12, p<ns). There was no significant effect of males immobility 
times X prenatal condition interaction for these data with (F(1,65)=1.65, p<ns). 
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A. Exposure Day (10min) 
 
B. Experimental Day (5min) 
 
 
Figure: Immobility times for the Porsolt task recorded from female’s offspring of gestationally stressed and Control 
rat Dams on the Exposure and Experimental Days.  
Data shown are Means ± SEM. 
* Significantly different, p<0.05, Bonferroni t-test. 
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EPM DAMS: 
Numerous studies carried out on anxiety found that the most commonly tests 
used to assess the symptoms of anxiety- like behaviour in rodents are open 
field (OFT), elevated plus maze (EPM) and light–dark box (LDB) (Ramos, 
2008).  
Open field test consists of a large arena (larger than the rodent‘s cage) with 
high walls to prevent the rodents escaping. In this test mice or rats try to avoid 
the central of the arena. Thus, it is normally measure the time spent in the 
center of field, numbers of defecation and the first minutes of rodent‘s activity, it 
is used to assess anxiety- like behaviour and general locomotor activity levels in 
rodents (Hall, 1934; Archer, 1973; Walsh and Cummins, 1976; Gray, 1979; 
Suarez and Gallup Jr, 1981; Tachibana, 1982; Prut and Belzung, 2003; 
Stanford, 2007). 
The light-dark box (LDB) or black-white box (BWB) consists of two 
compartments connected to each other through a small opening. One 
compartment is smaller, black and non-illuminated and the other is larger, white 
and brightly lit, the test lasted for 5 minutes. Mice or rats explore the black 
compartment and try to avoid the white compartment, thus, the measures of 
exploration white compartment (e.g. entrances, time and locomotion) are used 
as experimental indices of animals behaviour especially anxiety-like behaviour 
(Crawley, 1981; Costall et al., 1989; Chaouloff et al., 1997; Bourin and Hascoët, 
2003). 
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Table showing animals number in each experiment 
Type of experiment 
Type of group 
CV CD SV SD 
Dams prenatal weight 46 as Control 42 as Stressed 
Dams postnatal weight (Sertraline) 10 13 10 11 
Dams postnatal weight (Imipramine) 10 13 10 11 
Offspring weight (Sertraline) 44 68 43 45 
Offspring weight (Imipramine) 35 30 35 35 
Prenatal Porsolt 19 as Control 22 as Stressed 
Postnatal Porsolt (Imipramine) 8 10 10 9 
Offspring Porsolt (Imipramine) 17 15 16 18 
Dams EPM (Imipramine) 2 2 4 2 
Offspring EPM (Sertraline) 45 67 43 45 
Maternal behaviour  4 6 5 5 
 
